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SUMMARY OF RESEARCH 
Bladder cancer is among the most common cancers in the UK, responsible for 
significant patient morbidity. Current techniques for detection suffer from low 
sensitivity, particularly for early stage disease, therefore new techniques are urgently 
sought.  
Among the suggested techniques to augment bladder cancer detection is the use of 
autofluorescence spectroscopy. Autofluorescence arises from a number of molecules in 
human tissue, giving a wealth of structural and metabolic information. 
Autofluorescence spectroscopy has previously been applied to the detection of a wide 
range of cancers, however clinical implementation of the technique to bladder cancer 
diagnosis is inhibited by a poor understanding of the contributions of individual 
fluorophores to autofluorescence. I sought primarily to use the multi-functional laser 
based diagnostic system “LAKK-M” to study the autofluorescence profiles of bladder 
cancer at the cell and tissue level, with the aim of developing a better understanding of 
bladder autofluorescence characteristics in health and disease. The significant findings 
of this research are threefold: 
1. Autofluorescence flow cytometry of cell optical redox ratio reveals metabolic 
abnormalities in bladder cancer cells, specifically a glycolytic switch in bladder 
cancer cells culminating in an increased optical redox (NADH/flavin, 
ex360em425-475/ex488em515/545) ratio relative to healthy bladder cells. 
2. Lab grown bladder cancer organoids show progressive changes in 
autofluorescence ratios relative to control samples – specifically reductions in 
the NADH/flavin (ex365em490/ex365em550), elastin/NADH 
(ex365em450/ex365em490) and elastin/flavin ratio 
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(ex365em450/ex365em550), suggestive of structural and metabolic changes in 
developing cancer.  
3. Analysis of human bladder tissue reveals significant differences in key 
fluorophores and diagnostic ratios between healthy and cancer tissue, 
amounting to increased porphyrin fluorescence and a decreased optical redox 
ratio (ex365em490/ex365em550) in cancer tissue compared to healthy control.  
These findings better inform our understanding of the autofluorescence properties of the 
bladder in health and disease at both the cell and tissue level, contributing to future 
development of diagnostic techniques. Additionally, in this thesis, I discuss the 
diagnostic worth of collagen analysis in bladder cancer using second harmonic 
generation imaging, the application of bladder tissue computer simulation to better 
elucidate fluorophore properties, and progress in novel laser therapy techniques for 
bladder cancer. The ultimate goal of this research is the development of a combined 
laser-based system for bladder cancer diagnosis and therapy.  
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1. INTRODUCTION  
1.1 Introduction to bladder cancer 
1.1.1 Bladder anatomy  
The human urinary bladder is the organ responsible for storage and excretion of human 
waste products in the form of urine. Anatomically, it consists of walls of functional 
detrusor muscle surrounding a trigone area containing the urethral opening. Alongside 
the urethral opening are two ureteric orifices. The ureteric orifices transport urine 
produced by the kidneys to the bladder for storage. Upon bladder emptying, the detrusor 
muscles contract, pushing urine through the urethral sphincter and out through the 
urethra. Due to the physiological nature of the bladder in the storage of urine, it has 
immense contractile and expansive properties, afforded by the bladder rugae (series of 
internal folds). The structure of the bladder is detailed below in Fig.1.  
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Figure 1 Cross-section diagram of the bladder showing major anatomical features  
On a tissue level, the bladder is composed of three main layers: the mucosal layer, 
containing the transitional epithelium/urothelium; submucosa, containing blood vessels 
and the underlying connective tissue of the lamina propria; and the muscular layer, 
containing the detrusor muscle which forms the main bladder wall (Fig.2).  
 
Figure 2 The main layers of the bladder wall 
The role of the muscle layer is to promote bladder constriction upon voiding, while the 
urothelium is crucial for its function in maintaining a barrier between the tissue and the 
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outside world. The urothelium is similar to many other epithelial cell types in similar 
locations in contact with the outside world - such as the oral cavity – however it 
displays high elasticity to allow for the contractive and expansive properties of the 
bladder. Due to its location, the transitional cells which make up the urothelium are 
repeatedly exposed to toxins and potential pathogens on a day-to-day basis, leaving the 
bladder susceptible to infection, inflammation and malignant transformation.  
1.1.2 Bladder cancer incidence 
Bladder cancer (BCa) is among the most common cancers worldwide. In the UK, 
10,341 new BCa diagnoses are made each year, making it the 9th most common cancer 
in the UK, 4th most common in men1. Of the new cases of BCa reported each year, some 
90% affect the transitional cells of the urothelium, referred to as transitional cell 
carcinoma (TCC). The remaining 10% of diagnosed BCa cases consist primarily of 
squamous cell carcinomas (much more common in developing countries)2 and 
adenocarcinoma3. The 10 year survival rate of bladder cancer is around 50% and 
decreases with age (all incidence and mortality statistics taken from Cancer Research 
UK1). There are a number of risk factors suggested and proven to play significant roles 
in the development of BCa, including gender4,5 and race5. Cigarette smoking in 
particular has been demonstrated as an important prognostic factor in BCa 
development5,6 and shown to have an effect on disease recurrence and progression7. 
BCa risk is also known to be associated with occupation8 - possibly due to exposure to 
chemicals such as polycyclic aromatic hydrocarbons (PAHs)9 – risk is also associated 
with incidence of diabetes (in men)10. Toxins contained in cigarette smoke and PAHs 
are excreted in the urine – therefore the bladder, particularly the transitional cells at the 
luminal surface, as an interface with these toxins represents a common target for 
mutagenic effects and malignant transformation.  
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1.1.3 Diagnosis, staging and grading 
The gold standard methods for diagnosing BCa are as follows: patients presenting with 
pain and haematuria (blood in their urine) submit urine samples for voided urine 
cytology (VUC) by a trained pathologist11. VUC involves microscopic examination of 
slides containing urothelial cells shed in the urine, allowing pathologists to identify 
cellular abnormalities such as nuclear enlargement. Patients with positive urine cytology 
are scheduled for a routine cystoscopic examination using a fibre optic white light 
source, allowing the consultant to view inside the bladder for suspicious areas and 
lesions. This process, known as white light cystoscopy (WLC), is the most commonly 
used modality. Furthermore, WLC can be used in conjunction with surgical techniques 
to remove suspicious tissue by a process called trans-urethral resection of bladder 
tumour (TURBT). The tissue removed during TURBT is then sent to expert pathologists 
for detailed staging and grading. 
Of the ~9500 cases of TCC identified in the UK each year, some 75-80% will be 
classified as non-muscle-invasive bladder cancer (NMIBC), meaning the tumour, which 
has arisen in the urothelium, has not penetrated into the underlying muscular layer. By 
contrast, the remaining 20-25% of cases will be muscle invasive and penetrate through 
the urothelium into the underlying muscle. Muscle invasive bladder cancer, if not 
adequately dealt with, has the potential to be fatal. Muscle invasion in bladder cancer 
largely dictates the course of therapy. Often, small papillary lesions from NMIBC can 
be adequately dealt with by TURBT followed by intravesical instillation of 
chemotherapeutic agents such as Mitomycin C. By contrast, muscle invasive disease 
can often only be adequately dealt with by removing the entire bladder to prevent the 
spread of disease to lymph nodes and metastatic sites12. Radical cystectomy, the 
removal of the entire bladder, is a life-changing procedure for patients with muscle 
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invasive disease, with associated risks such as infection, blood clots and impotence, 
therefore it is imperative that bladder cancer is detected and treated as quickly as 
possible.  
NMIBC itself can pose a threat to patients, owing to its potential to recur and progress. 
NMIBC is a broad category which contains many stages and grades of cancer with 
varying degrees of aggressiveness. Reliable staging and grading of tumours is carried 
out on resected biopsy tissue by experienced pathologists. Grading and staging 
nomenclature for BCa are listed below (tables 1 & 2) and disease stages are depicted in 
Figure 3: 
Table 1 BCa grades and descriptions 
Grade Description 
Grade 1 Normal appearance and slow growing 
Grade 2 Moderately aggressive and abnormal 
Grade 3 Extremely abnormal; poorly differentiated 
 
Table 2 BCa stages and descriptions 
Stage Description 
Carcinoma in Situ (CIS) High grade flat lesion which exists only in 
the urothelium with aggressive potential 
Ta A tumour, often papillary, which exists 
only on the luminal lining of the bladder 
T1 Invasion into the lamina propria 
T2 Muscle invasion 
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T3 Invasion through muscle into adipose layer 
T4 Invasion out-with the bladder 
 
 
Figure 3 Diagram showing the layers of bladder tissue along with progressing stages of 
BCa from CIS to invasive stage T4 
Therefore, although NMIBC, and although early stage, CIS presents a dangerous flat 
dysplasia stage owing to its high grade and invasive potential13. BCa can also be 
characterised by incidence of metastasis and by local lymph node involvement.  
Although widely accepted as gold standard diagnostic procedures owing to their high 
specificity and low false positive rates, WLC and VUC often suffer from low 
sensitivity, particularly for early stage NMIBC. WLC is a useful technique for the 
detection and observation of papillary lesions but less so for flat lesions, including CIS, 
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and for small tumour margins during resection. It is estimated that the overall sensitivity 
of VUC for TCC cases is between 25%14 and 50%15 depending on the study, 
particularly lacking sensitivity for low grade cancer15. For WLC detection of TCC, 
sensitivity ranges from 60%16 to 70%17 but can be as low as 4% for CIS18. The lack of 
sensitivity of these gold standard techniques means many otherwise preventable early 
cancers are allowed to recur and progress to more dangerous forms. According to 
CRUK statistics in 2014, 42% of preventable BCa cases were missed1. The high rates of 
recurrence and progression associated with BCa mean it is essential to provide 
diagnosed patients with stringent follow-up monitoring months and years after initial 
diagnosis and intervention. These factors significantly affect patient quality of life and, 
furthermore, put a considerable burden on the health service each year. Monitoring and 
intervention strategies, along with patient lay-up time in hospitals and the necessity of 
having experienced consultants and pathologists on hand make BCa an expensive 
disease to manage19. BCa is estimated to be the single most expensive cancer to treat per 
patient on a lifetime basis, amounting to roughly £65 million pounds in costs per year in 
the UK. It is evident, then, that new avenues must be sought to improve the sensitivity 
of diagnostic techniques for BCa - particularly aggressive, early stage NMIBC such as 
CIS – to promote early diagnosis, effective monitoring and reliable identification of 
surgical margins. 
1.1.4 Photodynamic diagnosis and therapy 
In recent years, many efforts have been made to improve on the sensitivity of current 
gold standard techniques to promote earlier diagnosis and more effective disease 
follow-up. Progress has been made in improving the sensitivity of both urinary and 
cystoscopic examinations for bladder cancer, but at a cost.  
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The advent of photodynamic diagnosis (PDD) using photosensitising dyes (PS) has seen 
improvements to sensitivity for both cystoscopic and urinary examination for BCa 
detection. PS agents, including Hexaminolaevulinate (HAL) and 5-Aminolaevulinic 
Acid (5-ALA) have been developed to preferentially accumulate in tumours. The 
preferential accumulation of PS agents in tumours can be explained by the enhanced 
permeability and retention effect (EPR), whereby cancer cells lose lymphatic drainage 
and expression of adhesion molecules20, causing them to be more loosely distributed 
and creating “leaky” gaps between cells. It is thought that this morphological change in 
cancer cells allows them to participate more freely in invasion and metastasis. Changes 
in environmental pH in cancer cells also contribute to the preferential uptake and 
retention of PS agents. PS agents such as HAL and 5-ALA are precursors in the process 
of the heme biosynthetic pathway. Heme metabolism is often  elevated in cancer cells, 
therefore inundating cells with HAL and 5-ALA causes accumulation of the fluorescent 
heme precursor Protoporphyrin IX (PpIX) in cancer cells21. PpIX strongly absorbs and 
emits blue and red light, respectively (PpIX also strongly absorbs red light)21,22. 
Instillation of the bladder with PS, followed by illumination with blue light during 
cystoscopy, enables surgeons to clearly visualise tumours owing to their bright red 
fluorescence. Although we will cover the subject in much greater detail in the following 
section, fluorescence can broadly be described as a process by which an excited 
molecule can release energy to return to a relaxed state. The absorption of energy, in the 
form of blue light, by PS agents causes them to emit energy in the form of red light 
(Figure 4).  
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Figure 4 Diagram showing the standard technical setup for tumour PDD. Tumour area 
selectively accumulates PS agents, strongly fluorescing red under blue excitation.  
PDD has been shown to significantly increase sensitivity of detection of bladder cancer, 
leading to lower recurrence rates compared to WLC23,24, also dramatically increasing 
the sensitivity of CIS diagnosis16,18,25. PDD using HAL has recently been recommended 
by a panel of urologists in the USA for diagnosis and surveillance of NMIBC26. 
Furthermore, PDD has shown diagnostic worth as an adjunct to urinary cytology, with 
voided urine cells from carcinoma displaying increased porphyrin fluorescence 
compared to healthy cells27,28. Bladder tumour detection by WLC (left) and PDD (right) 
is shown in Figure 5. 
Tumours are not the only tissue type which display leaky architecture, however: it is 
often noted that inflamed and infected tissue contains loosely packed epithelial cells, 
permitting the accumulation of PS agents. Several studies have now recognised that, 
although significantly more sensitive for bladder cancer diagnosis, PDD is a less 
specific methodology than its counterpart, WLC17,19. Reduced specificity and increased 
false positive rate of PDD is particularly noticeable after previous intravesical therapy29. 
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As a result of the practicalities of PS instillation and the increased false positive rates 
seen with PDD, it is considered a more costly option than WLC30 – the costliness of 
PDD is suggested for further review31. The monetary and diagnostic costs to using PDD 
must therefore be carefully weighed against the benefits of increased sensitivity. There 
is ongoing work in the field by many research groups to increase the specificity of PS 
localisation for PDD regimens32.  
 
Figure 5 Comparison of cystoscopic images of BCa obtained using WLC (left) and PDD 
(right) courtesy Cauberg Evelyne et al.33 (reproduced with permission under a CC 
Attribution Non-commercial Share Alike License) 
The same processes of absorption of light which contribute to tissue fluorescence in 
photodynamic diagnosis can also be utilised to selectively kill cancer cells, in a process 
known as photodynamic therapy (PDT), covered expertly here34. PS agents possess a 
strong probability to enter a longer-lived excited triplet state, allowing time for the 
excited PS to interact with molecular oxygen and cellular components. Entry of the PS 
into a longer-lived triplet state is necessary for effective PDT While PDD relies on 
excited singlet state PS agents relaxing to ground state by emitting fluorescence, PDT 
relies on the donation of molecular energy from the excited triplet state PS agent to 
surrounding molecules via type I and type II reactions. The reactions between excited 
PS agents and nearby molecules generate reactive oxygen species (ROS). The 
generation of high levels of ROS within cells is associated with cell toxicity35 owing to 
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modification and denaturation of fatty acids36, DNA37 and peptides38. Of particular 
importance in PDT are type II reactions, whereby excited PS agents donate energy 
directly to molecular oxygen to form singlet oxygen (1O2). Singlet oxygen is potently 
reactive and rapidly affects surrounding cell organelles, particularly the 
mitochondria39,40, leading to apoptosis (Figure 6), necrosis (Figure 7) and long lasting 
anti-tumour immune response41,42. It has been suggested that the mechanism of PS 
action can have an effect on the mode of death a cell experiences (apoptosis or 
necrosis)41. Targeting of the mitochondria during PDT via messengers such as Bax and 
Bcl-2 has been suggested to lead to quiescent apoptotic cell death through the release of 
apoptotic messengers to the nucleus (Figure 6). Conversely, targeting of the lysosome 
or cell membrane during PDT has been suggested to lead to necrotic cell death and the 
release of danger signals, promoting inflammation (Figure 7). PDT has enjoyed ongoing 
success in cancers other than BCa, including skin cancer43. In BCa, PDT enjoys 
considerable success as a tissue sparing therapeutic modality, particularly in patients 
who fail to respond to intravesical Mitomycin C instillation.  
 
Figure 6 Molecular pathways following PDT leading to apoptosis. Photosensitiser (PS) 
excited by 405nm light enters a stable triplet state, donating energy to molecular 
oxygen to form singlet oxygen. Effects of singlet oxygen on mitochondria causes release 
of apoptotic messengers to the nucleus, leading to quiescent apoptotic cell death. 
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Figure 7 Molecular pathways following PDT leading to necrotic cell death. 
Photosensitiser (PS) excited by 405nm light enters excited triplet state, donating energy 
to form singlet oxygen and ROS. Interaction between singlet oxygen and ROS with cell 
membrane and lysosomal membrane, leading to membrane rupturing, necrotic cell 
death and release of danger signals. 
 
Alongside the specificity issues associated with PDD using PS agents, PDT efficacy, 
especially for deeper lying tumours, can be hampered both by the penetration of PS dye 
and activating light into tissue, leading to incomplete clearance of tumour areas. 633nm 
light can penetrate up to 20mm into bladder tissue44, which may cause limited tumour 
clearance in areas of extensive epithelial thickening. Recurrence at 30 months was 
found to be around 40% for PDT treated NMIBC patients45. Furthermore, high fluence 
rates can cause healthy tissue necrosis and inflammation46. In an animal model of PDT, 
irradiation was associated with tissue fibrosis, epithelial sloughing and haemorrhaging, 
depending on the light dose47. New technologies are therefore required for PDT, 
possibly at longer wavelengths, to increase tissue penetration and avoid aberrant side 
effects on tissue.  
1.1.5 Nuclear Matrix Protein 22 (NMP22) and other urine analysis techniques 
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Similarly, efforts are ongoing to increase the sensitivity of urine analysis modalities for 
BCa, especially for early stages such as CIS. Urine analysis presents an attractive 
alternative to WLC for diagnosis and follow up of disease as it is completely non-
invasive and can be performed in an out-patient environment, reducing patient 
morbidity and associated costs. These tests rely on the detection of shed urinary 
biomarkers such as nuclear matrix protein 22 (NMP22)48, chromosomal abnormalities 
(Urovysion)49 or bladder tumour antigen (BTA stat)50. The NMP22 test has been shown 
to display increased sensitivity compared to VUC48 while also being cost effective51, 
however it displays reduced specificity compared to VUC52,53 and is adversely affected 
by a number of factors, including urinary tract infection54. Due to confounding factors 
which may cause false positives and the need for experienced operators, NMP22 test 
has been suggested as not recommendable for application as a point of care test55 or as a 
follow up test to replace WLC56. Similarly, BTA stat does not possess adequate 
sensitivity for follow up56.  
1.1.6 Diagnosis and therapy in the context of “The Hallmarks of Cancer” 
In 2000, Hanahan and Weinberg published the seminal paper “The hallmarks of 
cancer”57, updated in 2011 as “The next generation”58. In these comprehensive reviews, 
the fundamental differences between healthy and cancer cells are discussed, with the 
aim of exploiting these differences to develop new methods for cancer diagnosis and 
therapy. The key features highlighted by Hanahan and Weinberg are reproduced below 
(Figure 8): 
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Figure 8 The "Hallmarks of Cancer", according to Hanahan and Weinberg57 
(reproduced with permission from Elsevier) 
Broadly, cancer cells will drive genetic instability and mutation and deregulate their 
metabolism to enable them to adapt to new environments, often the poorly oxygenated 
environments of the tumour inner core. This, coupled with inducing angiogenesis and 
invasive behaviour allows cancer cells to escape their native environment and migrate 
(metastasise to distant regions of the body). In addition to promoting metastasis, 
angiogenesis also provides cells in growing tumours with the nutrients they require to 
continue replicating (aided by enabling replicative immortality). From this we can see a 
wide range of factors which could contribute to the malignant and invasive phenotype 
of aggressive BCa, the scope of which is far too large to adequately cover here. Below 
is a quick summary of how some of the classical hallmarks of cancer may apply to BCa, 
and how these may be used to better diagnose and treat the disease.  
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1. As briefly discussed earlier, the induction of angiogenesis by developing 
tumours – a hallmark of cancer – is a factor which is taken advantage of by the 
use of photosensitising agents and other drugs. The weak, leaky vessel walls of 
tumours is much more penetrable to PS agents than are the surrounding healthy 
tissues, leading to preferential uptake of PS into tumours.  
2. The theoretical basis of urinary fluorescence in situ hybridisation (FISH) tests 
such as Urovysion is that of genomic instability in cancer cells. By targeting 
mutations in bladder cancer cells, including to the p16 tumour suppressor gene, 
pathologists can non-invasively assess the presence of bladder cancer from 
patient urine49. Tests such as the NMP22 test also rely on genomic instability – 
alongside cancer cell ability to enable replicative immortality – by targeting 
nuclear matrix proteins, which are expressed at much higher levels in rapidly 
replicating bladder cancer cells59. 
3. Inflammation associated with tumours can provide a strong indicator of 
suspicious lesions when inspecting the bladder using WLC. Often, bladder 
tumours show up visibly redder than healthy tissue, however this can also prove 
misleading in cases of benign inflammation such as urinary tract disease. 
Furthermore, tissue inflammation can contribute to blood vessel leakiness (to 
promote immune cell extravasation), enhancing tissue uptake of PS agents. 
Inflammation has been implicated in pathogenesis of many cancers, including 
breast cancer (through mediators including cyclooxygenase and 
prostaglandins)60, ovarian cancer (via C-reactive protein)61 and gastric cancer 
(via Toll-like receptors)62. In particular, IFN-y induced inflammatory mediators 
have been implicated in a wide range of cancers63. COX-2 has been suggested to 
play a role in bladder cancer64, as has C-reactive protein65. C-reactive protein 
levels can also be used to predict outcomes in bladder cancer66.  
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Two of the main hallmarks of cancer which will provide the focus of this thesis are the 
deregulation of cellular energetics (through the Warburg effect) and the invasion of 
tissue by growing tumours. As will be seen, these hallmarks provide ways with which to 
study the onset and progression of bladder cancer, with promising real world 
applications for disease detection.  
1.1.7 Next generation diagnosis and therapy 
To improve diagnosis and reduce patient morbidity and associated treatment costs, there 
has been a great deal of research in recent years with the aim of improving the 
sensitivity of BCa diagnosis without having to compromise on specificity. The need for 
diagnostic tools which balance sensitivity and specificity has opened up many new 
avenues of research, some displaying strong promise.  
The PS agent Hypericin, taken from St. John’s wort, has been suggested as an upgrade 
on conventional PS agents such as 5-ALA and HAL67, owing to its improved specificity 
compared to these agents. HY uptake by tumours is hypothesised to occur by different 
mechanisms than those which dictate conventional PS uptake. These are likely 
structural changes in tissue, possibly including changes in Cadherin and Catenin 
levels68. Specificity of BCa diagnosis using Hypericin has been recorded as high as 
98%69, a considerable upgrade on the specificity levels achieved by conventional PDD. 
Hypericin can also be instilled directly into the bladder, offering an improvement on the 
systemic administration of first generation PS agents by avoiding the risk of non-
specific toxicity and skin photosensitivity (although HY can still display phototoxic 
effect on healthy tissue70). Furthermore, HY possesses an increased absorption 
maximum compared to conventional PS agents (540-590nm vs 400nm for HAL/5-
ALA) - as it does not rely on PpIX accumulation – allowing for deeper tissue 
penetration by activating light. Direct instillation of HY into the bladder is, however, 
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associated with increased patient lay-up time, for up to several hours prior to inspection. 
D’Hallewin et al. discuss this69 as one of the drawbacks of Hypericin use – Hypericin 
must also be in direct contact with all bladder areas during instillation, excluding the use 
of this technique for patients presenting with diverticula or other related health issues. A 
further drawback to the use of Hypericin is its lipophilicity, meaning it forms aggregates 
in aqueous solutions. This is a significant issue to the clinical application of Hypericin 
based diagnosis, with several research groups focussing on the development of new 
strategies to better solubilise Hypericin71,72.  
Many research groups have focussed their attentions on nano-applications for photo-
diagnosis and therapy of BCa. In particular, functionalised quantum dots (QD) have 
been suggested as a suitable theranostic tool owing to the high quantum yield of QDs, 
along with their high degree of specificity afforded by functionalisation with 
monoclonal antibodies against tumour specific antigens. QD excitation and emission 
profiles can be tightly regulated by particle size, allowing wavelength specific targeting 
of molecules and tissues of choice. A major concern which has limited the 
implementation of nano-medicine is the accumulation and systemic toxicity of quantum 
dots, gold nano-rods and others. Valizadeh et al. discuss in great detail the synthesis, 
potential applications and toxicity concerns associated with QDs73. The development of 
biocompatible QDs for clinical application is considered by Rosenthal et al.74.  
Along with improving the sensitivity and specificity of diagnosis, a major aim of 
current research should be working towards non- or minimally-invasive techniques 
which are capable of grading and staging tumours without the needs for repeat 
cystoscopy and biopsy. In recent years a major focus has been on the development of 
diagnostic imaging techniques which rely on inherent structural or molecular properties 
of tissue. These techniques aim to create “fingerprints” of tissues of interest, 
corresponding to particular structural or molecular contributions. Within this field there 
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is a wide scope of techniques available for the analysis of tissue constituents. Liu et al. 
expertly cover the current standing of a wide range of novel diagnostic techniques, 
including laser endomicroscopy, optical coherence tomography (OCT) and narrow band 
imaging (NBI), particularly focusing on the need for clinical prospective studies using 
these techniques75. We ourselves have also reviewed the current standing of novel 
optical techniques for bladder cancer diagnosis76. Some of the most promising 
endogenous imaging techniques for BCa will be discussed here. Firstly, NBI is a 
technique which relies upon differential absorption and scattering of light by blood 
vessels, permitting straightforward observation of tumour vasculature and increased 
urothelial contrast to clinicians. NBI is gaining recognition and beginning to become 
implemented in clinical settings by affording improved sensitivity of BCa detection77,78, 
increased quality of TURBT79 and reduced recurrence rates after TURBT (comparable 
to PDD)80. An NBI image is compared to the same tissue site under WLC in Fig. 9. 
 
Figure 9 Comparison of TCC of urinary bladder imaged using WLC (left) and NBI 
(right) courtesy Cauberg Evelyne et al.33 (reproduced with permission under a CC 
Attribution Non-Commercial Share Alike License) 
NBI requires detailed post-processing and image analysis by trained professionals to 
obtain useful diagnostic information. In addition, NBI provides little information on a 
molecular level, therefore it may not be a suitable technique for providing optical 
biopsies including staging and grading reports.  
Page 40 of 232 
 
Scott Palmer  July 2016 
To obtain detailed molecular information about tissues of interest, Raman spectroscopy 
is undergoing development into a potential clinical modality, demonstrating diagnostic 
worth in the detection of cervical81, oral82, skin83 and brain cancer84 as well as bladder 
cancer at the tissue85,86 and cellular level87,88. Raman spectroscopy relies on the process 
of “Raman scattering”, by which molecular components of cells and tissues interact 
with light, causing specific energy shifts in accordance with the specific molecular 
properties of tissue. Raman spectroscopy can therefore give detailed information on the 
presence and quantity of amino acids, carbohydrates and lipids, etc. in tissue, allowing 
analyses of any differences between the levels of these components in healthy and 
cancerous tissue. Crow et al. have demonstrated reliably high sensitivity and specificity 
BCa diagnosis (>90%) using a Raman microscopy setup89, indicating potential as a 
diagnostic modality to provide the sensitivity lacking from conventional WLC 
alongside specificity missing from PDD. Crucially, In vivo application of Raman 
spectroscopy can be hampered by out of focus signals which reduce the specificity of 
diagnosis (discussed by Barman et al.90). Steps are being made to improve the 
specificity of In vivo imaging modalities by reducing the out of focus signal90 but this 
remains a major barrier in the clinical application of Raman spectroscopy to BCa 
diagnosis.  
Another useful technique for structural imaging of tissue is second harmonic generation 
(SHG) imaging, generally using pulsed femtosecond infrared lasers. This process relies 
on the inelastic interactions between light and molecules with non-centrosymmetric 
surfaces. The biophysical processes by which SHG occurs will be discussed later. By 
far the largest contributor to SHG in human tissue is type I collagen91, with collagen 
destruction or modification leading to a loss in SHG signal intensity. Changes in SHG 
signal intensity can therefore be used as a non-invasive indicator of cancer. 
Furthermore, changes to the orientation of collagen fibrils during carcinogenesis can be 
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identified and used as diagnostic markers, as demonstrated in breast92 and ovarian 
cancer diagnosis93. Conklin et al. discovered hallmark signatures, known as “tumour 
associated collagen signatures” in SHG imaging of breast cancer, suggesting the worth 
of these signatures for disease diagnosis94. Conventional setups used for SHG imaging 
generally also allow for multi-photon fluorescence microscopy, therefore multi-modal 
imaging of epithelial cells and underlying connective tissue is afforded by this 
methodology95. Non-linear imaging, particularly SHG, is still poorly investigated in 
BCa, with preliminary studies setting out optimal measurement techniques in mouse 
models96 or clinical studies with small sample sizes97,98. The clinical data derived from 
patient biopsy in97 and98 show good correlation with histopathology data, suggesting the 
diagnostic worth of this modality for bladder cancer, particularly CIS. Larger scale 
studies are undoubtedly required into SHG imaging of BCa, to determine the true 
diagnostic worth and clinical application of this modality.  Thomas et al. consider that, 
in general, there are very few studies applying clinical SHG imaging to an In Vivo 
setting (with the exception of skin cancer) and that this is the next big step towards 
developing it as a clinical modality99.  
1.1.8 Autofluorescence Spectroscopy 
A useful method for incorporating the structural elements of SHG with the detailed 
molecular profiling provided by applications such as Raman spectroscopy is the use of 
autofluorescence spectroscopy (AS)100. AS works similarly to PDD, with the exception 
that no PS is added to tissue. Instead, the signals received from tissue arise entirely from 
inherent molecules of interest. Tissue autofluorescence spectroscopy can give 
information on the presence and quantity of a wide range of diagnostically relevant 
molecules, including amino acids, lipids, metabolic cofactors and heme precursors. 
Molecules of interest can be specifically targeted and studied in tissues (either using 
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lasers or broadband illumination sources) based on the intrinsic excitation and emission 
properties of the molecule of interest. The most commonly studied endogenous 
fluorophores in human tissue are listed in table 3 below:  
Table 3 Common endogenous tissue fluorophores (courtesy Wikipedia.org) 
Molecule Excitation (nm) Emission (nm) Role 
Tyrosine  270 300 Amino acid, protein 
component 
Tryptophan 270-280 300-350 Amino acid, protein 
component 
Collagen 270-370 300-450 Structural protein 
Elastin 340-390 400-450 Structural protein 
NADH 350-400 450-490 Metabolic cofactor 
Flavin 350-450 500-600 Metabolic cofactor 
Lipofuscin 410-530 500-700 Lysosomal pigment 
Porphyrin 550-650 700-710 Heme pathway 
 
Therefore fluorescence spectroscopy of tissue using different wavelengths of excitation 
light will provide spectral information with very different molecular information about 
tissue. UV spectroscopy provides structural and metabolic information based on 
fluorescence from contributors such as collagen, elastin, NADH and flavins, while at 
longer wavelengths, red light can be used to study heme pathway precursors.  
Autofluorescence imaging in animal tissue was first described in the early 1900s, using 
microscopy setups with UV excitation sources to capture the fluorescence properties of 
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cartilage, bone, skin and other tissues101. In the 1980s, researchers including Alfano et 
al. had begun to utilise UV light sources to demarcate breast cancer based on 
autofluorescence imaging102. Autofluorescence imaging has previously successfully 
been applied to detection and analysis of ulcerative colitis103, diabetes104 and macular 
degeneration105 in addition to a wide range of cancers106,107, being comprehensively 
reviewed by Ramanujam100. AS has been reported to greatly improve the accuracy of 
laryngeal cancer detection108. He et al. report a greatly improved sensitivity but reduced 
specificity of AS for lung cancer compared to gold standard white light 
bronchoscopy109, lack of specificity of AS has been corroborated in oral cancer by 
Awan et al.110. The first recorded application of autofluorescence spectroscopy to BCa 
analysis was by D’Hallewin et al.111. In the intervening years, many subsequent 
analyses of bladder cancer autofluorescence have been published112-114. Rokahr et al. 
noted an increased accuracy of tumour margin demarcation using autofluorescence 
imaging of bladder tissue compared with PDD115. In a spectrofluorometric analysis of 
ex vivo bladder samples, Zheng et al. demonstrated that the most useful excitation 
wavelengths for bladder cancer detection were 280nm and 330nm114. The In vivo 
application of a 150W light source (similar to that used in the study by Zheng et al.) to 
the human bladder would cause tissue damage through heating, so it is imperative for us 
to determine how bladder tissue responds to light of reduced optical power. One 
recurring theme of several AS studies of bladder cancer is a decrease in the area under 
the curve (AUC) fluorescence in bladder cancer samples excited using UV and blue 
light112,116,117. This is attributed to thickening of urothelium in bladder cancer tissue, 
obscuring underlying fluorescence signals from structural proteins such as collagen. 
D’Hallewin et al. have discussed this phenomenon118, from which it can be concluded 
that this technique may prove little worth in the detection of CIS, which does not cause 
noticeable tissue thickening. Non-specific spectral ratio analysis has also been applied 
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to bladder cancer detection, with promising diagnostic ratios including 335/440nm at 
308nm excitation119 and 385/455nm at 337nm excitation113. Recently, a comparative 
study with PDD demonstrated both increased sensitivity and moderately increased 
specificity of AS for bladder cancer120. Promising laboratory and pre-clinical results are 
yet to be fully realised clinically, however. This may be due to the inability to separate 
distinct fluorophores in complex spectra, and the inability to apply in vitro results – 
using bulky laboratory equipment – in vivo. Limited applicability to CIS detection is a 
contributing factor. Additionally, autofluorescence is known to vary considerably even 
among healthy individuals due to natural differences in tissue composition and function. 
More work in the field is required, therefore, to uncover new optical disease biomarkers 
which are independent of tissue thickening. Anidjar et al. attempted to address this issue 
by studying tryptophan levels in healthy and cancerous bladder mucosa121, indicating a 
new biomarker which may be of worth for CIS detection.  
Recent work has sought to delineate fluorophore contributions using multi-photon 
microscopy (MPM). A recent MPM study of ex vivo human bladder tissue showed 
strong autofluorescence from the urothelial layers (corresponding to NADH and flavins) 
with a strong SHG signal underneath from collagen in the connective tissue97. 
Mukherjee et al. demonstrated that structural and functional tissue imaging using MPM 
could differentiate between healthy mucosa and bladder cancer, similar to haematoxylin 
and eosin (H & E) staining of fixed pathology slides. Although this study did not focus 
on autofluorescence intensity, it demonstrates the increasing worth of AS applications 
for optical biopsy.  
Another factor of tissue autofluorescence which can provide diagnostic worth is 
fluorescence lifetime, the duration of time for which a molecule fluoresces following 
excitation before returning fully to ground state. Fluorescence lifetime imaging (FLIM) 
studies allow for very specific analysis of cell and tissue status as changes in pH and 
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oxygenation can all influence the fluorescence lifetimes of molecules of interest such as 
NADH, and id independent of molecular concentration. In theory, detection of 
fluorescence lifetimes outside of “normal” parameters for a molecule of interest may 
point towards a cellular abnormality such as cancer. FLIM is of interest in cancer 
research because it is less affected by heterogeneity in tissue thickness than other 
quantitative fluorescence analysis techniques, therefore it may be of use for CIS 
detection. Furthermore, FLIM can be used to delineate between fluorophores with 
overlapping spectra - for instance NADH vs NADPH and free vs bound NADH – and to 
study a range of the fluorophores discussed previously in this thesis (including 
tryptophan122 and flavins123). FLIM has been utilised widely since the development of 
applicable systems in the early 1990s which allowed for simultaneous lifetime 
measurement and fluorescence localisation through imaging124. The use of FLIM for 
tissue analysis has been reviewed comprehensively125-127 and has enjoyed application to 
the study of oral carcinoma, Barrett’s oesophagus and colon adenoma among others125. 
Although decay dynamics have been found to differ between healthy and cancerous 
tissue, specific details vary between tissues: for instance colon adenoma spectra were 
found to decay faster than healthy colon, while oral carcinoma spectra have been found 
to decay much less quickly than healthy tissue. To date, FLIM studies of bladder tissue 
are limited to one time resolved autofluorescence study of CIS98, therefore there 
remains great scope in the field to apply FLIM to the study of bladder cancer in future.  
Application of FLIM In Vivo has previously been limited by bulky, expensive 
equipment, however in recent years FLIM probes have started to receive attention as a 
means by which to study dynamics in intact tissue, an example being FLIM confocal 
endomicroscopes128. FLIM probe studies have revealed a great deal about the 
autofluorescence dynamics of healthy and tumour tissue: a decrease in the mean 
fluorescence lifetime in colon neoplasia compared to healthy colon in an Ex Vivo 
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study129; a decrease in fluorescence lifetime in oral cancer in an In Vivo hamster 
model130 and increased NADH fluorescence lifetime in apoptotic tissue compared to 
necrotic in an In Vivo study of mouse keratinocytes131. FLIM probes have also been and 
applied to the study of exogenous dye uptake by tumour tissue132, and combined with 
Raman probes for In Vivo application133. In future, FLIM studies may help to further 
elucidate the profiles and dynamics of fluorophores of interest in the bladder both in 
health and disease.  
A further limitation to our understanding of AS is that multi-parametric non-invasive 
analyses of bladder tissue using multiple excitation sources are few in number, with 
most studies relying on single excitation sources, usually in the UV wavelength range. 
As we will discuss in later sections, UV spectroscopy can often be hampered by the low 
penetration of the short wavelength, especially in the detection of deep and flat lesions. 
One further factor impeding the clinical application of autofluorescence diagnosis of 
bladder cancer is a poor understanding of changing autofluorescence profiles as tumours 
grow and develop. Organoids (in vitro mimics of tissues or cell systems) have recently 
enjoyed application to study cellular responses to drugs134. Bladder organoids have 
previously been derived from porcine135 and human tissue136 and provide a useful 
platform with which to study progressive changes in cells and tissues over time. Work is 
also underway into the development of organoids which accurately recapitulate 
cancer137. The application of AS to developing bladder cancer organoids may serve to 
address the issue of our poor understanding of changes in autofluorescence profiles as 
tumours develop, however this has so far not been achieved.  
Previous biochemical studies into bladder cancer have shed new light on the structural 
and molecular makeup of the disease, yielding information which could better help the 
design of AS systems for bladder cancer diagnosis.  
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With regards to structural proteins, the role of collagen in cancer progression has been 
studied extensively. Collagen in connective tissue surrounding epithelial tissues is 
known to be modified by progressing tumours in order to provide space and the 
opportunity for tumour invasion. It is well-known that developing tumours secrete 
matrix metalloproteinases (MMPs) which break down collagen in surrounding tissues, 
facilitating tumour growth and invasion138,139, resulting in reduced local collagen levels. 
MMP-1 in particular has been well studied in bladder cancer, potentially playing a 
driving role in pathogenesis140 while MMP-9 detection has also shown prognostic value 
in bladder cancer141 and MMP-7 has shown promise for predicting bladder cancer 
metastasis142. The larger picture of collagen involvement in cancer is not so clear, 
however, as discussed by Fang et al.143, with clinical implications in breast cancer144. 
Positive feedback signalling between cancer cells and local collagen may therefore also 
serve to facilitate cancer progression and invasion. Autofluorescence imaging of 
collagen has previously been used to study tissue repair145 and to shed light on cancers 
of the prostate146 and cervix147. Interestingly, both of these studies have reported 
reductions in the relative levels of collagen. Collagen fluorescence properties in bladder 
cancer have not been extensively studied, however the role of collagen in bladder 
extracellular matrix (ECM) and its architectural modifications during disease has been 
comprehensively reviewed148. It is known that invading cancer cells actively adhere to 
collagen fibrils in the ECM and utilise these fibrils to facilitate their invasion deeper 
into tissue149. 
Likewise, elastin is a major component of the ECM, partially responsible for providing 
the functional properties of bladder tissue. Genetically modified mice which lack elastin 
in the bladder were shown to present with altered bladder function150. Elastin fibre 
arrangement and modification has previously been studied to great effect in Marfan 
syndrome – a genetic condition affecting connective tissue production and distribution 
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in the body - using two-photon excited autofluorescence151. Furthermore, 
autofluorescence imaging of elastin in the dermis has been used to elucidate a wealth of 
information about skin disorders152. Elastin fluorescence properties in bladder cancer 
have not been extensively studied, however it has been reported that elastin 
fluorescence (alongside collagen fluorescence) can be used to characterise bladder 
tissue in an ex vivo study of mouse organs153.  
The autofluorescence information received from collagen and elastin, particularly using 
spectroscopy, may be obscured somewhat by the presence of the amino acids 
tryptophan and tyrosine, which possess similar excitation and emission profiles. These 
amino acids are used by cells for the production of structural and functional proteins, 
therefore the enhanced activity of cancer cells compared to normal may give rise to 
increases in local amino acid levels. Tryptophan has been shown to accumulate in breast 
cancer, studied using native autofluorescence, at both the cellular154 and tissue level155. 
Increased tryptophan fluorescence has also been demonstrated in colon cancer156, while 
chemotherapy studies have shown decreases in tryptophan fluorescence in bladder 
cancer cells in response to drug treatment157. In addition, tyrosine phosphorylation of 
proteins has been found to increase in bladder cancer158, therefore tyrosine may play an 
as-yet unknown role in bladder cancer progression.  
The metabolic cofactors NADH and flavins have been studied in a wide range of 
cancers. Metabolic anomalies in cancer cells often cause alterations to the way these 
cells generate energy, resulting in changes to endogenous NADH and Flavin levels. 
NADH and NADPH fluorescence is often referred to as “NAD(P)H”, due to the close 
structural and spectral similarities between NADH and the related NADPH. While 
NADH is involved in energy metabolism, NADPH is often involved in cellular 
antioxidant defence159. As these molecules are spectroscopically indistinguishable160, 
understanding of the redox profile of a cell or tissue can be influenced by the presence 
Page 49 of 232 
 
Scott Palmer  July 2016 
of NADPH, therefore being skewed by its antioxidant defences. One way to 
individually localise and quantify NADH and NADPH is to take advantage of their 
differing fluorescence lifetimes. For instance, bound NADPH has been shown to 
possess a longer fluorescence lifetime than bound NADH161. Blacker and Duchen 
suggest that the ratio between NADH and NADPH lifetimes could serve as a useful tool 
for the detection of pathological conditions161.  
Much of the work in the field on NADH and flavins concentrates on the optical redox 
ratio (ORR), which will be discussed in greater detail shortly. NADH and Flavin levels 
are very sensitive to perturbations in tissue thickness associated with cancer 
progression, therefore it is often much more suitable to apply a diagnostic ratio to 
account for this. NADH exists in both free and bound (proteins, etc.) forms, which 
possess slight differences in their emission profiles and considerable differences in their 
fluorescence lifetimes160 due to the physical properties of the fluorophore. Fluorescence 
lifetime of NAD(P)H has been shown to increase upon binding with a protein. This 
increase has been shown to range from 1-6.5ns, depending on the molecule NAD(P)H 
binds to160. Multi-photon microscopy has been used to differentiate between free and 
bound NADH, detailing relative levels of both forms of NADH during an animal model 
of ischaemia162. Free to bound NADH ratios have recently been used to identify oral 
squamous cell carcinomas163 and bound NADH lifetime imaging has been used to 
detect pre-cancerous epithelia164. NADH FLIM has also been used to monitor breast 
cancer cell response to drug treatment165. The role of NADH levels alone in bladder 
cancer have not been extensively studied, although one previous study using 
fluorescence microscopy of fixed slides has suggested that NADH fluorescence alone is 
not suitable for bladder cancer detection166. Flavin fluorescence has been used to 
characterise glioblastoma cell lines167.  
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Lipofuscin pigments are well known for their involvement and increased presence in 
aged and damaged tissues as a marker of “wear and tear”. Lipofuscin accumulation has 
previously been linked to macular degeneration168 and Alzheimer’s disease169, among 
others. The inherent autofluorescence of lipofuscin pigments across 560-730nm has 
proved a useful tool with which to study these diseases170. The presence of lipofuscin 
granules in urothelial cells was only recently discovered171, and may provide an 
opportunity with which to study tissue inflammatory status due to its apparent link with 
oxidative stress. Lipofuscin levels were found to increase with both age and disease 
stage in a multi-photon microscopy study of ovarian cancer172. 
Finally, porphyrins are a class of molecule involved in heme production, with the most 
common form in humans being Protoporphyrin IX (PpIX). Porphyrins are perhaps best 
known for their selective accumulation in cancer tissue following administration of PS 
agents such as 5-ALA (covered earlier), however endogenous porphyrins also show 
some promise in the detection of cancer. Porphyrin like fluorescence has previously 
been identified for its diagnostic worth in oral cancer173. Furthermore, baseline PpIX 
levels were demonstrably lower in healthy renal cells compared to renal carcinoma 
cells174 (without addition of PS) and in the blood175 and tumour area176 of mice 
implanted with renal cell carcinoma. So far, no studies have demonstrated differences in 
the baseline porphyrin levels of non-sensitised healthy and cancerous bladder tissue, 
however the efficacy of PDD using PS agents suggests a deficiency in the heme 
biosynthetic pathway of bladder cancer cells which may also result in changes in 
autofluorescence. Koenig et al. previously concluded that porphyrin presence should be 
expected in the majority of aerobic tissues owing to its key role in heme/haemoglobin 
biosynthesis for oxygen transport177, therefore we consider that endogenous porphyrin 
quantification may be of worth in the disease. Porphyrin possesses several absorption 
peaks, thereby allowing fluorescence to be excited both at its excitation maximum 
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(405nm) and closer to the tissue optical window (630nm), theoretically allowing deeper 
tissue penetration. Longer wavelength excitation of porphyrins has been utilised in 
studies of PDD for bladder TCC178 and in the study of endogenous porphyrins in oral 
mucosa179, therefore it is a reliable methodology for future study.  
The emission profiles of several endogenous fluorophores under 366nm excitation have 
been collected by Croce et al.180 (Fig. 10). We can see that a great deal of endogenous 
fluorophores are excited to fluoresce under UV illumination, thereby contributing to 
complex fluorescence spectra. Delineation of individual fluorophores contributing to the 
spectra of healthy and cancerous tissue is therefore crucial. In this review, Croce et al. 
also discuss the essential need for light-tissue modelling using techniques such as 
Monte-Carlo modelling (this technique will be covered in greater detail later).  
 
Figure 10 Emission profiles of the most common endogenous fluorophores under 
366nm excitation (reproduced with permission under Creative Commons attribution 
non-commercial license, courtesy Croce et al.180) 
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Included below (Fig. 11) is a cross section of bladder tissue showing major structural 
elements and the expected fluorophores at each level of tissue: 
 
Figure 11 Cross section of the urinary bladder showing the main layers and related 
fluorophores (adapted from Wikiwand and included under a public domain license) 
One of the advantages of autofluorescence spectroscopy, compared to WLC or NBI for 
instance, is that it has the potential to be applied across every step of diagnosis, 
including urine and shed cell analysis as well as tissue analysis during cystoscopy. At 
the cellular level, autofluorescence microscopy and related methodologies can be used 
to elucidate the metabolic processes occurring in cancer cells. Autofluorescence 
microscopy has recently contributed to the identification of specific cancer stem cell 
populations181. At the tissue level, the picture of autofluorescence becomes more 
complicated, with contributions from structural proteins such as collagen and elastin 
and the scattering of light by blood in tissue and, in some cases, melanin. 
Urine autofluorescence also displays promise as a non-invasive clinical adjunct. Urine 
emits significant fluorescence under UV and blue light irradiation, possibly related to 
shed NADH, flavins and amino acids. Masilamani et al. suggest that the major 
contributors to urine fluorescence are flavoproteins and porphyrins182. Clinical 
relationships have been observed previously between urine autofluorescence and the 
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presence of ovarian183, colorectal184 and lung cancer185 as well as bacteriuria186, 
however there is very little research in the field concerning the diagnostic worth of urine 
fluorescence spectroscopy for BCa.  
To account for the variability in autofluorescence intensity between patients, a great 
deal of the current research in AS is in the development of diagnostic ratios to aid and 
improve sensitivity and specificity. The most frequently studied diagnostic ratio is the 
optical redox ratio (ORR), which gives a measure of the metabolic state of cells and 
tissues by ratioing fluorescence from NADH against fluorescence from flavins 
(equation 1): 
 
Equation 1 Calculation of the optical redox ratio (ORR) 
The theoretical basis for the ORR lies with the Warburg effect187, whereby it is 
hypothesised that as cells become malignant and change their functional machinery to 
promote an invasive and rapidly proliferating phenotype, they undergo a metabolic 
switch. Normal cells will tend to address their energy needs by producing adenosine 
triphosphate (ATP) by the process of aerobic respiration. To do this, glucose is 
catabolised and fed into the Krebs cycle, following which the metabolic intermediates 
NADH and FADH act as electron transporters to fuel ATP synthase in the mitochondria 
via oxidative phosphorylation, yielding NAD/FAD + H+. Cancer cells which have 
undergone metabolic modifications according to the Warburg effect no longer generate 
energy via oxidative phosphorylation, instead meeting their energy needs via 
accelerated glycolysis. As a result, NADH generated in the first steps of the respiratory 
process can no longer act as electron donors for oxidative phosphorylation, leading to 
an accumulation of NADH within cells. Crucially, it is only the reduced form of NADH 
(NADH) and the oxidised form of FAD (FAD) which fluoresce, therefore the ORR 
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considering NADH and FAD levels can act as a marker of the increased rate of 
glycolysis compared to oxidative phosphorylation in a cell. The biochemical 
underpinning of the Warburg effect is detailed in Fig. 12. 
 
Figure 12 Molecular and cellular consequences of the Warburg Effect, adapted 
partially from text by Vander Heiden et al.187 and text and figures by Chiarugi et al.188. 
Glycolytic switch in cancer cells causes a shutdown of the electron transport chain and 
an accumulation of NADH. 
There exist various methods by which to calculate the redox ratio (e.g. NADH/FAD, 
FAD/NADH, FAD-NADH/FAD+NADH) but the crucial aspect of the ORR is that it 
reflects an increased relative NADH content in cancer cells (for instance ORR measured 
as NADH/FAD is higher in cancer cells than normal cells while ORR measured as 
FAD/NADH is lower in cancer cells than normal cells). ORR measurements have also 
been applied to the differentiation of healthy and pre-cancerous epithelia189, identifying 
subtypes of breast cancer cell190 and demarcating brain tumour margins191. Cicchi et al. 
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previously observed a statistically significant ORR between healthy bladder mucosa and 
CIS in a small sample study98. Other diagnostically relevant ratios include the 
tryptophan to NADH ratio192 and collagen to NADH ratio193. The ability of the ORR in 
particular to identify pre-cancerous mucosa marks it as an attractive modality for the 
study of bladder cancer, potentially providing an opportunity with which to detect CIS, 
however ORR imaging has yet to be applied clinically.  
In summary, BCa is a common disease associated with high morbidity and high 
recurrence and progression rates. Current gold standard detection techniques suffer from 
low sensitivity, especially for early stage cancers and the pre-malignant CIS. Steps have 
been taken to remedy the sensitivity issues encountered by gold standard techniques, 
namely with the development of PDD using PS and a wide range of urine diagnostic 
kits. These next generation techniques have suffered from low specificity, inter-user 
variability issues and increased cost compared to gold standards. Current research in the 
field aims to overcome the sensitivity/specificity dilemma of BCa diagnosis, however 
issues still remain: novel PS agents still suffer from low tissue penetration, nano-
particles are shown to accumulate in tissue and contribute to systemic toxicity and the 
nascent field of autofluorescence spectroscopy, although promising, requires extensive 
validation and clinical testing before being considered a useful diagnostic adjunct. 
Similarly, PDT of BCa has been faced with similar issues, including non-specific 
toxicity and poor tissue penetration of dyes and activating light. Improved 
methodologies for the diagnosis and therapy of BCa which address some of these issues 
could allow the development of reliable clinical tools to reduce cost and increase patient 
quality of life.  
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1.1.9 Light-Oxygen Effect 
A potential method for improving PDT is to do away with PS altogether. It has 
previously been suggested in the literature that direct irradiation of tissue in the near 
infrared at 1268nm can induce potent singlet oxygen generation, leading to cell death, 
the so-called light-oxygen effect (LOE). This is accomplished through the direct spin 
transition of molecular oxygen from triplet to singlet state through donation of energy 
by 1268nm light, rather than by the excitation of PS with subsequent release of singlet 
oxygen. This could prove beneficial for situations in which PDT is hampered by limited 
PS distribution, low light penetration into tissue containing deeper lying tumours and 
also in reducing non-specific toxicity. Furthermore, the application of LOE would 
remove the associated cost of PS, patient lay-up time and discomfort during PS 
administration.  
Direct generation of singlet oxygen through spin transition following 1268nm 
irradiation was first observed by Matheson et al. in the 1970s194. Subsequently, much 
work has been done on the LOE in animal models and cell lines to characterise cellular 
and systemic effects195. The LOE has shown significant effects in both breast cancer and 
HeLa cell lines. The effects of LOE on HeLa cells were not reproduced in healthy 
HaCaT cells – this was attributed to the differential activation of Calcium channels and 
their respective effects on cell signalling196. Anquez et al. assessed the morphological 
effects of breast cancer cells exposed to 1268nm laser irradiation over time, 
demonstrating progressive morphological changes suggestive of apoptosis197.  
Crucially, LOE has not been demonstrated for bladder cancer, so we have no knowledge 
of its applicability to this disease. The validation of LOE in bladder cancer cells could 
allow for the development of a multi-functional laser system which detects (using AS) 
and eradicates bladder tumours (using LOE) without the need for administration of PS. 
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1.2 Light-tissue interactions 
Human tissue can generally be considered as a non-uniform, turbid, light-scattering 
medium with contributions from various cellular and molecular components. Light 
entering tissue may encounter a wide range of different molecules which can either 
scatter or absorb the incident light. Occasionally, some light can also be entirely 
transmitted through tissue. The degree to which light is scattered, absorbed or 
transmitted through tissue depends greatly on the tissue type and thickness and can be 
influenced by the presence of blood, water and melanin. The physical underpinning of 
the optical properties of biological tissue has been comprehensively covered by Jacques 
et al.198. Detailed below are the possible fates of incident light when entering tissue 
(Fig. 13): 
 
Figure 13 Fates of light entering tissue: light can either be scattered (A), for instance 
by cellular components such as nuclei; absorbed (B), for instance by hemoglobin, water 
and tissue fluorophores; or transmitted through full tissue (C) 
The physical properties of tissue can have a significant bearing on how to measure the 
tissue autofluorescence. Briefly, in order to study tissue autofluorescence the following 
must be achieved: deliver sufficient light to be absorbed by the molecules of interest; 
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deliver the optimal excitation wavelength of light for the molecule of interest; detect the 
emitted fluorescence with high sensitivity. The scattering properties of tissue can affect 
both the first and third of these.  
1.2.1 Scattering of light 
Scattering of light occurs when a photon interacts elastically or inelastically with a 
molecule without being fully absorbed. Many components of mammalian cells are 
potent light scatterers, including the cell nucleus and mitochondria. The scattering 
properties of a tissue are denoted by its coefficient of scattering (µs). Within each cell, 
light will encounter dozens of scatterers. This must be considered when applying 
appropriate imaging methodologies. There are many forms of scattering which occur at 
a cell/tissue level, including Mie, Rayleigh and Raman scattering. Furthermore, the 
scattering properties of tissue are known to change as healthy tissue turns to cancer, in 
particular due to nuclear enlargement, tissue thickening and increased blood content due 
to inflammation and neovascularisation.  
The wavelength of light can affect its inherent scattering properties – for instance, the 
short wavelength of UV light means it is more likely to encounter interactions with 
small molecular scatterers within cells and tissues than longer wavelength red light. 
Propagation of light through tissue also depends on the direction of scattering events 
(dictated by the physical nature of a tissue’s constituent molecules). Forward scattering 
of light by molecules serves to help light propagate further into tissue, while back-
scattering of light by molecules impedes propagation resulting partly in diffuse 
reflectance. With regards to AS, scattering events which propagate light deeper into 
tissue may increase the fluorophores which light comes into contact with. 
Another issue to consider when applying AS is how to measure the emitted 
fluorescence, especially in a highly absorbing and scattering environment. Both blood 
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and melanin are known to strongly absorb UV and visible light. Increased blood and 
melanin content in tissue have been shown to correlate with reductions in the measured 
tissue NADH fluorescence 199.   
1.2.2 Absorption of light 
Absorption of light occurs when the relative energy of incident light is suitable to raise 
the energy profile of an absorber. This is known as “excitation” and is denoted as a 
transition from S0 to S1, as denoted in the Jablonski diagram below (Fig. 14): 
 
Figure 14 Jablonski diagram denoting the absorption of light by a molecule (purple 
arrow) and energy release (blue arrow) 
Jablonski diagrams depict the discrete energy levels present in a specific molecule, at 
both the ground state and excited states. In this case, the purple arrow on the left 
represents the excitation of a molecule to singlet state through the absorption of a 
photon of light (purple arrow). Excitation of a molecule can be followed by vibrational 
relaxation (yellow arrow), often in the form of heat loss. Finally, during fluorescence, 
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the remaining energy is released in the form of an emitted photon (blue arrow) returning 
the energy of the molecule to ground state. The absorption of light by a tissue will 
depend heavily on the “absorption maxima” of its constituent molecules and is defined 
by its coefficient of absorption (µa). Fig. 15 below details the absorption spectra of 
NADH and its oxidised form NAD, showing their absorption maxima at 260-270nm, 
with an additional strong absorption peak for NADH at 340nm. The absorption 
properties of these molecules can be applied to differentiate between them.  
 
Figure 15 Absorption spectra of NAD+ (solid black line) and reduced counterpart 
NADH (dashed black line) between 240-360nm (courtesy Cronholm114 via 
Wikipedia.org, reproduced through public domain access (By Cronholm144 - Own 
work, Public Domain, https://commons.wikimedia.org/w/index.php?curid=3258108)) 
 
Most molecules in the human body will absorb light energy, but not all will fluoresce. 
The absorption maximum of a molecule relates to the amount of energy required to 
elevate it to its excited state. The donation of energy by light to molecules is heavily 
dependent on its wavelength, as shorter wavelength light (towards UV) contains higher 
relative energy per photon than longer wavelength light (towards IR). Fig. 16 shows the 
conventionally used wavelength range for AS applications within the electromagnetic 
spectrum. 
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Figure 16 Electromagnetic spectrum showing the wavelengths of UV and visible light 
(reproduced freely under CC-BY license, courtesy Philip Ronan via 
commons.wikimedia.org (https://commons.wikimedia.org/wiki/File:EM_spectrum.svg)) 
Generally, most of the common endogenous fluorophores contain excitation/absorption 
maxima in the UV range, therefore illumination of tissue with UV light often causes 
simultaneous fluorescence from a range of molecules (demonstrated in Fig.10). 
Furthermore, light entering tissue can also be absorbed by both blood and by melanin. 
Much like scattering, the absorption of light by tissue is heavily dependent on the tissue 
type. In the bladder, we know from morphological studies that the main fluorophores in 
the top layers of mucosa will be the metabolic cofactors NADH and flavins, with 
possible contributions from lipofuscin and porphyrins. Therefore, the majority of UV 
light entering bladder tissue from the mucosal side will be absorbed by (and stimulate 
fluorescence from) these molecules. Although UV light is capable of exciting 
fluorescence from the structural proteins elastin and collagen in connective tissue, we 
may consider that the excitation of these molecules in intact bladder tissue will be 
impeded by light absorption and scattering from the mucosal layer. This is complicated 
somewhat by the higher quantum efficiency of structural proteins (defined as photons 
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out/photons in) compared to NADH and flavins. Additionally, emitted fluorescence 
from these molecules may be strongly absorbed by NADH and flavins in the mucosal 
layer, impeding detection.  
The effects of wavelength on tissue absorption and transmission can easily be 
demonstrated when holding a torch to human tissue. The reverse of the tissue appears 
red, not due to the illumination of blood vessels as once thought, but due to the 
complete transmission of red light through tissue, in contrast to shorter wavelength blue 
and green light.  
One further concern when using UV illumination are the deleterious effects of UV 
exposure on human cells. UV irradiation of cells and tissues is known to be a potent 
carcinogen. With particular regards to cancer, therefore, we must be careful when 
employing UV AS that we do not induce new instances of cancer while diagnosing the 
old.  
In recent years, multi-photon microscopy (MPM) has been enjoying increasing success 
for application to imaging biological systems. The basis of multi-photon microscopy is 
that the energy needs of a fluorophore can be met by the donation of energy by either 1 
photon of high energy (short wavelength) or 2 photons of exactly half the energy 
(exactly double the wavelength). In theory, MPM allows imaging deeper into tissue and 
without the risk of deleterious effects of UV irradiation. A further benefit of MPM is 
that it can be used in conjunction with SHG to provide both structural and functional 
information on tissues. MPM is still yet to enjoy clinical application as laboratory 
setups for MPM devices are often bulky, requiring large high powered lasers and 
complex lensing systems. 
An area of interest in biophotonics is in the “optical window” (Fig. 17), a range where 
absorption of light by blood and melanin (lower wavelengths) and water (higher 
Page 63 of 232 
 
Scott Palmer  July 2016 
wavelengths) are minimal. In this region, light penetration through tissue is at its 
greatest extent. In theory, this wavelength range should prove useful for the application 
of AS for the detection of deeper lying tumours and pre-cancerous tissue such as CIS, 
however the difficulty lies in finding a suitable fluorophore which is excited optimally 
at such long wavelengths. One suggestion is the excitation of endogenous porphyrins 
such as PpIX using 630nm light and recording the fluorescence emission at 710nm. 
 
Figure 17 Diagram of the "Tissue Optical Window" displaying absorption of light by 
oxygenated blood (cyan line), deoxygenated blood (red line) and water (blue line) 
between the wavelength range of 600-1100nm (reproduced with permission from 
Nature Publishing Group, courtesy Phan & Bullen, 2010200 
1.2.3 Energy release 
Molecules in excited state are inherently unstable and release energy (“relaxation”) 
through one of a few ways, including through thermal release, phosphorescence and 
fluorescence. The third, downward pointing arrow in the Jablonski diagram relates to 
the release of energy as a molecule relaxes. Often, molecules release energy in the form 
of heat, but some molecules (endogenous fluorophores) release energy in the form of an 
emitted photon. Owing to laws of energy conservation and the loss of a small amount of 
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energy as heat (the second arrow in the Jablonski diagram), the emitted photon is 
always of a lower energy than the exciting photon. For instance, fluorophores excited 
using blue light will emit fluorescence in the green and yellow region, but never the UV 
region. The intensity with which a fluorophore fluoresces depends on the absorption 
cross-section of the molecules, its quantum efficiency and also the wavelength of 
excitation light. NADH, for instance, possesses an absorption maximum at 260-270nm 
(seen above), therefore it will fluoresce more intensely under illumination with this 
wavelength of light. NADH will cease to absorb light above approximately 400nm, 
therefore wavelengths of light longer than UV are inefficient for exciting NADH 
fluorescence.  
Endogenous fluorophores each have a specific molecular fingerprint with regards to 
fluorescence. Generally, excited fluorophores emit photons within a narrow range of 
wavelengths, the full range of which can be seen when measuring a fluorescence 
spectrum. The emission profile of NADH, for instance, may span the wavelengths of 
420-520nm with an emission maximum at 490nm. This means the most commonly 
emitted wavelength of photon by an excited NADH molecule is at 490nm. The emitted 
fluorescence spectrum of a given molecule will depend on the interactions between this 
molecule and others (for instance, bound NADH has slightly different optical properties 
from free NADH).  
Non-specific heating of tissue should also be considered when applying AS. The 
absorption of light by water and blood will undoubtedly cause thermal effects in tissue, 
related to the optical power applied. Thermal effects on tissue can include the 
destruction of cellular DNA and protein denaturation. A balance must be struck in AS 
between extremely low power light with little damaging side effects at the expense of 
limited tissue fluorescence and extremely high powered light sources which excite 
significant tissue fluorescence at the expense of extensive tissue damage.  
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1.2.4 Second harmonic generation 
In certain molecules with non-centrosymmetric surfaces (collagen being the best 
example), incident light can interact inelastically to produce forward propagating light 
of double the frequency through second harmonic generation (SHG). Crucially, in SHG 
the incident energy is entirely conserved, so there are no deleterious effects of energy 
absorption by tissue. Light in the NIR range (within the optical window) can thereby be 
used to study the presence, volume and spatial distribution of collagen in tissue non-
invasively. The use of SHG to study collagen presents a few advantages over AS 
(optimal collagen autofluorescence is excited in the 200-300nm UV range): firstly, the 
longer wavelength of light used for SHG (generally around 800-900nm) can penetrate 
deeper into tissue as it exists in the “optical window” and is thus less readily absorbed 
by tissue. Secondly, the longer wavelength of light used causes fewer deleterious effects 
to tissue, especially when considering that SHG is an energy conserving process.  
1.2.5 Modelling light tissue interactions 
The clinical application of AS techniques may be enhanced through the use of computer 
simulations of tissues of interest. Computer modelling programmes such as TracePro 
allow users to create tissue models based on the optical properties (µa, µs) of the tissues 
of interest. Such models allow researchers to investigate the trajectory and interactions 
of incoming light of different wavelengths and intensities using Monte Carlo 
simulations for instance. Such simulations may inform the layout of optical probes, the 
choice of appropriate wavelengths of light for tissue diagnosis and therapy and the 
identification and monitoring of optical effects of tissue transformation. Monte Carlo 
modelling has previously been utilised to represent skin tissue across a range of 
wavelengths201 and for the study of NIR properties in healthy and diseased breast 
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tissue202. The development of an AS system for bladder cancer diagnosis with an 
accessory simulated tissue model could be of real clinical worth.  
1.3 Multi-Functional Laser Based Non-Invasive Diagnostic Systems (MLNDS) 
One class of medical technology receiving increased attention of late is that of multi-
functional laser based non-invasive diagnostic systems (MLNDS). The term MLNDS 
covers a wide range of related systems, all with the broad function of diagnosis and 
therapy of disease non-invasively. Lasers are particularly suitable for application in non-
invasive diagnosis as their wavelengths can be narrowly specified for fluorophores of 
interest. The setup of a laser is based around the stimulated emission of radiation of in 
phase light through a gain medium. The wavelength of laser light is tightly controlled 
by the choice of gain medium and the power can be controlled by setting the initial 
voltage. The advantages over broadband or white light illumination include increased 
specificity and efficiency of imaging processes along with the need for reduced optical 
powers. Most lasers used for medical spectroscopy nowadays possess optical powers in 
the range of milliwatts (mW) so as to avoid damaging effects on tissue through non-
specific heating. The range of lasers commonly available nowadays (Fig. 18) are 
detailed below: 
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Gain media within the laser cavity are excited by the source (electrical or optical) to 
emit a photon (stimulated emission). Photons emitted by molecules within the gain 
media excite photon emission from further molecules, amplifying the initial photonic 
signal which is reflected by mirrors on each side of the cavity before exiting as a single 
beam. The uniform nature of the gain media ensures that emitted photons are in-phase 
and of the same direction and wavelength.  
Page 68 of 232 
 
Scott Palmer  July 2016 
 
Figure 18 Range of commercially available lasers, reproduced freely under a CC-BY-
SA license (original figure created by Danh, via Wikipedia.org: 
https://en.wikipedia.org/wiki/Laser#/media/File:Commercial_laser_lines.svg) 
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MLNDS are easily applicable to accessible tissue surfaces such as skin, oral mucosa 
and bladder mucosa. Among the MLNDS is the “LAKK-M” system, developed by 
SPE-LAZMA, Russia. This device contains within it light sources and channels for 
measuring tissue oxygenation, tissue blood flow and tissue autofluorescence, connected 
to an optical probe for in situ application. The experimental setup of the LAKK-M 
system is detailed below (Fig. 19): 
 
Figure 19 Experimental setup of the LAKK-M system 
The functional unit of the LAKK-M (top left) contains the laser sources for AS, LDF 
and TRO. The sources for these channels are coupled to fibre optics which are delivered 
to the biological object (for instance tissue) by an optical probe with 2 mm diameter.  
The specific details of each laser source, including wavelength, function and optical 
power are included below (Table 4) alongside an illustration of the fibre layout within 
the optical probe (Fig. 20):  
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Table 4 Wavelength, source and optical power of the lasers used by the LAKK-M system 
Wavelength Function Source Filter Power (mW) 
UV (365nm) AS LED, continuous 
mode 
Longpass, 
370-
2200nm 
1.5 
Blue (450nm) AS QD 
semiconductor 
laser, continuous 
mode 
Longpass, 
460-
2200nm 
3.5 
Green (532nm) AS 
 
TRO 
Solid state laser, 
continuous mode 
Solid state laser, 
pulsed mode 
Longpass,  
540-
2200nm 
4.5 
 
0.8 
Red (635nm) AS 
 
TRO 
Semiconductor 
laser, continuous 
mode 
Semiconductor 
laser, pulsed 
mode 
Longpass, 
650-
2200nm 
5.5 
 
0.5 
NIR (1064nm) LDF QD 
semiconductor 
laser, continuous 
mode 
- 1.2-1.5 
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Figure 20 Layout of the LAKK-M optical probe including the source and detector 
fibres: (2.1) Green laser; (2.2) UV laser; (2.3) NIR laser; (2.4) Blue laser; (2.5) Red 
laser; (2.6) LDF detector; (2.7) TRO detector; (2.8) LDF detector; (2.9) AS detector. 
Separation distance between fibres = 1mm, diameter of each fibre = 100µm (120µm 
including cladding). NA for each fibre = 0.22. 
The light is delivered to the biological object by gently touching the optical probe to the 
tissue surface. The light is transformed by tissue according to the parameter of interest 
and detected by detection channels in the optical probe. For AS, each excitation channel 
is separated from the detection channel by a distance of 1mm, measured centre-to-
centre. The diameter of each fibre (excitation and detection) is 100µm (120µm 
including cladding) and each fibre has an NA = 0.22. For AS, the detected light is 
passed through a longpass filter to block the intensity of the back-scattered signal (the 
back-scattered intensity of incident laser light is often much more intense than that of 
fluorescence), following which the fluorescence is detected by a charge-coupled device 
(CCD) at 0.2nm increments between 350-823nm. Maximum transmission in the 
rejected region is 0.001%. Fluorescent light transmitted through the filter is dispersed in 
a polychromator, detected on a CCD and displayed in the analysis software as a 
complex fluorescence spectrum, normally with two peaks, the first of which represents 
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back-scattered light of the same wavelength as the excitation light, and the second of 
which is the complex tissue fluorescence spectrum.  
The AS laser sources included within the LAKK-M system are listed below alongside 
the endogenous fluorophores which they excite (Table 5)203: 
Table 5 Excitation sources on the LAKK-M for AS 
COLOUR WAVELENGTH FLUOROPHORES 
UV 365nm Collagen, Elastin, NADH, 
Flavins 
Blue 450nm Flavins 
Green 532nm Lipofuscin 
Red 635nm Porphyrins 
 
From the complex fluorescence spectra recorded and displayed by the LAKK-M, it is 
possible to measure endogenous fluorophores of interest and calculate diagnostic ratios 
such as the ORR. An example spectrometer readout is included below with annotations 
(Fig. 21): 
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Figure 21  Annotated screenshot of the LAKK-M spectrometer showing back-scattered 
laser light, fluorescence across 380-820nm and the measured parameters of 
fluorescence intensity for each fluorophore.  
Fluorescence spectra measured using different excitation sources exhibit different 
fluorescence spectra, related to the varying contributions of endogenous fluorophores. 
Below are included example fluorescence spectra recorded from the skin of the finger 
using the four laser sources, annotated to include the wavelengths at which endogenous 
fluorophores of interest can be measured (Fig. 22-25). Wavelengths at which each 
fluorophore of interest are measured are selected in order to minimise spectral overlap 
between fluorophores, in keeping with previous work on tissue autofluorescence180,204, 
including works utilising the LAKK-M system179,199,205,206: Comparison with 
measurements from fluorophores in solution are included in chapter 2. 
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Figure 22 Example of a fluorescence spectrum recorded from the finger under UV 
excitation at 365nm 
 
Figure 23 Example of a fluorescence spectrum recorded from the finger under blue 
excitation (450nm) 
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Figure 24 Fluorescence spectrum recorded from finger tissue excited using green light 
(535nm) 
 
Figure 25 Fluorescence spectrum recorded from finger tissue excited using red light 
(633nm) 
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As seen in Fig. 22, UV excitation of tissue gives rise to a complex fluorescence 
spectrum with contribution from several endogenous fluorophores. Tissue excited using 
longer wavelengths of light (Fig. 23-25) gives rise to less complex fluorescence spectra 
as longer wavelengths of light outwith the UV range excite fewer fluorophores. Flavin 
fluorescence can be excited and recorded in both the UV and blue channels, as flavins 
are optimally excited around 450nm. The wavelength at which flavins are recorded 
changes between UV and blue spectra, due to the contribution to UV fluorescence from 
several other fluorophores (for instance, NADH).  
Work is still ongoing to develop and apply the AS channel of the LAKK-M system 
clinically and diagnostically. Mayevsky et al. previously devised a similar system for 
multi-parametric measurements of NADH in brain tissue207. Recently, the LAKK-M 
was used to delineate differences in endogenous fluorophore levels such as NADH and 
flavins in a mouse model of cardiovascular disease205. Further work is also underway to 
optimise the technical performance of the device208.  
Our group previously reported the effects of various tissue parameters (such as blood 
volume and melanin content) on the measured parameters of fluorescence using the 
LAKK-M199. In this study, multi-parametric measurements were performed on 
volunteers with different skin colours and levels of nutritive blood flow. We measured 
the ORR values from different volunteers to better understand how this varies between 
healthy individuals. Melanin content was shown to inversely affect the measured 
parameters of UV fluorescence and the subsequent quantified levels of NADH, flavins, 
etc. Furthermore, nutritive blood flow was shown to significantly inversely effect the 
measured parameters of fluorescence from NADH and flavins. The fluorescence 
parameters of tissue in varying circumstance can therefore be probed successfully using 
the LAKK-M system. The physical properties of tissue (nutritive blood flow, melanin 
content, normal tissue variation, etc.) must also be taken into account when making 
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measurements, although melanin content is of little consequence in bladder fluorescence 
analysis.  
AS using the LAKK-M may be of worth to detect spectral differences between healthy 
and cancerous bladder tissue, however the worth of this device for the disease has not 
previously been studied. Work is required in the field to identify suitable biomarkers of 
bladder cancer which may be accurately monitored by the LAKK-M system, allowing 
its adaptation into a clinical device.  
In addition to the AS channel, the LAKK-M system also possesses channels for 
measuring tissue blood flow parameters (using laser Doppler flowmetry (LDF)) and 
tissue oxygenation (using tissue reflectance oximetry (TRO)). Briefly, LDF works on 
the basis of Doppler shift of reflected NIR light by blood in tissue. NIR light directed to 
the capillaries via the optical probe is reflected by red blood cells. This reflected light is 
picked up by the LDF detector channel within the LAKK-M probe. Variations in blood 
flow velocity and red blood cell concentration are shown by variations in intensity of 
reflected light (proportional to Doppler shift of reflected light) which are recorded (as 
index of microcirculation (Im)) and can be used as the basis for medical diagnosis. 
Function and recent developments in LDF methodology have been reviewed 
elsewhere209. The effects of various physiological stimuli (exercise, occlusion tests, 
temperature, etc.) on the microcirculation can be evaluated using LDF. Furthermore, 
disorders and diseases can have an impact on tissue blood flow, affecting its regulation 
at several levels (neurogenic, myogenic, etc.), affecting the microcirculation within 
capillaries. LDF has been employed to study the blood flow and total blood volume of 
gastric cancer, in which blood flow was found to correlate with the presence of 
endothelial markers, particularly at the tumour periphery210. LDF can also be used to 
assess the efficacy of anti-angiogenic tumour treatment211  LDF was first used to study 
bladder blood flow in 1996212 and has previously been used for diagnosis of 
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microvascular dysfunction in skin213 and for the study of bladder cystitis214. TRO 
measurements are based on the preferential absorption of red and green light by 
oxygenated and deoxygenated haemoglobin in the blood, the proportions of which can 
change during the onset of disease. Index of microcirculation and values of tissue 
oxygenation (recorded as StO2) combined can give values of tissue relative blood 
volume215.  Our group have previously described the LDF and TRO channels of the 
LAKK-M device in greater detail, using the system to study the synchronisation of 
blood flow and oxygenation rhythms215. An annotated screenshot of LAKK-M readouts 
for index of microcirculation, tissue oxygenation and relative blood volume is included 
below (Fig. 26): 
 
Figure 26 Annotated screenshot of the LDF and TRO channel of the LAKK-M, 
including measured graphs and recorded values for index of microcirculation 
(perfusion), tissue oxygenation and relative blood volume 
The roles of tissue oxygenation and blood flow in tumour development and progression 
are being widely studied in oncology. We know, for instance, that as tumours grow and 
develop, their interiors often become hypoxic216, causing the need for angiogenesis 
which partially gives rise to the enhanced permeability and retention (EPR) effect, by 
which leaky, acidified tumours with high interstitial pressure take up and preferentially 
retain nanoparticles and some dyes. The effect of this is twofold: oxygenation of 
tumours relative to healthy tissue may decrease and the tumour may derive its blood 
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supply from smaller, weaker blood vessels which are subject to alternative methods of 
regulation. Comprehensive simultaneous measurements of bladder tumours using the 
LAKK-M system (blood flow patterns, tissue oxygenation and biomarker 
quantification) may shed new light on the dynamic processes underpinning the disease.  
Furthermore, with small adjustments to setup or measurement protocols, the LAKK-M 
could also serve to act as a spectrofluorimeter for fluorescence measurements of cell or 
molecular suspensions. Similarly, small modifications to the functional unit of the 
LAKK-M system could allow the addition of an extra channel for LOE. With particular 
reference to bladder cancer, the identification and validation of suitable biomarkers at 
the cellular and tissue level based on AS could pave the way for next-generation 
MLNDS for bladder cancer diagnosis. 
1.4 Aims and objectives 
 
The ultimate goal of the development of the LAKK-M system is a multi-functional 
medical device with the capacity to provide a wide range of diagnostic parameters to 
surgeons and clinicians through minimally invasive interaction with tissue of interest. 
Clinical application of the LAKK-M device as a spectroscopic probe for tumour 
detection relies heavily on technical substantiation. It is essential to identify reliable 
biomarkers with which to use the LAKK-M system to detect bladder cancer. Results of 
fluorescence analysis at the cellular and tissue level using the LAKK-M system will 
also hopefully help to corroborate earlier key studies in the field, including those by 
Koenig113, Zheng114, Aboumarzouk112, Schafauer116 and others.  
The aim of this thesis is to explore the autofluorescence properties of bladder cancer 
across the range of cell to tissue with particular focus on diagnostic ratios such as the 
ORR. I also seek to address the applicability of the novel MLNDS system “LAKK-M” 
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for diagnosis of bladder cancer at these levels. In conjunction with investigation into 
cell and tissue autofluorescence, lab grown bladder cancer organoids and computer 
tissue simulations with which to monitor and model endogenous fluorescence in 
developing bladder cancers are also explored. Finally, the applicability of the LOE 
using IR irradiation to bladder cancer cells is explored, discussing the therapeutic worth 
of this technique for the disease. The three main objectives, therefore, were: 
1. Investigate the ORR in bladder cancer cell lines as a means to diagnose the 
disease from voided urine 
2. Develop bladder cancer organoids with which to monitor changes in tissue 
fluorescence from metabolic and structural fluorophores over days and weeks. 
3. Investigate the ORR in human bladder tissue using the LAKK-M system and 
identify other potential diagnostically relevant biomarkers 
Primary hypotheses are that healthy bladder and bladder cancer at both the cell and 
tissue level would display significant differences in autofluorescence profiles - related 
to relative levels of structural proteins and metabolic cofactors – and the MLNDS 
system “LAKK-M” would be sensitive to these differences. In addition, I hypothesise 
that developing bladder cancer organoids will display progressive changes in 
fluorophore levels (both metabolic and structural fluorophores) as cancer grows over 
days and weeks. Finally, it is hypothesised that the IR treatment of bladder cancer cells 
will result in cell death through the pathway known as LOE.  
The significant findings from this research were as follows: 
1. Cancer cells display an elevated ORR (measured by flow cytometry as 
ex360em425-475/ex488em515-545) in comparison with healthy controls. This 
could potentially pave the way for novel non-invasive diagnostic techniques 
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2. Bladder cancer organoids grown in the lab show obvious changes in 
fluorescence profiles relative to control as tumours progress, specifically 
changes in the ORR (ex365em490/ex365em550), elastin to NADH ratio 
(ex365em450/ex365em490) and elastin/flavin ratio (ex365em450/ex365em550). 
3. Bladder cancer tissue from human volunteers displays reduced ORR 
(ex365em490/ex365em550) and elevated porphyrin levels relative to healthy 
tissue. This finding could aid in the development of the LAKK-M system into a 
minimally invasive probe for the early detection of the disease 
In addition, conclusions and future avenues of study for the application of second 
harmonic imaging of organoids, bladder tissue modelling using computer simulation 
and bladder cancer therapy using the light oxygen effect are discussed. 
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2. CELLULAR FLUORESCENCE ANALYSIS  
2.1 Background  
The aim of this work was to assess differences in autofluorescence between healthy 
bladder cells and bladder cancer cells. The ability to discriminate between healthy 
bladder and bladder cancer at the cellular level presents the opportunity to implement 
early diagnosis techniques for the disease non-invasively, analysing cells shed in the 
urine.  
The perfect diagnostic technique for bladder cancer is sensitive, specific, quick and non-
invasive. Urine analysis (urinalysis) is a completely non-invasive diagnostic technique, 
thereby causing no pain or discomfort to patients. Applications and limitations of 
bladder cancer screening have previously been discussed, being suggested as feasible 
but hampered by the lack of useful urinary biomarkers217. Urinalysis for diagnosis of 
bladder cancer has previously been explored extensively. Schmitz-Drager et al. among 
others have discussed the urgent need for novel urinary biomarkers for bladder 
cancer218, while Karaoglu discusses the limitations to current urinary biomarkers, 
especially for non-muscle invasive disease219. Among the most common urinalysis 
techniques are NMP22, BTA STAT and Urovysion, which rely on antigens and cells 
shed in urine, however these techniques are hampered by limited sensitivity or 
specificity and require interpretation by skilled pathologists. Oge et al. demonstrated 
that BTA STAT detects bladder cancer with higher sensitivity than NMP22, however it 
was not sensitive enough to replace conventional cystoscopy59. Hosseini et al. also 
discuss the limited specificity of the NMP22 test52. It is clear, therefore, that 
advancements in the field of urinalysis for bladder cancer diagnosis are required to 
address the shortcomings of current modalities. Parker et al. have discussed some of the 
promising new modalities in urinalysis for bladder cancer detection220. 
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Within cells, the main endogenous fluorophores of interest are the metabolic cofactors 
NADH and flavins. These fluorophores can be used to calculate the optical redox ratio 
(ORR), discussed in chapter 1, which is a measure of the metabolic activity of cells. 
Briefly, the Warburg effect occurring in cancer cells causes a glycolytic switch187 which 
leads to relative increases in cellular NADH, increasing the ORR (calculated as 
NADH/flavins), therefore the ORR can be a useful tool for discriminating between 
healthy and cancer cells which have undergone a glycolytic switch. As the Warburg 
effect can occur in cells early in cancer development, in theory the ORR is capable of 
detecting early stage, low grade cancer cells.  ORR differences between healthy and 
cancer cells have been previously reported for a wide range of cancers and pre-
cancerous epithelia189,221, alongside differentiating between different cancer subtypes222. 
ORR values for bladder cancer have not been extensively covered previously, therefore 
I intended to compare the ORR of healthy bladder and bladder cancer cell lines, with an 
aim to establish ORR analysis as an effective diagnostic technique for urothelial cells 
shed in urine.  
Much is still unknown about how the autofluorescence properties of individual cells 
compare with that of complete tissues. Undoubtedly, there will be fluorophores 
contributing to tissue fluorescence which are not present in individual cells, especially 
in shed epithelial cells. The multi-functional laser system LAKK-M presents an 
opportunity to study and directly compare fluorescence of cells and tissues to discover 
similarities and differences.  
Based on previous observations of other diseases, it is hypothesised that cancer cells 
will display an increased ORR compared to healthy cells. I propose that this difference 
will be detectable using the LAKK-M system, establishing it as a potential tool for 
voided urine cytology for bladder cancer diagnosis. Briefly, methodology involved: the 
design of cuvettes for use with the LAKK-M device (in matte black to minimise 
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background noise); analysis of the fluorescence properties of NADH and flavins using 
this system; confirmation of mitochondrial origin of cellular autofluorescence; analysis 
of ORR discrepancies using a validated technique (flow cytometry) and finally the 
comparison of cells using the LAKK-M system.  
2.2 Methods 
2.2.1 LAKK-M System 
LAKK-M multi-functional laser based non-invasive diagnostic system (MLNDS) was 
used for all fluorescence spectroscopy measurements. The LAKK-M contains sources 
for performing laser Doppler flowmetry (LDF), tissue reflectance oximetry (TRO) and 
autofluorescence spectroscopy (AS) and contains 5 laser sources for the various 
applications. The technical aspects of LAKK-M setup208 and applications for skin tissue 
blood flow215 and fluorescence analysis199 have been covered previously. For 
fluorescence measurements, the following lasers are used: UV at 365nm; blue at 
450nm; green at 530nm and red at 633nm. Laser sources are coupled to a fibre optic 
probe with diameter 2mm in which the source and detector are separated by a distance 
of approximately 1mm. Excitation light is supplied to tissue samples by gently but 
firmly touching the tip of the optical probe to the surface of the tissue of interest. 
Excitation light is supplied to the liquid solution or suspension samples by suspending 
the optical probe in the centre of the solution. This is made easier by the use of custom 
made cuvettes with lids to hold the optical probe in place. The subsequent fluorescence 
intensity from the object of interest is recorded in the detection channel of the optical 
probe, passed through the requisite filter and converted to an electronic signal via a 
CCD connected to an in-built spectrophotometer. The LAKK-M device is connected to 
a laptop with custom-made recording and analysis software “LDF” (version 3 of which 
was used for our work) created by SPE-LAZMA, Moscow, Russia, which displays the 
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fluorescence intensities recorded by the inbuilt spectrophotometer in the form of a 
complex spectrum. Fluorescence measurements are performed in darkness to minimise 
interference and background noise from other light sources. To record spectra, “new 
experiment” is selected from the computer interface, the optical probe is put in the 
region of interest (ROI) and “start spectrometer setup” is selected, to calibrate the 
fluorescence channel. Upon receiving a green signal saying “spectrometer calibrated”, 
lasers can be switched on by pressing the corresponding button. Switching on the blue 
laser automatically switches off the UV laser, switching on the green laser automatically 
switches off the blue laser, and so on. The probe is held still for 30 seconds to ensure a 
stable signal, following which fluorescence spectra are recorded sequentially through 
UV, blue, green and red excitation sources.  The optical probe is held perfectly in place 
for the duration of measurement. Spectra are recorded for each excitation source by 
selecting the button on the user interface saying “remember”, followed by “continue” to 
carry on study. Once all four spectra for a given sample are recorded, the study is 
stopped by selecting “stop” and “save” from the user interface. Excitation sources are 
associated with specific physical filters to block the intensity of back-scattered light 
(detailed in Table 4). These were changed accordingly as each measurement progressed 
from UV to red sources. The laser source must always be changed prior to the filter, to 
prevent aberrant results. From the database view, recorded spectra can be named and 
viewed to calculate fluorescence intensity parameters. From the spectrum view, data can 
be exported to excel spreadsheets in “csv” format by selecting from the user interface 
“export” -> “export data as”. The “csv” data contains 2 columns: wavelength (in nm) 
increasing in 0.2nm increments and corresponding amplitude of fluorescence in 
arbitrary units (AU). Figure 27 details the LAKK-M with accessory computer. The 
diagnostic probe of the LAKK-M is inserted into a cuvette for fluorophore 
measurements.  
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Figure 27 Experimental setup including LAKK-M system, attached laptop and cuvette 
2.2.2 Cuvettes 
For fluorophore and cell suspension fluorescence measurements, a cuvette (outer 
dimensions 10mm x 10mm x 30mm and inner dimensions 8mm x 8mm x 29mm) with a 
lid (dimensions 10mm x 10mm x 1mm, with a centred circular hole of diameter 2mm) 
was designed using 3D modelling software “123D” by Autodesk inventor, and printed 
in matte black plastic using a MakerBot 3D printer, Fulton Building, University of 
Dundee (Fig. 28B). The cuvette was designed to contain liquid solutions with a 2mm 
gap in the lid to allow addition of solutions, and to accurately hold the optical probe of 
the LAKK-M device in place. The development of cuvette informed further design of a 
more advanced custom cuvette in matte black plastic by SPE-LAZMA, Moscow, Russia 
(Fig. 28C). The custom built cuvette contained a matte black holding chamber with a 
stainless steel screw lid threaded to the exact dimensions of the chamber. The stainless 
steel lid contained a central holding reservoir for the LAKK-M optical probe (detailed 
below). Two similar types of custom matte black cuvette were designed, one with 
variable volume 100-300µl and one with variable volume 1-5ml.  
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The ability of custom made cuvettes to minimise background noise was tested by 
comparing them with a conventional clear plastic cuvette (Fig. 28A). All measurements 
were performed in the optics lab, Ninewells hospital, Dundee, in a dark room with the 
door closed to minimise background light. The LAKK-M system was switched on at 
least 30 minutes prior to use. First, the empty clear cuvette was placed beside the 
LAKK-M, with the optical probe held stably at a 2mm depth within the cuvette, with 
measurements being recorded across all 4 spectra. The 3D printed cuvette was then 
studied by attaching the lid and connecting the optical probe of LAKK-M through the 
holder to a depth of 2-3mm into the empty cuvette. Measurements were then recorded 
across all 4 spectra. Finally, the custom built cuvette was studied by screwing on the 
stainless steel lid and attaching the optical probe to the holder, holding the probe level 
with the top of the cuvette. Measurements were recorded across all 4 spectra. 
Measurements for all 3 cuvettes were repeated with the addition of 2ml PBS to each 
cuvette and recorded across all 4 spectra. Spectra were saved to the LDF analysis 
software, exported to excel files and graphed using Origin Pro 8 analysis software. A 
comparison of the background fluorescence across all 4 spectra from the 3 cuvette types 
is compared in the following section.   
In addition, UV and blue fluorescence spectra were measured from a custom black 
cuvette positioned on a Gilson Labstir containing a magnetic stir bar, to determine the 
applicability of mechanical stirring to ORR measurements from cells. The setup of the 
custom cuvette on the LabStir, containing the stir bar, is included as Fig. 29 below. 
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Figure 28 Cuvette types used for comparison: (a) conventional clear plastic cuvette; (b) 
3D printed matte black cuvette; (c) custom made matte black cuvette 
 
Figure 29 Setup of custom black cuvette on Gilson LabStir containing magnetic stir bar 
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2.2.3 Fluorophore Analysis 
Reduced Nicotinamide Dinucleotide (NADH), Flavin Adenine Dinucleotide (FAD), 
Tyrosine, Tryptophan and Protoporphyrin IX powders were purchased from Sigma-
Aldrich and prepared to serial dilutions starting at 1M in Phosphate Buffered Saline 
(PBS), purchased from Sigma-Aldrich. 300 µl of each fluorophore solution were added 
to the custom built matte black cuvette (SPE-LAZMA) (Fig. 30): the optical probe was 
attached following the previous protocol and fluorescence spectra of fluorophores were 
recorded across all four excitation wavelengths and archived to database for future 
reference. Additionally, a 1:1 mixture of NADH and FAD was studied across all 4 
excitation wavelengths in the 300µl cuvette and compared to measurements of solutions 
of the pure fluorophores alone. 300µl Phosphate Buffered Saline (PBS) alone was added 
to matte black cuvette and analysed to determine background fluorescence. Serial 
mixtures of NADH and FAD were studied in the 5ml custom cuvette (Table 6) to assess 
accuracy of the computed optical redox ratio (ORR) parameters at the three suggested 
wavelengths (flavins measured at excitation 365nm emission 550; excitation 450 
emission 510; excitation 450 emission 550): 
Table 6 Relative NADH concentrations used to measure ORR using LAKK-M system 
NADH Volume (ml) FAD Volume (ml) Relative NADH (%) 
5 0 100 
4 1 80 
3 2 60 
2.5 2.5 50 
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2 3 40 
1 4 20 
0 5 0 
 
 
Figure 30 Cuvette setup for fluorophore and cell analysis: (a) solutions are pipetted 
into the top of the empty cuvette; (b) the stainless steel lid is screwed into place; (c) the 
optical probe of the LAKK-M device is placed into the holder in the lid 
2.2.4 Cell Culture 
Cells were seeded in sterile tissue culture hoods and grown in tissue culture incubators 
in the lab block of Ninewells Hospital and medical school, James Arrott Drive, Dundee, 
UK. The facilities used had no previous history of mycoplasma contamination and cells 
were certified mycoplasma-free upon delivery. Prior to all cell and tissue culture work, 
tissue culture hoods were opened, sprayed with 70% ethanol and cleaned thoroughly, 
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then fans were switched on and left to run for at least 30 minutes prior to work being 
carried out.  
The healthy bladder cell line “Human Urothelial Cell” (HUC), a weakly adherent cell 
line derived from human bladder urothelium, was purchased from ScienCell Research 
laboratories (Carlsbad, USA) and grown in 75cm2 Corning culture flasks (Sigma-
Aldrich) treated with Poly-L-Lysine solution (Sigma-Aldrich) to promote adherence. 
Culture flasks were treated with Poly-L-Lysine by adding 3ml Poly-L-Lysine solution 
per flask, rocking to thoroughly cover the growth surface and incubating flask for 15 
minutes at 37oC, 5% CO2. Following incubation, the remaining solution was removed 
using a pipette and the growth surface was washed using PBS. Flasks were left for at 
least a day following polylysination before cell seeding. Cells were delivered on dry ice 
and rapidly thawed in a water bath set to 37oC, mixed gently but thoroughly using a 1ml 
pipette and transferred to culture flask at a concentration of roughly 7500cells/cm2 (cell 
concentration calculated using either a benchtop Coulter counter or haemocytometer). 
Cells were grown in complete Urothelial Cell Medium (UCM) (ScienCell Research 
laboratories) consisting of basal medium containing 1% Urothelial cell growth 
supplement (UCGS) and 1% Penicillin-Streptomycin. 15ml complete UCM was used 
per flask.  
Human bladder grade II transitional cell carcinoma cell line “5637”, an adherent cell 
line with p53 mutation derived from a 68 year old Caucasian male, was purchased from 
American Type Culture Collection (ATCC) and grown in 75cm2 Corning culture flasks 
in Dulbecco’s Modified Eagle Medium (DMEM) containing 10% Fetal Bovine Serum 
(FBS) and 1% Penicillin-Streptomycin using 15ml complete media per flask. Cells were 
delivered on dry ice to Ninewells hospital, thawed rapidly in a water bath set to 37oC 
and gently but thoroughly re-suspended by pipetting. 
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Both cell types were maintained in a standard incubator set to 37oC with 5% CO2 and 
media was replaced for both cell types every two days. Cells were split upon reaching 
75% confluence to ensure normal growth was maintained. To do this, supernatant media 
was removed from flasks using a pipette. Cells were then washed in 2ml per flask 0.1% 
Trypsin-ethyldiaminetetraacetic acid (EDTA) to neutralise and remove remaining 
culture media. Following this, cells were incubated at 37oC, 5% CO2 for 5-10 minutes 
in 3ml per flask 0.1% Trypsin-EDTA. After this period, cells were detached by gently 
nudging culture flasks. Cells were then re-suspended in 7ml complete DMEM to 
neutralise trypsin-EDTA solution. HUC cells were re-seeded at a concentration of 1:2 or 
1:3 (cells from one flask used to reseed two or three new flasks), 5637 cells were re-
seeded at concentration of 1:3 to 1:4.  
To freeze, 1 x 106 cells detached by trypsinisation were spun at 1500RPM for 5 minutes 
in a benchtop centrifuge to form a cell pellet. Supernatant was removed and cells were 
re-suspended in complete DMEM containing 10% dimethyl sulfoxide (DMSO) an anti-
crystallisation agent which enables cells to survive freeze/thaw. Frozen cells were 
maintained either in a -80oC freezer or in liquid Nitrogen until further required.  
2.2.5 Cell Fluorescence Analysis – Confocal Microscopy 
5637 cells were grown to 75% confluence in #1.5 thickness coverslip bottom Petri 
dishes from Willcowells. Mitochondrial dye MitoTracker Red (Life Technologies) was 
prepared to a 1mM stock solution in DMSO and diluted to a 100nm solution in PBS 
(1% FBS). Prior to analysis, supernatant culture media was removed from cells in Petri 
dishes using a pipette, and cells were treated with 1ml/dish 100nM solution 
MitoTracker Red. Cells were incubated for 45 minutes with MitoTracker, after which 
solution was removed and 1ml PBS containing 10% FBS was added to Petri dish. 
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Stained cells in Petri dish were transported to the College of Life Sciences, main 
campus, University of Dundee for analysis in the light microscopy facility.  
A Carl Zeiss 710 confocal microscope was used to observe cellular fluorescence using a 
63x objective. NADH fluorescence was excited using a 60mW 355nm UV laser set to 
100% power and recorded using a PMT across 401-462nm. Flavin fluorescence was 
excited using a 30mW 458nm blue laser set to 100% power and recorded using a PMT 
across 496-545nm. MitoTracker Red fluorescence was excited using a 30mW 543nm 
green laser set to 2% power and recorded using a PMT across 548-683nm. Optical 
powers were measured at sample. Images were saved to computer and transferred for 
visualisation and analysis using ImageJ image analysis software.  
2.2.6 Cell Fluorescence Analysis – Flow Cytometry 
5637 cells and HUC cells grown according to standard protocol to 75% confluence were 
trypsinised, neutralised and gently resuspended in PBS (1% FBS) using a 1ml pipette. 
Cell suspensions were filtered using a 30µl filter and kept on ice in FACS tubes until 
use. Samples were then transported in triplicate to flow cytometry core facility, College 
of Life Science, University of Dundee, Dundee for analysis.  
A Becton Dickinson “Fortessa” flow cytometer was used. The flow cytometer was setup 
according to standard protocol, with forward scatter and signal width being examined 
by a blue laser of wavelength 488nm set to 162V. Following this, cellular NADH was 
excited using a 360nm laser set to 211V and recorded between 425-475nm and cellular 
FAD was excited using a 488nm laser set to 397V and recorded between 515-545nm. 
10,000 cells were analysed from each sample (3 x HUC + 3 x 5637) with the results of 
forward scatter, side scatter and autofluorescence intensity saved in FCS files. The 
NADH value for each cell was calculated as a total intensity across excitation at 360nm, 
with emission at 425-475nm. The FAD value for each cell was calculated as a total 
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intensity across excitation at 488nm, with emission at 515-545nm. FCS files were 
opened using “FCS Express” analysis software and dead cells were excluded from 
analysis using an elliptical inclusive gate between co-ordinates 3.8K, 68K and 113K, 
154K, including 20,883 cancer cells and 19,564 healthy cells for analysis. Relative 
NADH and FAD contents were plotted on bivariate dot plots to create “redox overview” 
and NADH and FAD values for each cell were exported to excel spreadsheets. Taking 
the ORR value rather than absolute amplitudes meant calibration was not required. ORR 
values for each cell were calculated in excel by dividing NADH by FAD. ORR values 
for each cell were exported to SPSS for statistical analysis, cells being classified by cell 
type (1 = healthy, 2 = cancer). 19,564 healthy cells (taken from 3 flasks on the same 
day) were compared with 20,883 cancer cells (taken from 3 flasks on the same day) 
using ANOVA test in SPSS, with p value <0.05 being classed as statistically significant. 
Bar graphs charting average ORR and standard error of the mean (SEM) for each 
population were plotted using Origin Pro 8 analysis software. 
2.2.7 Cell Fluorescence Analysis – LAKK-M 
The LAKK-M system was switched on at least 30 minutes prior to use. Cells were 
freshly detached from culture flasks by trypsinisation, re-suspended in PBS to various 
concentrations and kept on ice until further use. Background fluorescence spectra across 
all four excitation wavelengths were recorded from empty matte black cuvette and 
cuvette containing 300µl PBS, following which spectra were recorded for 300µl cell 
suspensions. Amplitudes of fluorescence for fluorophores of interest were recorded as 
follows (Table 7), in keeping with previously recorded literature: 
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Table 7 Wavelengths at which metabolic fluorophores were studied (excitation and 
emission) using the LAKK-M 
Fluorophore Excitation (nm) Emission (nm) 
NADH 365 490 
FAD 365 550 
FAD Blue 450 510 
FAD Blue 450 550 
 
In addition, the optical redox ratio (ORR) was measured as: NADH (ex365 
em490)/FAD (ex365 em550); NADH (ex365 em490/FAD Blue (ex450 em510) and 
NADH (ex365 em490/FAD Blue (ex450 em550). 
These measurements were used to assess dose dependence of cellular autofluorescence, 
repeatability of measurements and to compare healthy and cancer cell lines.  
2.2.8 Urine Fluorescence Analysis 
To assess the ability of the LAKK-M to detect cellular fluorescence from voided urine, 
urine was collected across 3 days from a healthy volunteer and studied using the 
LAKK-M system. 20ml voided urine was collected per study in a 50ml Falcon tube, 
from which 5ml was removed and added to 5ml custom cuvette, to which the lid and 
optical probe were attached. 3 independent measurements were made each day, spectra 
of which were averaged and compared to each other using Origin Pro 8. Spectra were 
also compared to the pre-recorded fluorophore database to suggest potential 
contributing fluorophores.  
To assess the individual components of urine, samples were spun at 1500RPM for 5 
minutes to pellet voided urine cells. Presence of cells was confirmed by benchtop 
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microscope observation. Pelleted cells were resuspended in PBS to concentration of 
approximately 1 x 104/ml. Fluorescence spectra of urine cells suspended in PBS was 
compared to PBS background, urine supernatant and complete urine spectra using 
Origin Pro 8.  
2.3 Results 
2.3.1 Comparison of Background Fluorescence in Cuvettes 
Background fluorescence spectra of standard clear plastic cuvette, 3D printed matte 
black cuvette and custom built cuvette were compared across all 4 excitation channels 
using the LAKK-M system. This was to ensure there was no background fluorescence 
from the equipment affecting fluorophore and cell measurements. The fluorescence 
spectra of cuvettes were compared both when empty (Fig. 31) and when containing the 
non-fluorescent chemical buffer phosphate buffered saline (PBS) (Fig. 32). Both the 3D 
printed cuvette and custom built cuvette display a marked reduction in background 
fluorescence compared to clear, standard cuvettes. There is a slight increase in the 
background fluorescence from custom built cuvettes under red excitation, which may be 
the result of material properties of the cuvette. This background fluorescence is far 
weaker than that observed in the clear cuvette under UV or blue excitation. As UV and 
blue excitation are considered the optimal wavelengths for measuring the ORR from 
cell suspensions, custom cuvettes were considered preferable despite this increased 
background red fluorescence. Custom cuvettes were selected for all future experiments 
due to their adjustable volume and attachable lid.  
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Figure 31 Background fluorescence recorded from standard plastic cuvette (black line), 
3D printed cuvette (red line) and custom built cuvette (blue line) under UV (a), blue (b), 
green (c) and red excitation (d). 
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Figure 32 PBS fluorescence measured in standard plastic cuvette (black line), 3D 
printed cuvette (red line) and custom built cuvette (blue line) under UV (a), blue (b), 
green (c) and red (d) excitation. 
From this data, we can clearly demonstrate that both the 3D printed and custom made 
matte black cuvettes provide a significant reduction in both background and PBS 
induced fluorescence across the desired UV and blue wavelength ranges. 3D printed 
cuvette was slightly better at reducing background fluorescence than the custom cuvette 
across all 4 wavelengths, however the custom cuvette was selected for use due to its 
flexibility.  
To determine whether a magnetic stir bar could be used to maintain cells in suspension, 
the background fluorescence of an empty custom cuvette was compared with that of a 
cuvette containing a white magnetic stir bar. From Figure 33, an increase in the 
background fluorescence measured using UV and blue excitation (wavelengths used to 
measure ORR) when including stir bar can be seen. Furthermore, magnetism between 
LabStor base and stir bar was disrupted by the thickness of the cuvette. For these 
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reasons, stir bar is not recommended when measuring cell or fluorophore fluorescence 
in custom cuvettes.  
 
Figure 33 Figure 34 Background fluorescence measured from empty cuvette (black 
line) and cuvette containing magnetic stir bar (red line) under UV (a), blue (b), green 
(c) and red (d) excitation 
2.3.2 Fluorophore Fluorescence Spectroscopy 
Fluorescence spectra of common cellular fluorophores NADH, flavins, tryptophan, 
tyrosine and Protoporphyrin IX were recorded on the LAKK-M system to assess 
fluorescence maxima. Spectra of fluorophores are detailed below (Fig. 34 – 36): 
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Figure 34 Fluorescence intensity of 1M solutions of tryptophan (a) and 1M tyrosine (B) 
in PBS measured under UV excitation (black line), blue excitation (blue line), green 
excitation (green line) and red excitation (red line). 
 
Figure 35 Fluorescence spectra of 1M NADH (a) and 1M flavin (b) under UV (black 
line); blue (blue line); green (green line) and red excitation (red line) 
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Figure 36 1M PpIX fluorescence under UV (black line); blue (blue line); green (green 
line) and red (red line) excitation 
From these figures we can clearly see that the fluorophores responding most strongly to 
UV irradiation are the metabolic cofactors NADH and flavins. NADH spectrum shows 
some artefacts and the spectral line is not completely smooth. As the concentration of 
NADH solution was quite high (1M), this may be due to an incomplete mix of the 
solution resulting in powder clumping. More likely, this may be due to the “inner filter 
effect” whereby light entering solution is entirely absorbed close to the light source, 
impeding light delivery to the rest of the solution and reducing fluorescence intensity 
measured by the detector. The LAKK-M spectrometer auto-calibrates before each 
measurement by measuring background noise prior to laser sources being switched on. 
Therefore, because spectra of other fluorophores (for instance flavins and PpIX) 
displayed expected fluorescence, the artefacts observed in NADH spectra are probably 
not due to calibration errors. The LAKK-M can also be recalibrated following hardware 
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modifications against plastic reference equipment of known optical properties, however 
this was not carried out prior to NADH analysis. Future analysis of NADH solutions at 
lower concentrations would be of worth to minimise the inner filter effect and remove 
spectral artefacts. Tryptophan and tyrosine were found to fluoresce modestly under UV 
excitation (maxima 450-500nm), however this wavelength is likely above the optimal 
wavelength for exciting fluorescence from the amino acids. As tryptophan and tyrosine 
residues are major contributors to collagen and elastin fluorescence, it can be considered 
that the UV excitation wavelength is sub-optimal to excite these fluorophores too. PpIX, 
a possible cellular component, was found to fluoresce strongly, but limited to the red 
region of the spectrum (maximum around 710nm), therefore not interfering with ORR 
measurements. NADH was found to fluoresce solely under UV excitation (maximum 
around 470-490nm), while flavins fluoresced under both UV and blue excitation 
(maxima around 530-550nm). Flavin fluorescence was found to be stronger under blue 
excitation than UV excitation. It is concluded, therefore, that the major components 
contributing to cellular fluorescence at the wavelengths of interest for calculating ORR 
are NADH and flavins. As powers varied slightly between light sources (1.5mW for 
UV, 3.5mW for blue, 4.5mW for green and 5.5mW for red), spectral intensity variations 
may be influenced slightly by optical powers. I further explored how the LAKK-M 
responds to increasing doses of fluorophores, using flavins as an example (Fig. 37): 
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Figure 37 Fluorescence measured from flavin solutions under blue (450nm) excitation. 
Black line depicts a 3.75uM solution, red line depicts a 7.5uM solution and blue line 
depicts a 15uM solution. 
 
From this it can be concluded that the LAKK-M can approximately represent increasing 
fluorophore concentrations. I then sought to assess in greater detail the relationship 
between NADH and flavins by comparing the fluorescence spectra of each to that of a 
mixed solution of both fluorophores (Fig. 38):  
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Figure 38 Fluorescence spectra of 1M NADH (black line), 1M flavins (red line) and a 
50:50 mix of NADH and flavins (blue line) under uv (a) and blue (b) excitation. 
It can be seen from Fig.38 that a combination of NADH and flavins under UV 
excitation (a) gives rise to a complex spectrum involving contributions from both 
fluorophores. There may also be some synergistic effect of combining both 
fluorophores. Blue excitation (b) gives rise to a spectrum which is identical to that of 
flavins, confirming that NADH contributes no fluorescence at this wavelength. As there 
is considerable overlap between NADH and flavin spectra under UV excitation, blue 
spectra may be more useful for studying flavins. Finally, I sought to assess the accuracy 
of the three suggested methods for measuring optical redox ratio (ORR), by measuring 
ORR values at increasing concentrations of NADH (Fig. 39):  
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Figure 39 Chart of ORR values measured at increasing NADH (ex365em490): Flavin 
ratios with flavins measured at ex365em550 (black line), ex450em510 (red line) and 
ex450em550 (blue line) 
It can be seen from Fig.39 that all 3 measurements of ORR reflect relative increases in 
NADH, although predicted ORR responses should be linear. This could be caused by 
incomplete mixing of solutions, however every care was taken to ensure solutions were 
well mixed prior to measurement. This may also be partially caused by an “inner filter 
effect” – discussed earlier – occurring at high NADH concentrations. It was shown 
earlier that there is a small amount of spectral overlap between NADH and flavins 
which may also account for the nonlinear nature of the response. Similarly, combination 
of fluorophores seems to cause a synergistic effect regarding fluorescence intensity 
which may contribute to the observed results. Due to the non-linear response of the 
LAKK-M to increasing NADH concentrations, care must be taken in future when 
interpreting ORR measurements.   
2.3.3 Confocal Analysis of Cell Fluorescence 
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Bladder cancer cell line “5637” was studied using confocal microscopy to understand 
and confirm the origin of the Autofluorescence at wavelengths of interest for calculating 
the ORR. Fig.40 (below) suggests that fluorescence excited and recorded across UV and 
blue spectra may be mitochondrial in origin and occurs from NADH and flavins 
respectively due to co-localisation with mitochondria-specific dye “MitoTracker”. More 
work using higher resolution microscopy and overlaying fluorophores will help to better 
elucidate this.  
 
Figure 40 Confocal Microscopy images from bladder cancer cells showing localisation 
of (a) MitoTracker Red, (b) NADH and (c) flavins 
2.3.4 Flow Cytometric Analysis of ORR 
To compare ORR values prior to LAKK-M analysis, healthy bladder and bladder cancer 
cells were analysed using a conventional flow cytometer with UV and blue laser sources 
to excite NADH and flavins, respectively. Relative NADH and flavin contents of all 
cells for healthy and cancer populations were plotted on bivariate dot plots (Fig.41) and 
population means were also compared for statistically significant differences in SPSS 
using ANOVA (Fig.42). Fig.41 shows that healthy and cancer bladder cells possess 
different population distributions with respect to NADH (x-axis) and flavins (y-axis).  
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Figure 41 Bivariate dot plots of (A, top row) healthy bladder and (B, bottom row) 
bladder cancer cells measured in triplicate, charting cellular content of NADH (x-axis) 
and flavins (y-axis) showing differences between population distributions 
Fig.42, comparing the mean ORR values of each cell type, demonstrates an increased 
mean ORR (measured as ex360em425-475/ex488em515-545) in bladder cancer cells 
(dark shaded) compared to healthy control (light shaded). This difference was found to 
be statistically significant (p = 2 x 10-16). This extremely low p value may be due to the 
lack of independence of measurements. Although cells from 3 separate flasks (3 x 
healthy flasks and 3 x cancer flasks), measurements were performed on the same day so 
are not technically independent. More work in future, particularly repeat experiments, 
will help to elucidate the true significance of this difference.  
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Figure 42 Comparison of ORR mean +/- SEM for healthy bladder cells (pale shaded) 
and bladder cancer cells (dark shaded). ORR measured as ex360em425-
475/ex488em515-545.  
2.3.5 LAKK-M Cell Autofluorescence Analysis 
Having determined a statistically significant increase in the ORR of bladder cancer cells 
compared to healthy bladder cells, the next aim was to determine whether this 
difference could be detected by the LAKK-M system. Both the stability of ORR 
measurements in cancer cells day to day and dose dependent changes in fluorophore 
levels were studied, alongside differences in ORR between bladder cancer cells and 
healthy control. Fig.43 below, charting cellular fluorescence spectra across all 4 spectra 
averaged from 5 datasets of bladder cancer cells, shows that cells fluorescence under 
UV and blue excitation, but not green or red excitation. Furthermore, comparing cell 
fluorescence under UV excitation (maximum 470-490nm) to fluorophore spectra 
suggests that cells contain a combination of both NADH and flavins with some possible 
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small contribution from tryptophan/tyrosine. Cell fluorescence under blue excitation 
(maximum 530-550nm) seems to arise solely from flavins: 
 
Figure 43 Cell fluorescence averaged from 5 measurements of 10^6 cells: cells (black 
line) under UV excitation (a) overlaid with NADH (blue line) and flavins (red line); 
cells under blue excitation (b) overlaid with flavins (red line); cells under green 
excitation (c); cells under red excitation (d) overlaid with porphyrins (red line). 
 
Stability measurements of cells (Fig.44 & 45) demonstrate that cell fluorescence under 
UV and blue excitation shows similar patterns but varies considerably. Each sample was 
measured after identical preparation. As cells were transported on ice, approximately 10 
minutes was allowed in each instance to stabilise to room temperature in a temperature 
controlled room. Small variations in acclimatisation period may account for variations 
in observed fluorescence. In particular, UV spectra show considerable variability in 
what look to be NADH and flavin contributions to cellular fluorescence, which would 
drastically skew the ORR if measured purely using UV values. Blue fluorescence 
spectra also show some variability, but are more stable than UV spectra:  
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Figure 44 Fluorescence spectra of 15 separate measurements of cellular fluorescence 
from individually prepared bladder cancer cells under UV excitation, showing signal 
variability  
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Figure 45 Fluorescence spectra of 15 separate measurements of cellular fluorescence 
under blue excitation showing signal variability 
Dose dependence measurements of cells under UV and blue excitation (Fig.46) 
demonstrate that fluorescence arises exclusively from cells and is dose dependent, 
however: 
 
Figure 46 Dose dependence of bladder cancer cell spectra using UV (a) and blue (b) 
excitation at concentrations ranging from 1.25 x 10^6 to 1 x 10^7 cells/ml in PBS 
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Comparison of ORR from healthy (dark shaded) and cancer (pale shaded) measured 
using LAKK-M (NADH ex365em490/flavin ex365 em550) show no significant 
difference (Fig.47): 
 
Figure 47 ORR mean +/- SEM values measured from bladder cancer (pale shaded, 5 
measurements) and healthy bladder (dark shaded, 5 measurements) cells. ORR 
measured as ex365em490/ex450em550 
 
Furthermore, analysis of ORR values from repeat measurements of bladder cancer cells 
shows large variability between samples (Fig.48). Again, each sample was prepared 
identically and measured following transport on ice and a 10 minute acclimatisation 
period to room temperature. In particular, the largest variability was found when 
exciting flavins at 450nm and recording them at 510nm. The lowest variability was 
recorded when exciting flavins at 365nm and recording at 550nm: 
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Figure 48 Scatter diagram charting ORR values of repeated measures from bladder 
cancer cells calculated in 3 ways (ex365em490/ex365em550 (“UV”); 
ex365em490/ex450em510 (“Blue”); ex365em490/ex450em550 (“Blue 550”)) 
It was also observed that time on bench has an effect on cell ORR measured using the 
LAKK-M (Fig.49). ORR drops significantly up to 15 minutes after initial measurement 
then plateaus after around 20 minutes. This suggests the need to compare cells of both 
type immediately after preparation. Reduced ORR may be a physical effect of cells 
settling in suspension or may more likely be suggestive of cell death on bench. 
Increased flavins and decreased NADH levels have been observed previously in 
Doxorubicin induced cell death, which would obviously skew the ORR223. 
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Figure 49 Average +/- SEM ORR values of bladder cancer cells measured at 5 minute 
intervals up to 35 minutes following initial measurement (ORR measured as 
ex365em490/ex365em550). 
2.3.6 Urine Fluorescence Analysis 
Fluorescence analysis of urine samples shows fluorescence spectra which vary in 
intensity from day-to-day, but which show similar spectral shapes (Fig.50): 
Page 115 of 232 
 
Scott Palmer  July 2016 
 
Figure 50 Spectra recorded from urine on days 1, 2 and 3 (black, red and blue lines) 
measured using UV (a) and blue excitation (b) 
Comparing urine fluorescence spectra with pre-recorded fluorophore analysis suggests 
the presence of large volumes of NADH and flavins in voided urine, although this 
requires further investigation as fluorescence may equally arise from excreted amino 
acids or dietary vitamins such as vitamin B. Crucially, the inherent fluorescence from 
urine supernatant contributes almost all of the total urine fluorescence (Fig.51), 
fluorescence of urine cells suspended in PBS shows very little signal compared to 
background PBS: 
 
Figure 51 comparison of the UV (a) and blue fluorescence (b) of PBS (black line); total 
urine fluorescence average (red line); urine cells in PBS (blue line) and average urine 
without cells (green line) 
Finally, dose response measurements of urine supernatant combined with PBS confirms 
that fluorescence arises almost exclusively from urine (Fig.52): 
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Figure 52 Fluorescence under UV (a) and blue excitation (b) arising from PBS (black 
line); 12.5% urine in PBS (red line); 25% urine in PBS (blue line); 50% urine in PBS 
(green line) and 100% urine (magenta line) 
2.4 Discussion 
Spectroscopic analysis of the fluorophores NADH and flavins was used, alongside 
previous relevant literature, to calculate the optimum wavelengths at which to study the 
fluorophores of interest and calculate the ORR, a measure of cell metabolic activity. 
Spectra in figure 34 clearly show UV excitation at 365nm can excite fluorescence from 
both solutions of NADH and flavins, whereas excitation using blue light at 450nm 
excites only fluorescence from flavins. These measurements were made in cuvettes 
specifically designed to minimise background fluorescence noise both from material 
and the environment. Optimal wavelengths at which to calculate the ORR using the 
LAKK-M were investigated by measuring varying ratios of NADH and flavins and 
charting linear or non-linear responses of ratios. The LAKK-M, with the use of custom 
built cuvettes to minimise background noise, is therefore capable of stably measuring 
fluorophores of interest and calculating relevant ratios including the ORR. Although 
measuring flavins at ex450em550 appears the optimal method to delineate this 
fluorophore from others in solution, lower variability in ORR values from cells when 
measuring flavins at ex365em550 compared to ex450em550 suggests that this is a more 
stable wavelength for making measurements diagnostically. Analysis of the ORR from 
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organoids (chapter 3) and human tissue (chapter 4) therefore use the ORR defined as 
NADH(ex365em490)/flavins(ex365em550) 
Confocal microscopy setup was prepared as closely to these parameters as possible, 
limited by the available equipment. From studies using the mitochondrial dye 
MitoTracker a strong association can be seen between MitoTracker fluorescence and 
that hypothesised to arise from cellular NADH and flavins. Elucidation of contributing 
cell fluorophores at the chosen wavelengths could be improved by obtaining higher 
resolution images and also by overlapping images obtained from MitoTracker and 
autofluorescence. There is a small amount of autofluorescence observed using confocal 
microscopy which does not associate with the mitochondria. It is possible that this 
fluorescence is arising from either bound or unbound non-mitochondrial (cytoplasmic) 
NADH/FAD or from fluorescent amino acids such as tyrosine and tryptophan. In my 
experience, and in previous literature224, the excitation wavelength used was out-with 
the optimal excitation wavelength for these amino acids however, as UV fluorescence 
spectroscopy of tryptophan and tyrosine solutions yielded far lower fluorescence 
intensity than from NADH and flavins. One concern to the use of such strong laser 
powers for confocal microscopy (up to 60mW) was the unwanted effects of irradiation 
on cells. Irradiation using a 355nm laser at 60mW may reduce cell viability over time. 
Future studies using similar setups should be careful therefore that similar laser powers 
do not affect the viability of sample cells.  
Data from flow cytometric analysis indicates that bladder cancer cells possess a 
statistically significantly increased ORR (ex360em425-475/ex488em515-545) 
compared to healthy cells (p = 2 x 10-16)225. This is in keeping with knowledge of the 
ORR in other models of cancer and pre-cancer, including breast cancer222. For this 
analysis, 10,000 cells were measured each, in triplicate, from healthy and cancer bladder 
cells. Optimal parameters were again limited by the availability of physical equipment, 
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meaning excitation and emission parameters differed up to 40nm either way from the 
setup used with the LAKK-M system or confocal microscopy. I believe, according to 
previous similar research in the field, that this will not cause significant analysis issues, 
as the use of flow cytometry to measure autofluorescence was previously suggested by 
Thorell in the 1980s226. The use of techniques to minimise background autofluorescence 
for conventional flow cytometry measurements suggests that autofluorescence signals 
are worth studying in their own right227. Results from this analysis suggest that flow 
cytometric analysis of ORR may be a worthwhile diagnostic technique to assess the 
metabolic parameters of urothelial cells shed in voided urine. In theory, the ability to 
measure both NADH and flavin levels in the same cell, allowing the construction of 
“redox overview” could prove a useful diagnostic tool. This setup has been 
demonstrated to be capable of measuring mitochondrial NADH and flavin levels on a 
cell-by-cell basis, while further equipment modifications may allow for the assessment 
of more endogenous fluorophores (for instance, an excitation wavelength closer to 
300nm could allow for the analysis of cellular tryptophan or tyrosine levels). The 
calculation of cell redox ratios means that compensation for cell size is not required, 
considerably simplifying the setup. In order to further progress this technique, it would 
be useful to simultaneously calculate cell viability using a dye such as To-PRO iodide. 
Cell viability was measured following this experiment and estimated to be around 95%, 
however this was using the less sensitive trypan blue dye exclusion analysis on a 
haemocytometer. Furthermore, in theory the 5% dead cells included in analysis may be 
unfairly skewing values. Additionally, a small secondary population of healthy cells 
with increased flavin content can be observed from the redox plots. It would be 
interesting in future to assess what contributes to this difference and how this population 
contributes to overall ORR measurements. It may be that the secondary population of 
cells with increased flavin content corresponds to the 5% dead cells measured using 
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Trypan Blue exclusion analysis. Further investigation into the autofluorescence profiles 
of dead and dying cell populations will help to better understand this. Flow cytometric 
analysis was hampered by slow turnover rate of primary “HUC” cells, therefore it is 
suggested that the use of a robust, immortalised healthy cell line, such as “SV-HUC” 
would be beneficial for establishing future results. SV-HUC cells have been used as 
healthy controls in many areas of contemporary urology research, however an initial 
concern was that the immortalisation of these cells may have caused metabolic 
alterations which skew the ORR towards a cancer phenotype.   
Speaking clinically, the use of ORR flow cytometry could prove an attractive technique 
as it is fast, completely non-invasive and detects a cellular defect which often occurs 
early in development of cancer. Conventional flow cytometry228 and DNA image 
cytometry229 have enjoyed application in bladder cancer detection previously, paving 
the way for potential application of ORR flow analysis. Furthermore, the visualisation 
of redox overviews allows for the observation of the redox profile of each cell in 
populations upwards of 10,000, therefore allowing the identification of very rare cells 
with potentially aberrant metabolism. As only cell lines were used, clinical 
implementation of this technique would likely require more thorough investigation of 
the phenomenon of increased ORR in cancer cells across a wide range of cell lines of 
varying grades and stages. This study was limited by time and financial constraints to 
the study of the “5637” cell line, therefore the study of a wide range of bladder cancer 
cell lines as a future avenue of study is suggested to move towards potential clinical 
applications. I hypothesise that cancer cell lines of higher stages and grades will 
demonstrate progressively increased ORR values compared to healthy control cells.  
Having confirmed the hypothesis that bladder cancer cells would possess an increased 
ORR relative to healthy bladder cells, I sought to investigate whether this phenomenon 
could be accurately identified using the LAKK-M system. Healthy and cancer cell line 
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fluorescence in the UV and blue spectra was found to broadly follow that of NADH and 
flavin solutions, indicating again that these are the major contributing fluorophores. 
Results indicate that, although there is a noticeable dose dependence in cellular 
autofluorescence measured by the LAKK-M, there is very low overall fluorescence. 
Furthermore, there was found to be noticeable day to day variations in ORR even within 
the same cell lines. It was found that in the region of 2-5 x 106 cells/ml minimum were 
required to receive adequate signals above the PBS background signal, which is far 
greater than the concentration of urothelial cells normally shed in urine. Due to the slow 
turnover rate and relatively low yield of healthy bladder cell line “HUC”, it was difficult 
to yield adequate cell concentrations for meaningful analysis. The existing 
measurements comparing healthy and bladder cancer cell lines show no statistically 
significant difference in the ORR. At present, therefore, the LAKK-M system is not 
suitable for measuring fluorescence from cell suspensions.  
The low fluorescence signal recorded from cell suspensions may be due to the low 
relative power of the laser sources in the LAKK-M system itself. The inherent power of 
the UV and blue lasers in the LAKK-M, measured using an optical power meter 
(ThorLabs) is in the region of 1-2mW. Considering that confocal microscopy 
measurements required 100% laser power in sources with 30mW (blue laser) and 
60mW (UV laser) optical power to elicit cellular fluorescence, it can be suggested that 
an increased laser power in the LAKK-M system would be of use for this application. 
Increasing laser power in the LAKK-M would bring new issues with its use on living 
tissue, as high power UV irradiation is known to be mutagenic230. It is suggested that 
the low fluorescence signal and high day to day variability from cell suspensions may 
also arise due to uneven distribution of cells in solution, leading to high levels of light 
scattering, discussed by Mourant et al.231. Previous studies using spectrophotometry and 
spectrofluorimetry to analyse cell suspensions have employed magnetic stir bars to 
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ensure even suspensions of cells in solution. I attempted to incorporate a magnetic stir 
bar (Gilson LabStir) into cell spectroscopy measurements (Fig. 29), however the 
thickness of the custom cuvette obscured the magnetism. It is suggested based on these 
findings that a new custom cuvette with a thinner base may allow for more even cell 
suspensions in solution and more accurate fluorescence measurements.  
A concern of using a magnetic stir bar for LAKK-M fluorescence measurements comes 
from the inherent fluorescence of the stir bar itself. The background fluorescence of an 
empty cuvette was compared with the fluorescence from a cuvette containing a stir bar, 
finding fluorescence in UV and blue spectra arising from the stir bar (Fig.33).  
Spectrofluorimetry measurements of cell suspensions generally employ a laser passing 
from one side of the cuvette to the other, entering the detector on the far side and 
bypassing the stir bar. As the LAKK-M contains both excitation source and detector in 
the same fibre, light travelling down into the cuvette and back will interact with the stir 
bar (Fig.53). Modifications to the cuvette, allowing the attachment of the optical probe 
to the side, or a custom design matte black stir bar may allow for measurements using 
this method.  
 
Figure 53 Diagrams of fluorescence spectroscopy using the LAKK-M system (a) and 
conventional spectrofluorimetry (b) 
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A potential future avenue of interest for urinalysis would be the comparison of 
autofluorescence of urine samples from healthy controls and patients with bladder 
cancer. It has been demonstrated that the majority of fluorescence from urine comes 
from the supernatant itself, with very little coming from the voided urine cells. 
Fluorescence analysis of voided urine has previously shown the ability to detect 
bacteriuria186, cervical cancer232 and ovarian cancer183, however there is no published 
research covering fluorescence analysis of urine in bladder cancer. It is suggested from 
fluorescence spectra that the main fluorophores in voided urine are NADH and flavins 
therefore the ORR could potentially be used to account for fluorescence amplitude 
variations between samples and day-to-day. It may also be feasible to study other 
fluorophores such as endogenous voided porphyrins. Based on this preliminary data, an 
application is underway to carry out a pilot study comparing autofluorescence from 
urine of bladder cancer patients with healthy control using the LAKK-M system.  
2.5 Conclusion 
To conclude, it has been demonstrated that the major contributing fluorophores to 
cellular autofluorescence at the wavelengths of interest are likely the mitochondrial 
NADH and flavins. There exists a statistically significant difference (p = 2 x 10-16) in 
the ORR (ex360em425-475/ex488em515-545) between healthy and bladder cells, 
determined using a customised flow cytometry setup. Further study in the field of 
autofluorescence flow cytometry, particularly using the ORR, could lead to novel 
clinical breakthroughs. The LAKK-M, although capable of making spectroscopic 
measurements, is not suitable at present for assessing ORR values from cell suspensions 
owing to low fluorescence yield and high incidence of scattering events. Increasing 
laser power of the LAKK-M system and modifying custom cuvettes to allow the 
addition of magnetic stir bars may serve to rectify these issues, providing the 
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opportunity to use this system for voided urine cytology. Analysis of urine supernatant 
autofluorescence from healthy and bladder cancer patients may provide novel insights 
into avenues for non-invasive disease diagnosis and monitoring.  
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3. ORGANOID DEVELOPMENT 
3.1 Introduction 
One of the main challenges facing autofluorescence spectroscopy for medical 
application is a poor understanding of individual fluorophore properties, particularly 
regarding changes as tumours progress through stages (CIS to non-invasive to muscle 
invasive). In chapter 2, early detection of bladder cancer by studying autofluorescence 
properties at a cellular level was discussed. The ability to analyse an autofluorescence 
model of bladder cancer which grows and progresses over time could allow new 
insights into the structural and metabolic processes occurring in developing tumours. 
This would allow researchers to more reliably identify biomarkers of interest, 
potentially leading to the application of autofluorescence spectroscopy to bladder cancer 
detection and diagnosis.  Among the most applicable and attractive methods with which 
to study developing tumours is the use of organoids. Organoids are small, organotypic 
reconstructions of human tissues which can be grown or maintained In vitro. Organoid 
models have previously been demonstrated for a range of tissue and disease types, such 
as colon233 and prostate cancer234. Organoids are generally split into 2 categories: those 
grown from small clusters of cancer cells and those which depend on a tissue scaffold 
for growth (developed from synthetic chemicals such as Matrigel, or from excised 
animal or human tissue). Bladder organoids have previously been developed using 
rat134,235, pig137 and human explant tissue136. Human bladder cancer cells have 
previously been shown to adhere to rat and porcine mucosal tissue, allowing research 
groups to better investigate how bladder cancer invasion, progression and recurrence 
occurs alongside assessing therapeutic options for disease In Vitro. Huygens et al. 
developed a bladder cancer organoid model from urothelial cells to study the 
penetration of the PS agent Hypericin into tissue236. Additionally, autofluorescence 
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imaging has been applied to the study of the optical redox ratio in breast cancer 
organoids in response to drug therapy237. Despite this increasing focus on cancer 
organoids in disease research, there exists no literature covering autofluorescence 
profiles in developing bladder cancer organoids. Second harmonic imaging of organoids 
is likewise poorly covered in the literature, however this technique may reveal 
progressive changes in collagen in the underlying connective tissue. SHG imaging has 
previously been used to identify hallmark collagen patterns in malignant breast tissue 
and ovarian tissue93, therefore it may also be of worth for bladder cancer. As urothelial 
thickening often obscures collagen autofluorescence signals in bladder cancer, 
combined use of autofluorescence and SHG imaging of tissue will be a useful tool to 
better assess the relationship between collagen and NADH/FAD profiles in disease. 
Combined MPM/SHG imaging has been used to assess morphology of mouse bladder 
tissue96 and to discern between healthy and cancerous bladder tissue in a small sample 
size98. The focus of this chapter, therefore, is the development of an organoid model of 
muscle invasive human transitional cell carcinoma of the bladder using porcine bladder 
tissue and a human bladder cancer cell line. This work was informed by previous work 
by Varley et al. in which human bladder mucosa was successfully reconstructed using 
urothelial cell lines136, and work by Janssen et al. to develop a straightforward bladder 
organoid model using porcine bladder biopsy135. Within this model, bladder cancer cells 
were found to adhere to tissue scaffold by day 2 of the study, culminating in invasion 
and an invasive TCC phenotype by day 12. My hypothesis was that application of 
autofluorescence spectroscopy to the developing organoids would reveal progressive 
changes in the optical properties of tissue, related to fluorescence intensity and 
fluorescence ratios such as the optical redox ratio. Furthermore, I hypothesised that 
second harmonic generation imaging of tissue sections would reveal differences in 
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collagen volume and orientation around the infiltrating cancer cells, in keeping with 
previous work on breast cancer.  
Autofluorescence spectroscopy of the developing organoids revealed significant 
changes in the optical properties (spectral shape and ORR values) compared to control 
samples. Furthermore, SHG of the tissue slides revealed significant differences in the 
collagen volume and texture surrounding cancer cells. It is hoped that these newly 
recognised factors can help to apply non-invasive medical imaging to human tissue, 
with a better understanding of potential diagnostically relevant biomarkers.  
3.2 Methods 
3.2.1 Porcine bladder scaffold 
Porcine bladders from freshly slaughtered pigs were purchased from Medical Meat 
Supplies Ltd. The tissue was halved to reveal the urothelial surface of the bladder. From 
one half of the bladder, a 20 cm2 (4cm x 5cm) section was cut with a scalpel. From this, 
the mucosa and a small section of muscle were cut away from the remaining muscle 
layer, to give a tissue scaffold with a remaining thickness of roughly 2-3mm. The 
mucosa/muscle layer was kept and the remaining muscle was discarded. Following this, 
the tissue scaffold was cut into 20 identical sections of 1cm2, washed x 3 in Phosphate 
Buffered Saline (PBS) (Sigma Aldrich) to remove leftover urine or contaminants, 
sterilised in 10,000 Units Penicillin- 10mg Streptomycin solution (Sigma Aldrich) and 
transferred to 0.25% Trypsin – EDTA solution (Sigma Aldrich) and incubated for 15 
minutes to disrupt urothelium, following which they were again washed in PBS x 3 and 
placed in individual wells of a Corning Costar 12 well plate (Sigma Aldrich). It is 
important to note that the scaffold was not acellular. A cross section of the tissue 
scaffold (54a) and an image of the optical probe in contact with the tissue (54b) are 
included in Fig.54. Tissue fluorescence measured in a plastic 12 well plate was 
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compared with tissue fluorescence in custom matte-black cuvette, ensuring that 
background plastic fluorescence did not interfere with measurements.  
 
Figure 54 Experimental setup of organoid measurement showing cross-section (A) and 
top-down view (B) of optical probe (1) touched to urothelial surface (2) overlaying 
connective tissue (3) and muscle layer (4) 
3.2.2 Cell culture 
Bladder cancer cell line “5637” was purchased from American Type Culture Collection 
and grown for several passages in Dulbecco’s Modified Eagle Medium (DMEM) 
(Sigma Aldrich) supplemented with 10% Fetal Bovine Serum (FBS) (Sigma Aldrich) 
and 1% Penicillin-Streptomycin (Sigma Aldrich) in 75cm2 cell culture flasks (Corning). 
At 70% confluence, cells from one flask were detached by conventional trypsinisation, 
re-suspended in DMEM, split into ten 15ml Falcon tubes (BD Biosciences) and spun at 
1500RPM for 10 minutes to form pellets. Pellets of approximately 106 cells were 
applied to ten of twenty bladder scaffolds, leaving ten scaffolds as a control. The 
scaffolds and cell pellets were each resuspended in 1ml DMEM (10% FBS, 1% 
penicillin-streptomycin, 1% Fungizone) and incubated overnight. 
3.2.3 Fluorescence spectroscopy 
Fluorescence spectroscopy was performed using multi-functional laser based non-
invasive diagnostic system “LAKK-M”, described in greater detail in Chapter 1. The 
Page 128 of 232 
 
Scott Palmer  July 2016 
system was initiated 30 minutes prior to study then transferred to the cell culture lab. 
Measurements were performed at the same time on all samples in the afternoon of each 
day on days 0, 1, 4, 7, 11, 14, 18 and 21 of study by gently bringing into contact, 
without pressing down, the probe of the “LAKK-M” to the exact centre of the mucosal 
(upward facing) surface of tissue each time. On day 0, tissue was measured prior to 
seeding of cancer cells to ensure all tissues displayed similar fluorescence. Fluorescence 
measurements were performed in the dark to prevent interference from background 
noise. Measurements were performed sequentially for each wavelength. Spectra 
recorded from tissue was visualised on accompanying laptop using custom-made 
software (LDF 3 v3.1.1.403, SPE “LAZMA” Ltd, Russia).  
3.2.4 Confirmation of invasion 
A pilot study was run using the steps described, but for two and twelve days, after 
which the samples were fixed in formalin and submitted to the Tayside Tissue Bank, 
Ninewells Hospital, Dundee, for sectioning and staining of tissue slides with 
Haematoxylin and Eosin (H & E). Attachment of cancer cells to scaffold in organoids 
by day two, and T1 transitional cell carcinoma phenotype by day 12, were confirmed by 
an experienced pathologist. Slides were imaged at 200x magnification using a Nikon 
Eclipse E600 microscope. H & E stained slides of control (55A), attachment (55B) and 
invasion (55C) are included below (Fig.55): 
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Figure 55 H & E stained sections of control (A), attachment of cancer cells (B) and 
invasion of cells into tissue (C) with tissue scaffold and cancer cell labelled as 
appropriate 
To compare tissue with human equivalent, H & E stains of human tissue were requested 
from Tayside tissue bank, photographed using the same setup and included below. 
Organoid and control sections stained with H & E are depicted below (Fig. 56).  
 
Figure 56 Comparison of H & E stained human healthy tissue (A) with organoid 
control (B) and human TCC (C) with cancer organoid (D) 
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3.2.5 Data analysis 
Data was analysed using custom made analysis software LDF 3 v3.1.1.403 (SPE 
“LAZMA” Ltd). The software calculates and records the amplitude of fluorescence (Af) 
at distinct pre-set wavelengths in accordance with previously published literature. The 
fluorophores of interest and their excitation and emission values were as follows (Table 
8)199: 
Table 8 Common tissue fluorophores measured using the LAKK-M system 
Fluorophore Excitation (nm) Emission (nm) 
Collagen 365 420 
Elastin 365 450 
NADH 365 490 
Flavin 365 550 
Flavin (450 ex.) 450 510 
Lipofuscin 532 570 
Carotene 532 608 
Porphyrin 633 710 
 
Optical redox ratio was calculated for each sample on each day as NADH (ex365 
em490)/Flavin (ex365 em550) as this was determined the most stable measurement in 
chapter 2. Additionally, the following ratios were also calculated: Elastin/NADH; 
NADH/Collagen and Elastin/Flavin. Elastin/NADH, elastin/flavin and NADH/collagen 
ratios were selected to address structural rather than metabolic changes in tissue and to 
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best reflect spectral differences between control and organoid samples by day 21. 
Average and ratio values were compared by plotting mean + SEM (Standard Error of 
the Mean) for control versus organoid over the 21 days of study. One control sample 
was removed from study on day 4 owing to fungal contamination. Two further control 
samples were removed on day 18 due to fungal contamination. Collected data were 
analysed and plotted as graphs using Origin Pro 8 (OriginLab). Data were compared 
and assessed for statistically significant differences at each time point using AOV 
(ANOVA) test in R Studio (leverage of residuals and Q-Q plots were assessed to ensure 
applicability of analysis) for p value with p < 0.05 considered statistically significant. 
Data from each day were compared and analysed separately for statistical significance 
to account for the removal of contaminated specimens on days 4 and 18. 
Based on this data, ROC curves were generated, charting sensitivity (y-axis) versus 1 – 
specificity (x axis). ROC curves were generated for ORR (NADH/FAD) and 
elastin/NADH on day 21 only using MATLAB and were qualified based on their 
calculated area under the curve (AUC) value. AUC values indicate the diagnostic worth 
of a test, ranging from 0.5 – 1.0 with 0.5 = useless and 1.0 = ideal.  
3.2.6 Second harmonic generation imaging 
Microscope slides containing 5µm thick H & E stained sections of control (n = 2) and 
organoid (n = 5) tissue were assessed using a Leica TCS SP8 confocal microscope with 
20x objective fitted with tunable IR for MPM and SHG (Fig. 57). SHG was excited 
from samples at 880nm and detected in the forward direction (below samples) using a 
photomultiplier tube (PMT) with a 440/20 band-pass filter to detect and report full 
signal between 430-450nm and discard all <430nm and >450nm. Cancer cell outlines 
were detected by transmitted light at 488nm detected above the sample by a transmitted 
light sensor. Individual and merged images were saved and opened in Leica “LASX” 
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microscope image analysis programme. Channel 1 (transmitted light) was not modified 
in the programme. Channel 2 (SHG signal) was compressed to a setting of 790/4095 for 
each image to improve contrast. Snapshots were taken of merged images, saved as 
JPEGs and exported for further analysis. From the JPEGs of dimension 420 x 420 
pixels, individual frames of 60 x 60 pixels were cut for study using Photoshop 6.0 from 
the area of connective tissue, displaying the strongest SHG intensity. In total, 24 frames 
were taken from 2 slides of control tissue and 29 frames were taken from 5 slides of 
organoid tissue. Selection of regions of interest from full scans are shown in Figure 58. 
Tissue sections were analysed in MATLAB using grey level co-occurrence matrix 
(GLCM) texture analysis. GLCM represents an estimate of the separation of adjacent 
grey levels in the matrix “i” and “j”. From the GLCM, energy, entropy, correlation, 
contrast and inverse different moment can be derived. The parameters, their derivations 
and what they represent are denoted in Table 9. Alongside GLCM analysis, average and 
maximum pixel intensity was calculated for each frame.  
Table 9 Parameters derived from GLCM 
Parameter Formula Information 
Energy 
 
Uniformity of pixel 
information 
Entropy 
 
Randomness of 
texture 
Contrast 
 
Local variations in 
GLCM 
Inverse Different 
Moment 
 
Local correlation of 
pixels 
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Figure 57 General setup of confocal imaging system used to generate SHG images, 
showing combination of SHG signal at 440nm with transmitted light at 488nm. 
 
Figure 58 Sectioning of SHG image to remove background signal and include areas of 
strong SHG signal for analysis (image generated as montage of fields of view from one 
healthy sample) 
3.2.7 Classification algorithms 
Classification algorithms were developed using MATLAB data processing software. 
For autofluorescence spectroscopy, the algorithm analyses a CSV file containing 
spectral fluorescence intensity data, calculating the area under the curve (AUC), ratio of 
450/490nm (elastin/NADH) and the ratio of 490/550nm (NADH/flavins), using pre-set 
diagnostic threshold to determine healthy from cancer. In each instance, a parameter of 
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interest was selected, either NADH/flavin or elastin/NADH, following which the 
measured value for the sample in question was compared against a threshold. For ORR 
values, the threshold was 2 (>2 = healthy, <2 = cancer) and for elastin/NADH the 
threshold was 1.1 (>1.1 = healthy, <1.1 = cancer). The programme then provides the 
spectral chart, alongside the opinion as to whether tissue is healthy or cancer. For SHG, 
the algorithm analyses the GLCM parameters from Table 9. The programme then 
provides a classification output based on a calculated parameter as to whether the tissue 
is healthy or cancerous, with diagnostic thresholds as follows: energy (<0.1 = cancer); 
entropy (>3.5 = cancer); contrast (>7.5 = cancer); correlation (<0.05 = cancer); average 
brightness (>60 = cancer); pixel/pixel ratio (>1 = cancer).  
3.3 Results 
3.3.1 Fluorescence spectra 
The average UV fluorescence spectra for both control and organoid samples were 
compiled and plotted at the beginning (Day 0) and end (Day 21) of experimental time 
course. Average fluorescence spectra on day 0 are similar (Fig.59a), however 
fluorescence spectra on day 21 (Fig.59b) show differences in line shape suggestive of 
altered levels of contributing fluorophores.  
 
Figure 59 Average UV spectra of control (orange line) and organoid (blue line) on days 
0 (A) and 21 (B). Orange and blue lines on A represent n = 10; orange line on B 
represents n = 7; blue line on B represents n = 10. 
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3.3.2 Optical redox ratio 
Data on each day was handled and analysed separately to account for the removal of 
contaminated specimens. Measurements of individual fluorophores over time (Fig. 60-
62) showed no consistent significant changes, with the exception of flavins, which show 
a general trend of increasing in organoids. Optical redox ratio (ORR) values (measured 
as NADH (ex365em490)/flavins (ex365em550)) show a sharp decrease in organoids, 
from equitable levels to control at day 0 to progressive decreases across day 1-21 
(Fig.63), which may be partially caused by the changes observed in flavins. Data at day 
0, before addition of cancer cells, were found to not be statistically significantly 
different (p = 0.334), however data on each subsequent day were found to be 
statistically significantly different (day 1, p = 0.0118; day 4, p = 0.000977; day 7, p = 1 
x 10-6; day 11, p = 9 x 10-10; day 14, p = 3.5 x 10-8, day 18, p = 7.8 x 10-7; day 21, p = 
5.15 x 10-6). Day to day variations in environment and instrumentation are accounted 
for by control. ORR calculated using flavins measured under blue excitation 
(ex450em510) showed no significant difference over the course of the experiment (day 
0, p = 0.918; day 1, p = 0.335; day 4, p = 0.712; day 7, p = 0.636; day 11, p = 0.232; day 
14, p = 0.204; day 18, p = 0.9; day 21, p = 0.483). The cause of this remains to be 
determined by future investigation.  
3.3.3 Elastin relative to metabolic cofactors 
Taking the ratio of elastin fluorescence (ex365em450) against that from both the 
metabolic cofactors NADH (ex365em490) (Fig.62) and flavins (ex365em550) (Fig.64) 
also shows significant decreases in the relative elastin levels compared to these 
fluorophores in organoids across the 21 day period. For elastin/NADH measurements, 
data at day 0 and day 1 were not statistically significant (p = 0.668 and p = 0.146, 
respectively), however differences in data from each subsequent day was statistically 
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significant (day 4, p = 0.00236; day 7, p = 5.3 x 10-7; day 11, p = 6.9 x 10-5; day 14, p = 
0.000102; day 18, p = 0.00282; day 21, p = 0.000146). Data from elastin/flavin 
measurements on day 0 were not statistically significant (p = 0.598), however 
differences in data were statistically significant on each subsequent day (day 1, p = 
0.0282; day 4, p = 0.000588, day 7, p = 2.14 x 10-7; day 11, p = 1.81 x 10-8; day 14, p = 
1.1 x 10-7; day 18, p = 1.27 x 10-5; day 21, p = 3.07 x 10-6), which again may be partially 
caused by the increased flavin values in organoids over time. Data from 
NADH/collagen showed no consistent statistically significant changes across the 
experimental period. Furthermore, data for this ratio on day 0 prior to addition of cancer 
cells was statistically significant (p = 0.0182). This is possibly due to very low relative 
fluorescence of collagen recorded at ex365em420 making it susceptible to background 
noise interference. 
 
Figure 60 Day to day variations in elastin fluorescence measured from samples at 
ex365em450. Black line depicts control average (n = 10 on days 0 &1, n = 9 on days 4, 
7, 11 & 14, n = 7 on days 18 & 21), red line depicts organoid average (n = 10 on each 
day). Error bars depict standard error of the mean (SEM) 
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Figure 61 Day to day variations in NADH fluorescence measured from samples at 
ex365em490. Black line depicts control average (n = 10 on days 0 &1, n = 9 on days 4, 
7, 11 & 14, n = 7 on days 18 & 21), red line depicts organoid average (n = 10 on each 
day). Error bars depict standard error of the mean (SEM) 
 
Figure 62 Day to day variation in flavin fluorescence measured from samples at 
ex365em550. Black line depicts control average (n = 10 on days 0 &1, n = 9 on days 4, 
7, 11 & 14, n = 7 on days 18 & 21), red line depicts organoid average (n = 10 on each 
day). Error bars depict standard error of the mean (SEM) 
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Figure 63 Average ORR values for control (solid line) and bladder cancer organoid 
(dashed line) across the 21 day measurement period (+/- SEM). Organoid n = 10 on 
each day. Control n = 10 on days 0 & 1, n = 9 on days 4, 7, 11 & 14 and n = 7 on days 
18 & 21. 
 
Figure 64 Average elastin/NADH ratios for control (solid line) and cancer organoids 
(dashed line) across the 21 day study (+/- SEM). Organoid n = 10 on each day. Control 
n = 10 on days 0 & 1, n = 9 on days 4, 7, 11 & 14 and n = 7 on days 18 & 21. 
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Figure 65 Average elastin/flavins ratios for control (solid line) and cancer organoids 
(dashed line) across the 21 day measurement period (+/- SEM). Organoid n = 10 on 
each day. Control n = 10 on days 0 & 1, n = 9 on days 4, 7, 11 & 14 and n = 7 on days 
18 & 21. 
3.3.4 Development of Diagnostic Algorithm 
The significant results for the ratios covered previously led to assessment of their worth 
as diagnostic criteria to classify control and organoid samples. It can clearly be seen 
based on the organoid data that the UV ORR (NADH/Flavins) is a good candidate with 
which to classify both control and organoid samples, with an ROC AUC value of 1 (Fig. 
66a). Elastin/NADH ROC analysis similarly delivered an AUC value of 0.99, indicating 
diagnostic promise (Fig. 66b). It would be of interest to determine how well these ratios 
apply to human biopsy data, therefore this was attempted in chapter 4. Below, Figure 67 
displays the diagnostic interface developed in MATLAB to provide diagnostic opinion 
based on automated analysis of ORR and elastin/NADH parameters, alongside spectral 
readout and fluorescence AUC value. Based on a small sample size, this programme 
was capable of cancer organoid detection with 100% sensitivity and 100% specificity.  
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Figure 66 ROC curves for ORR (A) and elastin/NADH (B) values 
 
Figure 67 Screenshot of diagnostic interface showing measured parameters of AUC, 
ORR and elastin/NADH along with tissue classification 
3.3.5 Second Harmonic Imaging 
From the images of control and organoid acquired using SHG microscopy, the different 
layers of tissue can clearly be seen (labelled, Fig. 68 & 69) demarcated by their varying 
levels of collagen (light blue). In the urothelial layer there is moderate SHG from the 
collagen underlying the epithelial cells, in the connective tissue zone there is a higher 
signal from collagen and in the underlying muscular region there is almost no noticeable 
SHG. The difference in SHG signal between urothelial and connective tissue layers can 
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clearly be seen in Fig.68, while the difference between connective tissue and muscular 
layers can clearly be seen in Fig.69. This is in keeping with previous understanding of 
collagen distribution in the bladder. Furthermore, from SHG scans of the organoid 
tissue (Fig. 70) the presence of the bladder cancer cells attaching to the urothelium and 
invading into the connective tissue, forming “collagen nests” which generate a higher 
SHG signal.  
Mathematical assessment in MATLAB of individual frames of connective tissue from 
control and cancer organoid revealed a number of differences between the two tissue 
types which could be of diagnostic worth. Statistically significant differences were 
found between populations for energy (p = 2 x 10-16), entropy (p = 2 x 10-16), contrast (p 
= 2 x 10-16), correlation (p = 2 x 10-16), average brightness (p = 2 x 10-16) and pixel ratio 
number (p = 2 x 10-16). These differences indicate that connective tissue from cancer 
organoid samples is modified by invading cancer cells. This manifests as cancer 
organoids possessing increased averaged collagen content, more complex and less 
uniform textural information and increased contrast between regions, depicted in Figure 
70. Figure 71 displays bar charts (+/- SEM) for each of the measured SHG parameters 
from organoids, while Fig. 72 depicts a screenshot of the diagnostic interface showing 
tissue classification as either healthy or cancer.  
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Figure 68 Merged SHG + transmitted light of control sample slide showing connective 
tissue and urothelium 
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Figure 69 Combined SHG + Transmitted light image of control sample slide showing 
connective tissue and muscle 
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Figure 70 Combined SHG + Transmitted light image of cancer organoid slide showing 
bladder cancer cells adhering and invading into tissue scaffold 
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Figure 71 Bar charts depicting mean +/- SEM for energy (A), entropy (B), contrast (C), 
correlation (D), average brightness (E) and pixel ratio (F) comparing control with 
organoid (in each case, healthy n = 24, cancer n = 29) 
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Figure 72 Screenshot of MATLAB diagnostic interface designed to classify images 
based on measured GLCM parameters 
3.4 Discussion 
From the data presented in this chapter, patterns of fluorescence emerge as tissue 
scaffold is adhered to and invaded by the cancer cells. Fluorescence has been assessed 
from distinct endogenous tissue fluorophores using the “LAKK-M” diagnostic system 
and based on analysis techniques previously followed by Dunaev et al.199 and Akbar et 
al.205 Previous studies generating bladder organoids from porcine bladders have 
demonstrated viability of cells within tissue scaffolds up to 3 weeks after induction. 
From this it was concluded that 3 weeks would be a suitable time frame for this 
fluorescence study. This work has shown that the UV spectrum of organoids changes 
relative to control across the experimental period. To investigate why this occurred, the 
properties of several endogenous fluorophores across the study period were assessed. 
The study of individual fluorophores is not well suited to this type of spectroscopy, as 
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day to day variations in both laser power and tissue condition can affect amplitudes of 
fluorescence. Therefore no consistent patterns of fluorescence were observed from 
individual fluorophores. Instead, we looked at ratios of particular fluorophores relative 
to one another. The measurement of ratios, as used previously by Georgakoudi193, 
Ostrander190 and ourselves225, among others, provides a much more robust measurement 
of fluorescence parameters. In particular, I focussed on the metabolic cofactors NADH 
and flavins, and the structural protein elastin, all known to fluoresce under UV 
excitation. As the source of NADH and flavins is primarily cellular, the conclusion is 
that the progressive decrease in ratios of elastin/NADH and elastin/flavins may reflect 
adherence, epithelialisation and invasion of tissue by cancer cells. Furthermore, it may 
also directly reflect the progressive destruction of the structural protein elastin in the 
surrounding connective tissue of the mucosa, lamina propria and muscular layers as 
cancer cells attach and begin to secrete digestive enzymes such as matrix 
metalloproteinases to promote invasion. It is known from previous studies that the 
urothelium (2-3 cells thick) contributes significantly to the NADH and flavin signals 
present in bladder tissue. In optical biopsies obtained by multi-photon microscopy, 
intense autofluorescence can be observed on the top layers of urothelium with strong 
second harmonic generation (SHG) signal from collagen observed below. It is 
considered that the main fluorophores contributing to organoid fluorescence may be 
NADH and flavins from the new tumour urothelium, while control fluorescence may 
contain a higher contribution from the underlying collagen and elastin matrix of the 
lamina propria and extra-cellular matrix (ECM) with NADH and flavin signals arising 
from the remaining mucosa. Comparisons between H & E stained samples from control 
slides with healthy human tissue indicate that although a certain amount of 
mucosa/urothelium is present in control sample, future studies would benefit from more 
thorough reconstitution of the urothelium through use of healthy urothelial cell lines. 
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This was not attempted as this work represented a first step pilot study. Comparisons 
between cancer organoid slides and human bladder TCC slides indicate morphological 
similarities, namely the infiltration of cancer cells deep into tissue and the formation of 
irregular tissue patterns.  
Previous studies have suggested increased optical redox ratios (increased NADH 
relative to flavins) in cancer cells and tumours compared to healthy controls. The 
opposite of this was observed – a reduced optical redox ratio (measured as 
ex365em490/ex365em450) in the tumour organoid. This could be a result of changes in 
structural proteins, rather than changes in metabolism. As the excitation and emission 
profiles of elastin overlap somewhat with that of NADH, the complex fluorescence 
spectrum arising from UV excited tissue likely contains an NADH signal at 490nm with 
underlying contribution from elastin. Research by Croce et al. suggests that this overlap 
should be minimal past 450nm180, however it is possible that there is some contribution. 
The epithelialisation of organoids results in increased cellular fluorophores, therefore 
the reduced ORR seen in organoids may be a function of the increased Flavin to elastin 
ratio we observe rather than a reduced NADH – flavin couple. It is suggested from this 
research that studying the relative changes in elastin and collagen compared to NADH 
and flavins may serve as a useful tool for monitoring bladder tumour development. 
Furthermore, the high sensitivity and specificity of the diagnostic ratios for fluorescence 
spectra obtained from bladder cancer organoids suggests that these ratios merit 
application to human bladder samples to assess diagnostic worth (covered in the 
subsequent chapter).  
SHG imaging of tissue slides reveals a number of potentially useful parameters for 
discriminating between healthy and cancerous bladder tissue. Analysis focussed solely 
on connective tissue of the extracellular matrix as this possessed the strongest SHG 
signal and because the ECM is known to contribute significantly to bladder pathology148 
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in which collagen is known to contribute directly to both pro- and anti-cancer effects143. 
Increases in average pixel intensity in organoid sample slides indicate that implanted 
cancer cells are stimulating the production of new collagen fibrils in tissue, potentially 
to facilitate the production of cancer cell nests. The initial hypothesis was that the 
addition of cancer cells to tissue scaffold may have resulted in a decreased relative 
collagen content as cancer cells secreted MMPs to facilitate further invasion139, however 
this has been disproved by these findings. Future studies would benefit from 
investigating average pixel intensity values in larger population sizes and with varying 
grades of cancer cell. Furthermore, GLCM analysis reveals that cancer organoid slides 
possess greater textural variation, reflected in greater contrast and entropy values than 
control, combined with reduced correlation values. These findings can be accounted for 
by studying H & E stained slides of both organoid and human cancer samples. In both 
human cancer and organoid, regular tissue structure is disrupted by the invasion of 
bladder cancer cells. It can be concluded that the cancer cells are extensively modifying 
their environment to facilitate tissue invasion, causing changes in textural correlation in 
surrounding tissue (particularly ECM) compared to control samples which still possess 
a uniform anatomical structure. Unlike previous work in breast cancer, no obvious 
changes were observed in patterns of collagen distribution, denoted earlier by 
“TACS”94. This may be a result of comparing organoid studies with human biopsy 
analysis, or may simply be a result of different tissues of interest. Nevertheless, TACS 
and associated diagnostic patterns are a useful tool to further understanding and the 
clinical application of SHG imaging. GLCM application to intact organoids may allow 
us to better understand the collagen remodelling process as it happens, and identify 
suitable collagen patterns as diagnostic indicators, similar to work on TACS.  
In this chapter, a method has been demonstrated for studying the day-to-day changes in 
fluorophore levels during colonisation and invasion of bladder tissue by tumour cells. 
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That cells were still viable by day 21 of the study suggests this model could be further 
used for evaluation of fluorescent responses to drug and treatment regimens such as 
Mitomycin C, akin to microscopy work done by Walsh et al. for breast cancer237. 
Moving forward, it would also be interesting to study the fluorescence properties of 
colonisation of scaffolds by cell lines representing different grades of urinary bladder 
cancer. Finally, researchers may benefit from the development of organoids derived 
from human explant tissue to account for any structural differences between porcine and 
human bladder tissue. Critical time points could then be identified where fluorescence 
differs, giving a clinical insight into spectral cues for malignancy and invasion in 
bladder cancer. The application of SHG imaging to slides taken from organoids clearly 
allows the demarcation of tissue layers by relative collagen content and identification of 
adherence and invasion by bladder cancer cells. From a small sample size, a number of 
potential diagnostic factors has been identified for the detection of bladder cancer which 
display statistically significant differences between control and cancer and which 
display extremely high levels of sensitivity and specificity for cancer. It would be of 
great value to study a much larger number of samples to give a clearer understanding of 
collagen profiles. At present, the current SHG microscopy setup is not well suited to the 
study of developing organoids due to the risk of contamination. Modifications to the 
SHG setup to allow its use under culture conditions, along with characterising the 
optical properties of full thickness organoid tissue (rather than microscope sections) 
would allow application of SHG imaging in a similar way to the autofluorescence study. 
This would allow the assessment of collagen profiles day by day. The use of SHG 
directly addresses one of the shortcomings of our autofluorescence study using the 
LAKK-M – the relatively low fluorescence yield of collagen under 365nm fluorescence 
excitation and detection at 420nm. A better understanding of collagen roles in 
developing tumours may help to put proposed changes into context and directly address 
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the issue of tissue thickening as a cause of autofluorescence variation in bladder cancer. 
Combined autofluorescence and SHG imaging of developing organoids could give a 
wealth of structural and metabolic imaging, leading to the identification of relevant 
diagnostic biomarkers. Studies of this type may benefit from the use of multi-photon 
microscopy to elicit autofluorescence, rather than autofluorescence spectroscopy, as this 
modality is easily combined with SHG and can give image characteristics of tissue, 
noted in previous research in the field96,98. Furthermore, MPM utilises longer 
wavelength light, so may be better suited to the study of deeper lying tissues during the 
carcinogenesis process by exploiting the tissue optical window.  
3.5 Conclusion 
 
Autofluorescence spectroscopy of the bladder cancer organoid models developed 
reveals progressive changes in spectra as cancer cells attach and invade into tissue. This 
is seen by progressive decreases in organoid ORR values (measured as 
ex365em490/ex365em550), alongside changes in the ratio of the structural protein 
elastin to metabolic cofactors NADH and flavins. These findings suggest the 
introduction of cancer cells to bladder cancer induce both structural and metabolic 
changes, both of which could improve our understanding of bladder cancer as a disease 
and allow us to develop new diagnostic techniques and therapies. Similarly, SHG 
imaging of tissue slides has identified significant differences in collagen volume and 
distribution in organoid tissue, suggestive of modifications by cancer cells. Combined 
autofluorescence/SHG imaging of developing organoids will allow a much greater 
understanding of the structural and metabolic alterations occurring as tissue transitions 
from health to muscle invasive disease.  
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4. ANALYSIS OF HUMAN TISSUE 
4.1 Introduction 
As discussed previously, BCa is the 4th most common cancer in men and the 9th most 
common cancer overall in the UK, accounting for 5200 deaths each year1. 
Unfortunately, white light cystoscopy (WLC) and voided urine cytology (VUC) suffer 
from low sensitivity, especially for low stage cancers such as flat NMIBC and pre-
cancerous lesions like CIS13. VUC sensitivity for TCC is considered to be between 25-
50%14,15, while WLC sensitivity for TCC ranges between 60-70%16,17 (but can be as low 
as 4% for CIS cases18). The result of this low sensitivity is a high rate of tumour 
progression and recurrence, which puts a large burden on health services each year. 
Furthermore, bladder cancers which progress to MIBC stage can often only be 
adequately dealt with by radical cystectomy12. Photosensitisers accumulate 
preferentially in tumour tissue due to the enhanced permeability and retention effect238, 
and vividly fluoresce under laser illumination through the promotion of endogenous 
porphyrin generation. PDD using common PS agents such as hexaminolaevulinate 
(HAL)21 and 5-aminolaevulinic acid (5-ALA)27 are shown to greatly improve the 
sensitivity of cytoscopic detection of bladder cancer compared to WLC23 – reducing 
NMIBC recurrence rates24 - but at the cost of greatly reduced specificity due to uptake 
by inflamed previously treated by surgery or chemotherapy17,29. According to meta-
analysis, sensitivity of PDD ranges from 80-100%, while specificity ranges from 36-
79%17). The result of reduced specificity is a greater number of false positives and an 
increase in unnecessary biopsy. There is a great deal of focus on addressing the 
sensitivity-specificity disparity in BCa detection, with many suggested solutions.  
Many of the molecules present in human tissue naturally fluoresce, including structural 
proteins (collagen145 and elastin152), metabolic cofactors (NADH165 and flavins167) and 
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blood precursors (porphyrins175). Metabolic perturbations in cancerous cells and tissues, 
along with the structural effects of tissue remodelling and tumour invasion, can lead to 
changes in the autofluorescence profile of tissue. Tissue remodelling by tumours has 
previously been shown to significantly reduce local collagen levels to promote invasion 
and metastasis138. Furthermore, metabolic disparity between healthy and cancerous 
tissue has been extensively explained by the Warburg effect187, which postulates that 
cancer cells preferentially generate energy by aerobic glycolysis at the expense of 
oxidative phosphorylation. Thus, electron carriers including NADH accumulate in 
cancer cells, skewing the ratio of reduced metabolic cofactors relative to oxidised 
counterparts such as flavins. The optical redox ratio (ORR) takes into account the 
accumulation of NADH in cancer cells by ratioing NADH content by flavin content to 
give a measure of the extent of the Warburg effect. The ORR has previously been used 
to good effect to discriminate between healthy and cancerous cells of a number of tissue 
types189-191, including by ourselves in bladder cancer225. The worth of autofluorescence 
spectroscopy for cancer diagnosis in a wide range of tissues has previously been 
covered comprehensively100. Early research in the field identified UV fluorescence 
spectroscopy as a useful tool for detecting breast and lung cancers102. Furthermore, 
compared with PDD, autofluorescence spectroscopy has been shown to improve bladder 
tumour margin demarcation115. Spectral differences between healthy and neoplastic 
bladder tissue have previously been identified using autofluorescence 
spectroscopy111,112,114,116.  
Fluorescence spectroscopy of bladder cancer has generally relied on the use of UV light, 
which is known to excite a wide range of endogenous tissue fluorophores, therefore 
giving rise to complex multi-component fluorescence spectra. A major limitation to 
understanding and application of autofluorescence spectroscopy for bladder cancer 
detection is an inability to detect and identify individual fluorophores of interest within 
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complex spectra, however some groups are seeking to overcome this by delineating 
individual fluorophores146,147. D’Hallewin et al. have extensively covered the use of 
autofluorescence spectroscopy for bladder cancer118, concluding that changes in 
autofluorescence spectra of bladder cancer tissue is largely a result of epithelial 
thickening obscuring signals from underlying fluorophores, in keeping with previous 
findings from prostate cancer146 and Barrett’s oesophagus193.  Previously, in chapter 3, 
the use of combined autofluorescence/SHG imaging was discussed as a means to 
overcome the issue of tissue thickening in bladder cancer. It has been suggested 
therefore that AS is of little worth for CIS detection as this flat dysplasia does not cause 
tissue thickening. CIS nevertheless possesses considerable malignant potential, 
therefore early detection is of utmost importance. This issue has been addressed by 
Anidjar et al., recording diagnostic worth of urothelial tryptophan fluorescence for CIS 
diagnosis121.  
In chapter 2, the application of ORR measurements to bladder cancer diagnosis at the 
cellular level was studied, identifying some promising early results from flow 
cytometry, reflected in an increased ORR in bladder cancer cells compared to healthy 
control (measured as ex360em425-475/ex488em515-545). In chapter 3 progressive 
changes were identified in the optical redox ratio of bladder cancer organoids as they 
progressed from cancer cell attachment to muscle invasion203. In this chapter the direct 
assessment of human tissue is performed to apply knowledge from cells and organoids 
to clinical diagnosis of bladder cancer. I sought to use the multi-functional laser 
diagnostic device “LAKK-M” to investigate whether the decreased ORR seen in 
progressing bladder cancer organoids would be corroborated in human bladder tissue.  
One final limitation of bladder cancer diagnosis is the short wavelength of light used 
(generally UV or blue). Short wavelength light is scattered and absorbed much more 
readily by tissue, impeding its penetration deeper into tissue. As a result, it may be less 
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applicable to detect deeper lying tumours including CIS and flat lesions using short 
wavelength light. Longer wavelength of light (for instance, green and red) could provide 
diagnostic worth from deeper lying tissue through the analysis of endogenous 
porphyrins. There is current interest in the study of tissue optical properties at longer 
wavelengths, into the tissue optical window (650-950nm)239. The secondary objective, 
therefore, was to use longer wavelength light (635nm) to investigate whether 
endogenous porphyrins can be used as a diagnostic marker of bladder cancer). The 
majority of research into the relationship between porphyrin levels and bladder cancer 
relates to their accumulation following the addition of PS agents, therefore researchers 
do not understand in great detail the properties of endogenous porphyrin in non-
sensitised tissue. Previously, however, porphyrins have been shown to accumulate in 
oral cancer173 and in the blood175 and tissue176 of mice bearing renal cell carcinoma. It 
was therefore considered that endogenous porphyrins may likewise accumulate in non-
sensitised human bladder tissue. Finally, tying together both avenues of research, I 
sought to corroborate previous findings by Aboumarzouk et al.112 of a statistically 
significant difference in the ratio of NADH/porphyrins. My main hypotheses, based on 
our previous findings and on contemporary research, were: bladder cancer tissue will 
possess a reduced ORR, an increased endogenous porphyrin concentration and a 
reduced NADH/porphyrin ratio relative to healthy tissue. Research findings confirm 
these hypotheses: firstly, the ORR of human bladder cancer samples (measured as 
ex365em490/ex365em550) was found to be statistically significantly lower than healthy 
tissue, in keeping with previous findings in organoids; secondly, endogenous porphyrin 
levels were found to statistically significantly increase in cancer samples compared to 
healthy. Finally, the NADH/porphyrin ratio was statistically significantly reduced in 
cancer samples in keeping with previous findings by Aboumarzouk et al. These findings 
may better inform understanding of autofluorescence analysis of bladder cancer through 
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the corroboration of human fluorescence by a lab-based organoid model (ORR values) 
and through the identification of a suitable cancer biomarker at a longer wavelength 
(endogenous porphyrins).  
4.2 Methods 
4.2.1 “LAKK-M” Setup 
“LAKK-M” setup for this experiment was identical to that used in chapter 3. The same 
system was used under the same operating protocol. For further information, please read 
section 3.2.1. 
4.2.2 Fluorophore Fluorescence Spectroscopy 
Fluorophores of interest (NADH, FAD and Protoporphyrin IX (PpIX)) were purchased 
as powders from Sigma-Aldrich (Gillingham, Dorset, UK) and prepared to 1M solutions 
in phosphate buffered saline (PBS). The LAKK-M MLNDS device was used to measure 
the fluorescence of the solutions in matte black cuvettes. NADH and FAD were excited 
at 365nm and measured across 400-823nm and PpIX was excited at 635nm and 
measured across 650-823nm. ASCII files containing fluorescence spectra of 
fluorophores were exported to Origin Pro 8 analysis software and used to generate line 
graphs.  
4.2.3 Patient Recruitment 
Ethical approval was sought and obtained from NRES London Central Ethics 
Committee for a research project named “ABLADE: Diagnosis of bladder cancer using 
multifunctional laser” (REC reference 14/LO/1076, approved 17.06.14) with 
sponsorship from TASC (University of Dundee/NHS Tayside). The ethical approval 
granted 12 months for the recruitment of 20 patients to the study under informed 
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consent. In total, 20 patients were recruited to the study. Patient number for recruitment 
was based on predicted number of samples obtained (approximately 100), scale of 
predicted differences between healthy and cancerous tissue and desired p value for 
statistical significance (p<0.05). The inclusion criteria were: patients between the ages 
of 16-90 with suspected bladder tumour undergoing cystoscopic examination solely by 
WLC, with transurethral resection of bladder tumour (TURBT) at Ninewells Hospital, 
Dundee. Potential participants were identified and approached solely by the research 
team. Participants were given a participant information sheet (PIS) and asked to provide 
informed consent by signing and initialling a consent form.  
4.2.4 Tissue Fluorescence Spectroscopy 
Tissue obtained from patients undergoing TURBT at Ninewells Hospital, Dundee was 
delivered by surgical staff to the research team prior to fixation. TURBT was carried out 
on patients exclusively using WLC, therefore there was no addition of PS agents to 
tissue. The LAKK-M system was switched on 30 minutes prior to study and the study 
was performed in darkness, either in the workroom adjacent to the urology theatre (in 
Ninewells Hospital, Dundee), or in the microscopy laboratory (within the Division of 
Imaging and Technology, University of Dundee, Ninewells Hospital, Dundee). Tissue 
was placed mucosal side face up where possible (some tissue was obscured by crush 
and cautery artefacts) in a matte black cuvette. The optical probe of the LAKK-M 
system was brought into contact with the tissue surface and held for 10 seconds to 
steady, following which fluorescence spectra were taken from tissue at each of the 4 
wavelengths (UV, blue, green and red). One measurement was taken for each spectrum 
from each sample, however there were often multiple samples from the same site, which 
were recorded and analysed individually. A schematic of the tissue measurement is 
presented in Fig.73. The fluorescence spectra were saved in the “LDF 3.1” inbuilt 
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database, denoted by patient ID (Participant 1 = “ABLADE 1”, etc.) and by tissue 
location and sample number from that location (the 3rd sample studied from the right 
bladder wall would be “RBW3”, etc.). Prior to fluorescence spectroscopy of the tissue, 
reference spectra for each of the 4 excitation wavelengths (UV, blue, green and red) 
were recorded from the matte black cuvette to ensure the background fluorescence was 
minimal. The pathology opinion of the tissue was not known to the research team at the 
time of analysis. Immediately after analysis, the biopsy samples were delivered to the 
pathology lab (in Ninewells Hospital, Dundee) by a member of the research team. In 
total, the process of receiving samples, measuring and returning to the pathology lab 
took no longer than 2 hours in each instance.  
 
Figure 73 Cross section of tissue fluorescence measurement showing optical probe (1) 
containing individual excitation and detection fibres, in contact with the mucosal 
surface of biopsy tissue (2) held in matte black cuvette (3) 
4.2.5 Histopathology as reference standard 
All pathology analyses were independently provided by an experienced, qualified NHS 
pathologist with no involvement in the research team and no knowledge of the 
spectroscopy results. In total, from 20 participants, 122 samples were received. Of the 
122 samples, 33 were confirmed healthy and 89 were diagnosed as bladder cancer. Of 
the 33 healthy samples, 10 were normal (non-inflamed) and 23 were inflamed 
(including cystitis cystica). Within the 89 bladder cancer samples, 6 were CIS, 7 were 
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squamous cell carcinoma (SCC) and the remaining 76 were transitional cell carcinoma 
(TCC). The TCC samples were further broken down by stage: 30 samples were Ta 
(tumour is contained entirely within the urothelium/transitional epithelium); 20 samples 
were T1 (tumour extends into connective tissue without invading muscle); 26 samples 
were T2 (tumour invades into underlying muscle). All 7 of the SCC samples were stage 
T2.  
4.2.6 Data Analysis 
Sample spectra were exported as ASCII files and combined, plotted and visualised 
using Origin Pro 8 analysis software. One blue spectrum and one green spectrum were 
disregarded due to instrumental error. Area under the curve (AUC) values for tissue 
fluorescence spectra were recorded as follows (sum values were divided by 5 to account 
for the 0.2nm increment step in spectrometer measurements, thus giving results in 
standard units (nm)): UV (Σ400-823nm); Blue (Σ470-823nm); Green(Σ550-823nm); 
Red(Σ650-823nm). From the custom-made LDF3.1 software, amplitudes of 
fluorescence for specific fluorophores of interest were recorded, in keeping with 
previous work by Dunaev et al199, Akbar et al.205 and Smirnova et al.206. The excitation 
and emission wavelengths for the endogenous fluorophores of interest were identical to 
chapter 3. 
Amplitudes of fluorescence for each fluorophore for each tissue were calculated at the 
listed parameters and included in a study master file. Additionally, the ORR for each 
sample was calculated as (NADH/FAD) in accordance with chapters 2 & 3 
(ex365em490/ex365em550). To ensure that porphyrin amplitude of fluorescence was 
not being affected by measurement angle, tissue turbidity or refractive index, the 
coefficient of fluorescent contrast (Kf) of porphyrin was also calculated according to 
previous methods179. 
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Biomarker amplitude values, ORR and NADH/porphyrin value and AUC values for 
each sample were collated in a master file spreadsheet using Microsoft Excel, alongside 
tissue opinion (1 = healthy, 2 = cancer). The study master file was imported to the 
analysis programme R Studio for statistical analysis. As populations were not normally 
distributed (this commonly occurs in tissue fluorescence spectroscopy), populations 
were compared using the analysis of variance (ANOVA) function in R Studio. 
Statistical analyses were performed to calculate the p value in every instance, with 
p<0.05 considered statistically significant. Non-inflamed and inflamed healthy tissue 
were compared by ANOVA for each parameter. No statistically significant differences 
were found between populations, therefore they were considered as a single population 
(healthy) for the purpose of this study. Data were log transformed during analysis to 
ensure better fit within Q-Q and residuals versus leverage plots. For factors with 
statistically significant differences between populations, bar charts were generated in 
Origin Pro 8 depicting the population mean +/- the standard error of the mean (SEM) 
for opinion (healthy vs cancer). In addition, for statistically significant factors, receiver 
operating characteristic (ROC) curves were generated using Origin Pro 8 analysis 
software to evaluate the diagnostic worth of each factor by comparing the 
sensitivity/specificity trade-off of a diagnostic parameter at different diagnostic 
thresholds. For ROC curves, AUC and asymptotic probability were calculated 
automatically, with AUC values ranging from 0.5 (worthless) to 1 (ideal).  
4.3 Results 
4.3.1 Analysis of fluorophore contribution to tissue fluorescence 
To assess the contribution of distinct tissue fluorophores to the overall fluorescence 
spectra received from tissue, 1M solutions of NADH, FAD and PpIX were studied 
using the LAKK-M system and superimposed over average fluorescence spectra from 
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healthy and cancerous tissue. Fluorescence spectra from 1M solutions of NADH and 
FAD, excited at 365nm, were superimposed over the tissue fluorescence spectra 
received at 365nm excitation (Fig. 74A). Fluorescence spectrum received from 1M 
solution of PpIX excited at 635nm was superimposed over tissue fluorescence spectra 
received at 635nm (Fig. 74B). Additionally, the blue fluorescence spectra were 
corroborated to arise from FAD fluorescence by fluorophore spectroscopy, however no 
significant differences were observed between the populations (p = 0.465, data not 
shown). Integrated green fluorescence spectra showed statistically significant 
differences between population types, but could not be corroborated by any of the 
studied fluorophores, so require further investigation. From Fig.74A it can clearly be 
seen that the spectral shape of tissue under 365nm excitation suggests a significant 
contribution from NADH (main tissue peak at 490nm) and FAD (shoulder peak at 
550nm), while fluorescence spectra of tissue under 635nm excitation (Fig.74B) suggests 
a significant contribution from porphyrins (main tissue peak 700-710nm). Slight 
differences in full width at half maximum between tissue and PpIX fluorescence may be 
explained by overlapping fluorescence from different forms of porphyrin in tissue. This 
observation may enable a better understanding of the contribution of individual 
fluorophores to the complex fluorescence spectra received from bladder tissue. It can be 
seen from Fig. 74A that the average fluorescence spectral intensity from healthy tissue 
is higher than that of cancer tissue, in keeping with previous findings (however, 
ANOVA analysis of UV AUC was not statistically significant). Differences in line 
shape of the UV spectra suggested possible differences in ORR values between 
populations. Furthermore, it can be seen from the average red fluorescence spectra that 
the intensity of fluorescence from cancer samples is almost double that of healthy 
tissue. AUC analysis confirms that this difference is extremely statistically significant. 
Cancer samples were further separated into CIS (n=6), SCC (n=7) and TCC (n=76) and 
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averages plotted alongside healthy and cancer average spectra for both 365nm 
excitation (Fig. 75A) and 635nm excitation (Fig. 75B). From these figures it can clearly 
be seen that cancer average spectra are largely dictated by TCC cases in both instances. 
CIS samples were found to display the lowest average intensity AUC values under 
365nm excitation, while SCC samples displayed the highest. Further observation 
indicates that the ORR was lowest in CIS samples.  
 
Figure 74 Comparison between healthy average (solid black line, n = 33) and cancer 
average (dashed black line, n = 89) under UV excitation (a) and red excitation (b). 
Figure 74a overlaid with spectra from 1M NADH (solid red line) and 1M FAD (dotted 
red line). Figure 74b overlaid with 1M protoporphyrin IX (solid red line) 
 
Figure 75 Comparison of healthy tissue fluorescence spectra (black line, n = 33) 
compared to cancer average (red line, n = 89) and cancer samples broken down into 
CIS (blue line, n = 6), TCC (magenta line, n = 76) and SCC (orange line, n = 7) 
Figure 76 depicts the standard deviation values of healthy and cancerous tissue under 
UV (76a) and red excitation (76b). From these figures, it can be seen that there was a 
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large deviation is fluorescence between samples. This has been accounted for when 
applying analysis.  
 
Figure 76 Average spectra +/- SD for healthy tissue (blue line +/- blue shading, n = 33) 
and cancer tissue (orange line +/- orange shading, n = 89) under UV (a) and red 
excitation (b) 
Figure 77 depicts the average fluorescence spectra of healthy and cancerous tissue under 
green (532nm) excitation, from which it can be seen that cancerous samples display 
increased fluorescence compared to healthy samples. From Figure 78, depicting the 
standard deviation values of green fluorescence of healthy and cancerous tissues, it can 
be seen that green fluorescence displays considerable deviation between samples. 
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Figure 77 Average fluorescence spectra of healthy bladder tissue (black line, n = 32) 
and bladder cancer tissue (red line, n = 89) excited using green (532nm) laser. 
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Figure 78 Average fluorescence spectra +/- SD values for healthy (blue line +/- blue 
shading, n = 32) and cancer (orange line +/- orange shading, n = 89) under green 
excitation. 
4.3.2 Fluorophore analysis 
Optical redox ratio (ORR) values for each sample were calculated and compared for 
statistically significant differences. The mean +/- SEM values for healthy and cancerous 
bladder tissue are depicted below (Fig. 79). No significant differences were found 
between populations for collagen, elastin, NADH or flavin intensities. A statistically 
significant difference in the ORR (ex365em490/ex365em550) can be seen between 
healthy and cancer tissue (p = 0.00891). This result is in keeping with previous finding 
of progressive reductions in the ORR of bladder cancer organoids in the lab as cancer 
grows and develops. The amplitude of fluorescence of porphyrins was recorded and 
analysed for statistically significant differences. The mean +/- SEM values for 
porphyrin fluorescence amplitude in healthy and cancer tissue are depicted below (Fig. 
79B). It can be seen from this data that porphyrin levels in cancer samples are greatly 
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increased compared to healthy samples. This difference was found to be statistically 
significant (p=0.00241). Calculation of Kf values from endogenous porphyrins also 
revealed a statistically significant difference of 0.0144 (data not shown), corroborating 
fluorescence intensity findings. Endogenous porphyrin levels may therefore present a 
useful biomarker for cancerous bladder tissue. From Fig.79C the average +/- SEM 
values for the NADH/porphyrin ratios for healthy and cancer samples can be seen. The 
difference between samples was also found to be extremely statistically significant 
(p=0.00624).  
 
Figure 79 Bar charts depicting mean +/- SEM for UV ORR (a); porphyrin amplitude of 
fluorescence (b) and NADH/porphyrin ratio (c) for healthy (white bars, n = 33) and 
cancer (light grey bars, n = 89). 
Furthermore, from figure 80, a statistically significant difference (p = 0.0392) can be 
seen in the integrated fluorescence intensity of healthy and cancerous tissue excited at 
532nm.  
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Figure 80 Mean +/- SEM values for integrated fluorescence intensity under green 
(532nm) excitation for healthy tissue (pale grey, n = 32) and bladder cancer tissue 
(dark grey, n = 89) 
 
4.3.3 ROC calculations 
ROC curves were generated for both UV ORR and endogenous porphyrin amplitude 
values to determine the diagnostic worth of these biomarkers for bladder cancer 
detection. Fig.81 below details these ROC curves. From Fig. 81A it can be seen that UV 
ORR (ex365em490/ex365em550) displays fair diagnostic worth for the detection of 
bladder cancer (AUC value = 0.64), however when comparing healthy samples to CIS 
samples alone (Fig. 81B), the AUC value increases to 0.83, indicating a much more 
promising diagnostic test. The accuracy of the CIS analysis is limited somewhat by 
small sample size (n = 6) so future studies would benefit from seeking to corroborate 
this finding. Considering porphyrins (Fig. 81C) the AUC value suggests a test with 
greater diagnostic worth than ORR for all bladder cancers (AUC = 0.71), at the expense 
of a reduced performance against CIS (AUC = 0.63). Finally, the ROC based on the 
Page 168 of 232 
 
Scott Palmer  July 2016 
ratio of NADH to porphyrins (Fig.81D) was found to have an AUC of 0.64. The AUC 
value for NADH/porphyrin detection of CIS was 0.69.  
 
Figure 81 ROC curves for UV ORR (a), UV ORR healthy vs CIS (b), porphyrin (c) and 
NADH/porphyrin ratio (d), including AUC values. 
4.4 Discussion 
The hypothesis at the onset of this research based on previous findings in organoid 
models (chapter 3) was that bladder cancer tissue would exhibit a reduced ORR 
compared to healthy tissue. Furthermore, owing to malfunctions in the heme 
biosynthetic pathway of cancer cells (the basis of PDD) and previous work by 
Aboumarzouk et al.112, it was hypothesised that it would be possible to detect an 
elevated level of endogenous porphyrins and a reduced NADH/porphyrin ratio in cancer 
tissue compared to healthy control. Results confirm these hypotheses. Firstly, it was 
demonstrated that tumours exhibit a reduced ORR (measured as 
ex365em490/ex365em550) compared to healthy tissue. This finding is in keeping with 
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previous findings in an organoid model of bladder cancer in chapter 3203, but in contrast 
with findings from cell lines alone in chapter 2. Most contemporary focus on the ORR 
suggests that the metabolic alterations which occur during cancer development skew the 
degree to which cancer cells use their electron transport chain, thus causing 
accumulation of the primary electron donor NADH in cancer cells. We ourselves have 
previously confirmed this finding in bladder cancer cell lines225, however the ORR has 
not been extensively covered regarding human bladder tissue. At the tissue level it may 
be considered that other fluorophores may contribute to the complex fluorescence 
spectrum obtained under UV illumination, such as the structural proteins collagen and 
elastin, however the spectral overlap of these proteins past 450nm has been shown to be 
minimal180. Previously, Mayevsky et al. used a similar system to the LAKK-M to study 
tissue NADH fluorescence up to 480nm207 so it is considered that this is the major 
contributing tissue fluorophore at 490nm. Comparisons between average tissue 
fluorescence under UV illumination and the endogenous fluorophores NADH and FAD 
seem to robustly confirm that these are the major contributing fluorophores to tissue 
fluorescence at this wavelength, however underlying contributions from collagen and 
elastin may account for the differences between healthy and cancerous tissue. No 
significant differences were found between populations for elastin/NADH or 
elastin/FAD (as were found in organoids), suggesting that this observation is largely a 
metabolic result. Previously, the potential of tissue remodelling and the catabolism of 
elastin and collagen in developing cancer was discussed as an underlying factor in the 
reduced ORR values seen in bladder cancer organoids compared with healthy 
controls203. It is possible that this phenomenon is also occurring in human bladder 
cancer tissue. Equally, the observed differences may be a result of altered metabolism in 
a variety of cell types, including not also cancer cells but also surrounding healthy 
urothelium and underlying fibroblasts. Previous research by Cicchi et al. using the ORR 
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observed an increased relative NADH content in bladder CIS in a small sample size. 
The difference between observations may stem from the equipment used (Cicchi et al. 
relied on fluorescence microscopy, while our system relies on spectroscopy) or may be 
a result of variations between patients. ROC curve analysis of the ORR suggests it 
displays some potential as a diagnostic tool, but is particularly effective at detecting CIS 
(based on a small sample number). CIS is commonly missed during WLC and displays 
malignant potential to progress into muscle invasive disease, therefore new techniques 
for its detection are crucial. Future studies should therefore seek to corroborate our 
findings regarding the ORR, with a particular focus on an increased population of CIS 
samples.  
Regarding porphyrin levels, the statistically significant increase in porphyrin levels in 
cancer tissue suggests a selective accumulation similar to that which is witnessed in 
PDD but without any need for PS administration. Furthermore, ROC calculations 
suggest that this biomarker possesses potential for diagnosis. One of the largest 
limitations to PDD is its reduced specificity. In particular, inflamed benign tissue is 
often recorded as cancer under PDD, owing to the leaky vasculature of previously 
treated tissue. This results in increased false positive rates and a large number of 
unnecessary invasive biopsies. That a statistically significant difference was observed in 
endogenous porphyrin levels between healthy (including inflamed tissue) and cancer 
suggests in future it may be possible to quantify porphyrin levels in non-sensitised 
tissue with the ability to discern between inflamed and cancer tissue. Increased 
endogenous porphyrin levels have previously been observed in renal cell carcinoma176. 
Similarly, iron levels (involved in the porphyrin biosynthetic pathway) have been 
shown to preferentially accumulate in mouse mammary tumours240 where they have 
been suggested to play a role in tumour cell survival and progression. Endogenous 
porphyrin fluorescence has previously been described in non-sensitised oral mucosa, 
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even in healthy tissue241. Oral mucosa possesses similar structure to that of the bladder, 
therefore it is considered that non-sensitised healthy bladder would likewise present 
some endogenous porphyrin fluorescence. In order to better exploit the tissue optical 
window and avoid fluorescence contributions from other fluorophores at lower 
wavelength (for instance, FAD and lipofuscin at 405nm), the secondary porphyrin peak 
at 635nm excitation/710nm emission was studied. This is in keeping with previous work 
in PDD of bladder TCC178 and in oral mucosa – in which identical measurement 
parameters observed increased endogenous porphyrin fluorescence in tumour tissue 
with small fluorescence signal from healthy tissue179. Average porphyrin fluorescence 
from both tumour and healthy tissue in this study was low compared with tissue 
fluorescence under UV excitation. In addition to intensity of porphyrin fluorescence, 
statistically significant differences in coefficient of fluorescent contrast (Kf) between 
healthy and cancer were observed, indicating that differences are due to porphyrin level 
itself rather than other factors such as tissue turbidity or refractive index. Previously, 
chronic hypoxia has been suggested as an underlying factor of increased porphyrin 
levels in oral mucosa179, therefore elevated porphyrin levels and reduced 
NADH/porphyrin ratio may reflect an effect of tissue hypoxia on the reduction of cell 
metabolic activity.  
One concern for the application of this technique is its low applicability to CIS 
detection. Similar to UV ORR measurements, expanding this pilot study to a larger 
study with a focus on larger CIS populations may allow us to better delineate porphyrin 
profiles in the disease. Theoretically, the use of longer wavelengths of light to 
investigate tissue should allow deeper penetration into tissue and the detection of a 
greater number of deeper lying tumours (for instance, CIS), therefore it may be that the 
metabolic perturbations resulting in increased porphyrin levels in obvious bladder 
cancer are not at play in pre-cancerous lesions. Finally, NADH/porphyrin levels were 
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observed to be decreased in cancer samples, in keeping with previous research 
findings112.  
In keeping with previous research in the field, average integrated UV fluorescence was 
greater in healthy tissue than in cancer, however this was not statistically significant. 
This could be due to the effects of tissue thickness on amplitude of fluorescence (which 
ranged from 2-15mm) and also angle and firmness of application of the diagnostic 
probe to tissue. Diagnostic ratios such as the ORR and NADH/Porphyrin ratio are less 
affected by these factors and are therefore more robust measurements for diagnosis. 
Therefore, in this study previous findings by ourselves203 and others112 have been 
corroborated and findings from other forms of cancer176 have been applied to the 
identification of a novel biomarker for bladder cancer (endogenous porphyrins).  
Green fluorescence displayed a statistically significant increase in cancerous tissue 
compared to healthy, therefore this may be a worthwhile avenue for future research. As 
it could not be corroborated with the fluorescence of any known fluorophore, green 
fluorescence was instead measured solely as integrated fluorescence intensity. Future 
work with a wider range of fluorophores may serve to better elucidate the contributing 
factors to tissue fluorescence excited using green light.  
As this was a pilot study of 20 participants, it would be of worth to expand this study 
with particular focus on diagnostic ratios such as ORR and NADH/porphyrins with 
particular focus on their applicability to CIS and early stage tumours. The LAKK-M 
system has not previously been used for the study of bladder cancer tissue, however 
understanding of the autofluorescence properties of bladder cancer113,114 and 
development of the LAKK-M for the study of individual fluorophore variability in 
healthy volunteers199 and its application to the diagnosis of cardiovascular disease205 
suggests its worth as a diagnostic tool. Furthermore, efforts are ongoing to better 
Page 173 of 232 
 
Scott Palmer  July 2016 
understand the tissue fluorescence by using tissue fluorescence simulation models242,243. 
The LAKK-M system also contains sources for LDF and TRO which have previously 
been assessed from a diagnostic perspective215. LDF has previously been used to 
identify and characterise interstitial cystitis214 while tumour hypoxia is a much-studied 
subject216, suggesting that identification and substantiation of suitable biomarkers of 
bladder cancer using the autofluorescence spectroscopy channel may allow the LAKK-
M system to be developed into an effective multi-functional diagnostic tool for bladder 
cancer. 
4.5 Conclusion 
In conclusion, this chapter has detailed a pilot study into the autofluorescence spectra 
across four different excitation wavelengths of healthy and cancerous human bladder 
tissue using the LAKK-M, identifying three main parameters with which to identify 
bladder cancer. These findings improve understanding of the contribution of several 
endogenous fluorophores to bladder cancer fluorescence spectra, identifying potential 
novel biomarkers with which to detect the disease. The LAKK-M system had not 
previously been used to study bladder cancer, however these findings present promise 
for the system to be developed into a multi-functional minimally invasive system for the 
diagnosis of the disease. The findings presented in this pilot study would benefit from 
corroboration in a large scale study, with particular focus on the discrimination of CIS.  
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5. LIGHT-OXYGEN EFFECT 
5.1 Introduction 
One of the benefits to the use of PDD for bladder cancer is that the areas in which PS 
agents are sequestered can also be killed via the generation of reactive oxygen species. 
This is known as photodynamic therapy (PDT) and where PDD relies on excited PS 
relaxing to ground state through fluorescence, PDT relies on the generation of reactive 
intermediates (Type I reactions) and singlet oxygen (Type II reactions) following 
excitation of PS agents to kill cancer cells. Sequestration of PS agents is caused by the 
enhanced permeability and retention effect due to leaky vasculature and hydrophobicity 
of tumour tissue238 while protoporphyrin IX accumulation is due to modifications to the 
heme biosynthetic pathway in cancer cells244. PDT is a useful therapeutic technique for 
surgical follow-up, especially in Mitomycin C and BCG refractive patients. Considering 
that the alternative for refractive patients is often radical cystectomy, PDT is an 
attractive alternative. Bladder anatomy is unique in that it can be assessed (and PS 
applied) using minimally invasive trans-urethral probes and catheters. Other, deeper 
lying tissues (such as kidney) often require surgery/laparoscopy to uncover. Conversely, 
skin cancer can be targeted completely non-invasively by topical application of PS43. 
Therefore, consideration must go into the design of imaging probes and irradiation 
sources for bladder cancer, defined by the strict dimensions of the urethra. The choice of 
PS agent defines the optimal administration route: PDT using 5-ALA and HAL can be 
achieved by oral administration (at the expense of potential systemic effects of PpIX), 
while hypericin can be instilled directly into the bladder, with selective tumour uptake 
occurring 15 minutes after instillation67. Type I reactions occur when excited PS agents 
rapidly transfer energy to molecular intermediates, which themselves generate ROS 
such as superoxide anion. ROS play a number of roles in the day-to-day function of 
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cells, ranging from homeostasis to immune defence. Normally they are counteracted at 
high levels by cellular anti-oxidants245, while low level ROS generation has been shown 
to play a role in cancer cell survival, promoting expression of pre-metabolic and pro-
angiogenic genes35. Type II reactions occur when excited PS agents interact with 
molecular oxygen, generating potently reactive singlet oxygen. Due to its inherent 
instability, singlet oxygen readily reacts with many electron-rich molecules, including 
fatty acids36, aromatic amino acids38 and the phosphate backbone of DNA37. Singlet 
oxygen was previously thought to have a very short half-life (40ns) and therefore a very 
short diffusion distance (20nm). Although this has recently been challenged246,247, it is 
generally considered that the cellular organelles in the location of singlet oxygen 
generation are its primary targets. The perfect PS agent is defined as having: high purity 
(to prevent adverse systemic effects); minimal dark toxicity (activation only in the 
presence of exciting light); preferential retention in tumours (to prevent damage to 
healthy tissue); low systemic toxicity together with swift pharmacokinetics (i.e. no 
accumulation in liver to cause systemic toxicity); high quantum yield and a strong 
absorption profile (to maximise photon efficiency and therapeutic efficacy). Dark 
toxicity can be expanded to include “non-specific toxicity”, that is, PS activation by 
light out-with therapeutic confines (such as sunlight). The development of PS agents 
with different desirable qualities has been a long running process over a number of 
years32. As discussed in previous chapters, clinical implementation of PDD has been 
hampered by its low specificity when compared to WLC17, the same is therefore also 
true for PDT. Lack of specificity of this therapeutic regime may cause damage and 
destruction of healthy tissue, contributing to patient morbidity. This issue has been 
tackled by developments in active targeting of tumours248, either via antibody tagging of 
PS agents against EGFR249 or p185250.   
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Delivery of PS agents to tumour cells has also been shown to be improved by the use of 
liposomes251 and modified nano-particles252, while quantum dots also show therapeutic 
and theranostic potential253,254, however concerns still remain about the systemic 
toxicity of these targeting and delivery agents.  
The activation wavelength of PS dye is another of the most crucial decisions to be made 
in PDT as it dictates tissue penetration and quantum efficiency of reactions. 
Conventional first generation PS agents such as 5-ALA have absorption maxima around 
400nm so are generally excited with blue light. Blue light has a number of advantages, 
including high relative energy compared to higher wavelength light, meaning a shorter 
irradiation period to obtain photosensitisation. Blue light unfortunately possesses 
comparatively low tissue penetration depths and high levels of scattering compared to 
light of higher wavelengths. The recently developed PS agent Hypericin has remedied 
this issue slightly, with absorption maxima at 540 and 590nm allowing excitation with 
longer wavelength green light67. To overcome the problems of limited tissue penetration 
and high scattering of low wavelength light in the blue and green regions, there has 
been considerable focus in recent years on two photon activated PS dyes (2P PDT). 
Activation of PS with two photons of infrared light at 700-800nm rather than one 
photon of UV/blue light at 350-400nm presented the opportunity of increased tissue 
penetration with less scattering and non-specific tissue damage. Unfortunately, early 
attempts at 2P PDT suffered from very low optical cross sections of absorbers, meaning 
a low efficiency for converting input photons to singlet oxygen generation. The 
consequence of this was a requirement of 6300J/cm2 over the course of a 4 hour 
irradiation period to kill 50% cancer cells in the study255. Recent work in the field has 
improved the optical cross section and thus efficiency of their absorbers almost ten-fold, 
presenting 2P PDT as a viable regime255.  
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Another issue of concern in PDT is the limited solubility of many PS agents. Tumours 
possess a number of physiological features which enhance their uptake and retention of 
PS compared to healthy tissue. The major issue is how to promote PS distribution 
through the bloodstream in the first place. First generation PS such as 5-ALA and HAL 
were known to suffer from low penetration owing to their low solubility, lipophilicity 
and tissue specificity. One of the largest groups of PS, phthalocyanines, suffers from 
severely limited solubility owing to the presence of phenyl groups in their chemical 
makeup. Hypericin has sought to offer improved tissue penetration compared with first 
generation PS but still requires chemical additives to heighten absorption, penetration 
and solubility. In particular, n-methyl pyrrolidone has been demonstrated as a useful 
adduct to PS agents to improve tissue penetration, even at concentrations of 0.05%256.  
Another possible solution to the issues of limited PS solubility and laser irradiation into 
tissue is the use of the light-oxygen effect, whereby infrared light at 1270nm is used to 
generate singlet oxygen in the absence of PS agents. Direct generation of singlet oxygen 
from 1270nm light irradiation was first demonstrated in the 1970s194. In the intervening 
years, it has been employed to assess effects on cells in aqueous solution257 and to 
directly target cancer cells. Recently, the light oxygen effect was discovered to induce 
cell death in the breast cancer cell line MCF-7197 independent of temperature effects. 
The absorption cross section of molecular oxygen was found to be 5 orders of 
magnitude weaker than conventional PS (suggesting a hugely energy inefficient 
process), however the threshold intensity of oxygen (4.6mM) required to induce cell 
death was in keeping with results using PS. Clinical implementation of light oxygen 
effect is still hampered by our limited understanding of the molecular mechanisms 
leading to cell death. This question has been partially answered using the cervical 
cancer cell line HeLa196, which was found to selectively accumulate ROS following 
1270nm irradiation compared to healthy control cells. This was hypothesised to be 
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caused by an impaired anti-oxidant machinery in the cancer cells. Patch clamp analysis 
on HeLa cells also revealed a differential calcium influx response to 1270nm compared 
to healthy cells, which may partially explain the differences in ROS accumulation due 
to the known feedback pathways between Calcium signalling and ROS. The application 
of light oxygen effect to bladder cancer therapy may be of use by improving on the low 
penetration of PS agents and activating light, however the dynamics of the process are 
still not fully understood.  
The aim of the research being undertaken in this chapter was to better elucidate the 
generation of singlet oxygen within bladder cancer cells, possible pathways of cell death 
and the effects of dose and fluence on cell viability. Preliminary results confirm the 
generation of singlet oxygen in aqueous media following irradiation with a 1270nm 
laser. Cell death analysis suggests, however, that any death observed in irradiated 
cancer cells is predominantly due to heating effects of the laser rather than the 
generation of singlet oxygen.  
5.2 Methods 
5.2.1 Cell culture 
The human bladder cancer cell line “5637” was purchased from ATCC and grown to 
75% confluence either in 12 well culture plates (VWR) or in #1.5 coverslip thickness 
bottomed petri dishes (Mattek) in Phenol red-free Dulbeccos’ Modified Eagle Medium 
(DMEM) (Life Technologies) containing 10% fetal bovine serum (FBS) (Life 
Technologies) and 1% penicillin-streptomycin (Sigma-Aldrich). Cells were grown in an 
incubator set to 37oC and 5% CO2. Prior to experiments, complete media was removed 
and replaced with serum free DMEM.  
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5.2.2 Laser Setup 
A fibre coupled InGaAs/InAs quantum dot 1268nm infrared diode laser (Innolume 
GmbH) was used. An optical fibre delivered the beam to the optics scaffold (lens, focus, 
filter disc) which was positioned 15cm above the irradiation platform. The maximum 
power output of the laser was 400mW and could be controlled by altering the drive 
current. The optical power was measured using an optical power meter (ThorLabs). The 
beam width was set to 2cm for all experiments. Cells in 12 well plates were irradiated 
for 1-30 minutes at irradiances of 100-400mW/cm2, yielding doses of 1.9J/cm2 to 
228J/cm2. Heating effects of laser were measured using a thermocouple implanted in 
media in one well of a 12 well plate during irradiation with doses ranging from 
1.9J/cm2 to 228J/cm2. Heating effects were also measured in a tissue mimic (pig 
bladder) using identical beam diameter and irradiation regimes. The setup was housed 
in a custom built platform and optical power was modified using a neutral density filter 
housed by the lensing apparatus. The laser setup is included below (Fig.82) and 
depicted in a schematic (Fig. 83) showing the lensing and filtering apparatus: 
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Figure 82 Basic experimental setup of laser showing laser diode connected to lensing 
apparatus via optical fibre 
 
Figure 83 Laser schematic showing optical fibre, diverging lens and neutral density 
filter. Approximate beam diameter at sample = 20mm 
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5.2.3 Irradiation of singlet oxygen sensor and cancer cells 
Dose was calculated, in J/cm2, as a function of optical power and exposure time as 
follows (equation 2):  
 
Equation 2 Calculation of dose applied to sample 
Therefore a beam of diameter 2cm covered circular area of 3.14cm2. Examples of doses 
achieved with a set beam width with varying optical powers and irradiation periods is 
included below (Table 10).  
Table 10 Examples of effects of optical power and irradiation period on delivered dose 
Optical power (W) Irradiation period (s) Dose (J/cm2) 
0.1 60 1.9 
0.1 120 3.9 
0.1 180 5.7 
0.4 600 76.4 
0.4 1200 152.9 
0.4 1800 229.2 
 
Singlet oxygen sensing dye anthracene 9-10 dipropionic acid (ADPA) was purchased 
from Abcam (Cambridge, UK) and prepared to a 10µM concentration (henceforth 
ADPA solution) in phosphate buffered saline (PBS) (Sigma-Aldrich).  
The fluorescence spectrum of non-irradiated ADPA solution was recorded by adding 
1ml solution to a matte black cuvette. ADPA fluorescence was excited using the UV 
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(365nm) laser source of the laser spectroscopy system LAKK-M (SPE-LAZMA, 
Moscow, Russia). 1ml solutions of ADPA were irradiated with 400mW optical power 
for between 5-60 minutes, yielding irradiation doses between 38-458J/cm2, after which 
they were added to matte black cuvette and UV excited fluorescence recorded between 
400-500nm (covering ADPA standard peaks). 1ml solutions of ADPA (1µM) were also 
measured following 5-60 minutes on the bench without irradiation, to determine 
background quenching of ADPA fluorescence. For apoptosis measurements, bladder 
cancer cell line 5637 was grown to 75% confluence in petri dishes as described above in 
serum free media and irradiated using 400mW optical power for 0, 10, 20 and 30 
minutes, yielding irradiation doses of 76, 153 & 229J/cm2, respectively. For trypan blue 
exclusion measurements, 5637 cells grown to 75% confluence in petri dishes as 
described above in serum free media were irradiated for 10 minutes at optical powers of 
100, 200, 300 & 400mW, yielding irradiation doses of 19, 38, 57 & 76J/cm2, 
respectively. For trypan blue measurements, serum free media was replaced with 
complete media following irradiation. In both cases, following irradiation, cells were 
returned to the incubator immediately following irradiation.  
To determine heating effects of laser, the sensor of a conventional thermocouple was 
attached to the inside of a well containing 1ml media. Media was irradiated for 4 
minutes using each optical power (100, 200, 300 and 400mW) in triplicate, using a new 
well for each measurement. The average measurement for each optical power was 
charted and used to calculate approximate appropriate temperatures for performing 
future temperature controls.    
5.2.4 Detecting apoptosis 
Five hours post-irradiation, serum free media was removed from irradiated cells and 
control. Cells were stained with 1nm solutions of Annexin V-Allophycocyanin (APC) 
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conjugate (Molecular Probes) and MitoTracker Green (Molecular Probes) in PBS and 
imaged using a Carl Zeiss 710 confocal microscope (Zeiss) using a 40x objective lens. 
MitoTracker fluorescence (green) was excited using a 488nm laser set to 50% power 
and recorded across 510-560nm using a photomultiplier tube (PMT). APC fluorescence 
(red) was excited using a 633nm laser set to 50% power and recorded across 660-
700nm using a PMT. The images were transferred to ImageJ for analysis and APC 
intensities from 50 cells from each sample were quantified for comparison.  
5.2.5 Detecting necrosis 
24 hours post-irradiation, media was removed from cells and cells were detached from 
wells using trypsin-EDTA solution (Sigma-Aldrich) and spun with cells in supernatant 
at 1500 RPM for 5 minutes. Cells were re-suspended in PBS to which live cell 
exclusion dye Trypan Blue (Sigma-Aldrich) was added in a 50:50 ratio. 10µl cell/trypan 
blue solution was injected under the coverslip of a VWR haemocytometer. 100 cells 
from each sample (4 irradiation regimes, each in triplicate) were counted by following 
conventional haemocytometer protocol and expressed as % viability. To account for 
heating effects of laser, cells grown following identical protocol were immersed for 10 
minutes in a water bath at 42oC, incubated, and assessed after 24 hours following an 
identical trypan blue staining protocol.  
5.3 Results 
5.3.1 Singlet oxygen generation in aqueous media 
ADPA kept on the bench for 1 hour without irradiation was found to have no effect on 
fluorescence at 365nm excitation (Figure 84). 1 hour irradiation of a 10mM solution of 
ADPA in PBS was found to induce a 4-fold reduction in fluorescence amplitude 
measured under 365nm excitation (Fig. 85), indicating production of singlet oxygen in 
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aqueous media during irradiation with the 1268nm laser. Progressive reduction in 
ADPA fluorescence with increasing irradiation periods suggests a dose-dependent effect 
of irradiation on singlet oxygen generation in aqueous media (PBS).  
 
Figure 84 Fluorescence spectra of 1uM solution of ADPA measured using UV 
excitation following preparation (black line) and following 30 minutes (red line) and 60 
minutes on bench without irradiation (blue line) 
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Figure 85 ADPA fluorescence recorded at 365nm excitation for 1ml ADPA solution 
irradiated for increasing periods 
5.3.2 Cell death analysis by Annexin-V expression  
To assess the effects of irradiation on apoptosis induction, Annexin-V was used to 
detect phosphatidylserine expression on cell membrane in non-irradiated (Fig. 86A), 
cells irradiated for 10 (Fig. 86B), 20 (Fig. 86C) and 30 (Fig. 86D) minutes with 400mW 
of optical power, imaged using a confocal microscope. Results indicate that irradiation 
does not induce any additional apoptosis compared to control sample (APC 
fluorescence was actually slightly elevated in control sample). Mitochondrial specific 
dye MitoTracker was used to stain cell mitochondria for imaging (green) and annexin-V 
was used to stain outer membrane (red). Future studies should utilise a positive control 
for apoptotic cell death, for instance a photosensitising dye.  
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Figure 86 Confocal microscopy of cells stained with MitoTracker Green (green) and 
Annexin V-APC (red): (A) non-irradiated control; (B) sample irradiated for 10 minutes; 
(C) sample irradiated for 20 minutes; (D) sample irradiated for 30 minutes 
5.3.3 Cell death analysis by Trypan blue exclusion dye 
To assess cell death at a later time point, cells were detached from culture wells and 
incubated with the dead cell dye trypan blue. Results indicate that increased optical 
power (100-400mW) with a set irradiation period (10 minutes) induces progressive cell 
death in bladder cancer cells (Fig. 87), however irradiation of cells for 4 minutes with 
400mW optical power causes a temperature increase of around 2.4oC, equalling roughly 
a 5oC temperature increase when extrapolated over 10 minutes (Fig.88). Comparison 
between cells irradiated at for 10 minutes with 400mW of optical power and a 
temperature control (heated water bath) reveals that the cell killing effects may be 
temperature dependent (Fig. 89).  
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Figure 87 Average +/- Standard deviation values for 3 measurements each of cell 
viability in control (blue) and following 10 minute irradiation at 200mW optical power 
(orange), 300mW optical power (grey) and 400mW optical power (yellow) 
 
Figure 88 Temperature increase in media irradiated for 4 minutes using 1268nm laser 
with set optical power of 100mW (black line), 200mW (red line), 300mW (blue line) and 
400mW (green line). Lines represent average of 3 measurements each. 
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Figure 89 Average +/- standard deviation values of 3 measurements each of cell 
viability for control (blue), for cells submerged for 10 minutes in a 42oC water bath 
(orange) and for cells irradiated for 10 minutes using 400mW optical power (grey) 
5.4 Discussion 
From the results presented in this chapter, it appears that 1268nm laser irradiation 
induces singlet oxygen generation in aqueous media. Analysis of ADPA fluorescence 
across increasing irradiation periods shows ADPA quenching suggestive of singlet 
oxygen generation in media. Control (non-irradiated) samples showed no observable 
decrease in ADPA fluorescence over time, although differences in ADPA concentration 
may cause slight discrepancies. Future studies should seek to corroborate these findings 
using identical ADPA concentrations, potentially measuring over longer time frames 
and with a greater number of time points to better elucidate the relationships between 
irradiation and singlet oxygen generation in media. Irradiation of bladder cancer cells 
was sufficient to cause limited cell death through necrosis, although this is likely 
attributable to the heating effects of the laser. This may be the result of an inherent 
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inability in the cell line used to undergo apoptosis, as depicted by Annexin V analysis. 
Future analysis would benefit from the use of a positive control for apoptosis when 
studying and measuring Annexin V – APC fluorescence. This could be achieved 
through an alternative singlet oxygen inducer such as a PS agent. The cell cycle 
regulator p53 (mutated in 5637 cells) is central to the regulation of cell growth and 
division. Intrinsic or extrinsic signals in malignant or infected cells are often enough to 
induce apoptosis, a tightly regulated process of cell death258, however many cancers are 
known to possess mutations in the tumour suppressor gene p53259. The escape from cell 
cycle checkpoints in bladder cancer, leading to invasive disease, is associated with p53 
mutation260. Previous work has demonstrated that 1268nm irradiation causes 
considerable increases in ROS levels and aberrations in calcium signalling within 
cancer cells. The high levels of ROS witnessed in cancer cells as an effect of 1268nm 
irradiation seem to be central to their death. The intracellular physiological 
modifications, together with the timing of cell death are suggestive of apoptotic cell 
death, although more work must be done to elucidate the distinct effects.  
The bladder cancer cell line 5637 is known to contain a p53 mutation (which results in 
its aberrant metabolic profile, as seen in chapter 2), therefore apoptotic signals may 
have no effect in this cell line. One other possibility for the negative results from 
apoptosis measurements could be dead and dying cells detaching from culture plates 
during or post-irradiation. As confocal microscopy analysis focussed solely on attached 
cells undergoing apoptosis, it is possible that a population of cells which had previously 
been killed were missed. In future, this may be remedied by developing a more elegant 
method for detecting and quantifying apoptosis, for instance using flow cytometry.  
In contrast to apoptosis, necrosis is considered to be an uncontrolled pathway of cell 
death suggestive of tissue destruction. Necrosis is caused by sudden disruption of the 
plasma membrane or lysosomes261. Cell death and therapeutic response suggest a role 
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for necrosis in tumour control post-PDT262. Necrosis causes immune infiltration by 
attracting immune cells and promoting their activation, however inflammation can be a 
double edged sword for cancer. Products of immune effector cells have previously been 
shown to promote malignant transformation of bystander cells263 along with cell growth 
and proliferation264. There is evidence of identical irradiation regimes with 5-ALA 
promoting apoptosis in some cell lines and necrosis in others42. Results from trypan 
blue dead cell dye analysis suggest that laser irradiation and the LOE induces a small 
decrease in cell viability, which may be attributable to necrotic cell death. An advantage 
to trypan blue inclusion analysis was the inclusion of cells in the culture supernatant. 
The result of this was that cells which had previously died and detached from culture 
wells were also accounted for during analysis. It is considered that cells killed by the 
temperature control would have died via necrosis as opposed to apoptosis, therefore the 
therapeutic ability of the LOE may be solely due to its effects on temperature of the 
culture media. Similarly to apoptosis measurements, trypan blue analysis would benefit 
from a positive control, for instance PS agents, to determine the efficacy of each regime. 
Calculations from irradiation measurements using a thermocouple indicate that 10 
minute irradiation of 1ml aqueous media with an optical power of 400mW would result 
in a local temperature increase in the region of 5oC, therefore a water bath at 42oC (5oC 
above body/incubator temperature) is a suitable temperature control. As expected, 
exposure to optical powers of 400mW causes greater heating of media than exposure to 
100, 200 and 300mW optical powers. Analysis of temperature changes indicates that 
this response is not dose dependent, however, therefore future investigation is required 
to determine the full heating effects of the laser on both media and tissue. To calculate 
the expected temperature increase after 10 minutes, results from measurements made 
over 4 minutes were approximately extrapolated, however response may not be entirely 
linear. This means temperature increase in media may be slightly more or slightly less 
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than 5oC. Future analysis should also better seek to account for acclimatisation periods 
on the bench, as the temperature control utilised in this study was considered as 5oC 
above incubator temperature (37oC). The mutagenic potential of necrotic environments 
suggests that the mode of cell killing (apoptosis vs necrosis) should be carefully 
balanced to avoid undesirable therapeutic results. 
In many instances, PDT may directly kill only a small proportion of tumour cells. A 
major driving force behind tumour clearance following PDT is its stimulating effects on 
the immune system265. Furthermore, PDT can induce rapid antigen specific responses 
on secondary insult266. Therefore, although only an approximately 5% cell kill was 
observed using LOE, it may be that the death of these cells would be sufficient to 
instigate a strong and long lasting anti-tumour immune response.  
Treatment regimens which maintain oxygen levels are generally demonstrated to lead to 
greater degrees of cancer cell death and tumour control267. Research by Anquez et al.197 
has demonstrated that low level but long period irradiation is suitable to induce 
morphological changes in breast cancer cells suggestive of cell death, possibly due to 
the oxygen sparing nature of this regime. It is possible that the fluences and fluence 
rates employed in this study were sufficient to generate singlet oxygen but also served 
to rapidly deplete oxygen levels in culture, therefore future studies may benefit from 
exploring the effects of irradiation regime on singlet oxygen generation. Low fluence, 
long exposure irradiation regimes are not directly applicable to bladder cancer therapy 
as the results would be substantial patient lay-up time. A balance must be struck, 
therefore, between fluences and fluence rates which are clinically feasible but also 
therapeutically effective. It would be of future interest to integrate a 1268nm irradiation 
source with a cell culture incubator, as done by Anquez et al., to determine the effects 
of long term exposure on oxygen levels and morphological response in cells.  
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There are a few additional experiments which may serve to improve the validity of these 
findings and to improve understanding of the effects of irradiation on cell death. The 
first, as already stated, is to utilise positive controls for apoptosis and necrosis 
experiments. This would allow assessment of the worth of the detection techniques 
utilised here.  
Secondly, as shown by thermocouple measurements, laser irradiation of media causes 
temperature increases which may cause non-specific killing of cells. In order to assess 
the wavelength dependence of irradiation on singlet oxygen generation and cell death, a 
control laser line could be employed. This may be achieved by directly irradiating 
ADPA and cells with a laser of similar wavelength which is outside the range to induce 
an oxygen spin transition (e.g. 1000-1100nm wavelength) at identical optical powers. 
Theoretically, irradiation of ADPA with a 1000nm laser using an identical setup should 
induce a similar temperature change without singlet oxygen generation, allowing 
observation of the effects of temperature on ADPA fluorescence (this could also be 
achieved with a water bath). Similarly, irradiation of cells with a control wavelength 
between 1000-1100nm would allow clear observation of the relative contributions of 
both temperature changes and singlet oxygen on cell death.  
Finally, to corroborate conclusively whether 1268nm irradiation acts via singlet oxygen, 
experiments should be performed in O2 free media, or in the presence of 
1O2 quenchers. 
Quenching could be achieved through the use of bovine serum albumin in media, for 
example. Both Anquez and Sokolovski proved the effects of laser irradiation in their 
experiments were cancelled out by the addition of singlet oxygen quenchers. 
Conversely, the effects of irradiation could also be observed in O2 enriched media. In 
the case of ADPA measurements, reductions in ADPA fluorescence following 
irradiation in the absence of O2 would suggest an unaccounted for effect to be 
considered in future experiments. Similarly, comparable cell death in the absence of O2 
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would suggest the role of irradiation induced singlet oxygen in cell death is minimal. 
This would point towards thermal effects as the significant contributor to cell death, 
which would be of limited worth therapeutically. 
As stated earlier, the application of tumour therapy must be specific to avoid unwanted 
destruction of healthy tissue. LOE has shown promise for the targeted ablation of 
tumour tissue through the generation of singlet oxygen, however care must be taken 
when applying this technique that the specific, singlet oxygen dependent effects of 
irradiation are separated from any non-specific destructive thermal effects. 
5.5 Conclusion 
 
To conclude, LOE has shown promise in previous studies for its ability to selectively 
kill cancer cells without the need for photosenstising dyes. The mode of action of 
therapy and its applicability to bladder cancer are still not known, however it could 
provide benefit for disease therapy in BCG/Mitomycin C refractive patients. Results 
included in this chapter indicate the following: 1268nm laser irradiation of aqueous 
solutions is suitable to induce dose dependent singlet oxygen generation; irradiation of 
cells is not sufficient to induce apoptosis; irradiation of cells may be sufficient to induce 
necrosis, however this is likely a result of the heating effects of the laser. Although early 
effects such as calcium signalling can be seen within minutes of irradiation, the cell 
death witnessed by Anquez et al.197 occurred only after up to 24 hours of continuous 
irradiation. The low optical cross section and quantum efficiency of singlet oxygen 
generation by the light oxygen effect suggests that in current form this is not a strategy 
which would lend itself well to bladder cancer therapy, owing to the time frames which 
would be needed for effective treatment. The benefits of the light oxygen effect are 
obvious: this would negate all issues regarding PS solubility, cost and patient lay-up 
time. The use of infrared lasers as excitation sources, as covered earlier, can 
Page 194 of 232 
 
Scott Palmer  July 2016 
theoretically double tissue penetration depth, greatly increasing the therapeutic potential 
of PDT. Complementarily, the design of small scale infrared diode lasers such as Nd-
YAG diodes and Ga-Al-As quantum well diodes now means that this could be achieved 
with compact, mobile irradiation sources. A major concern with the employment of the 
light-oxygen effect is an inability to selectively localise doses to, for instance, 
mitochondria or plasma membrane, meaning it may be difficult to specify pathways of 
cell death. As discussed, PS localisation and irradiation regime have profound effects on 
the expression of transcription factors and the expression of inflammatory molecules, 
which in turn effects the method of cell death. Much more work is needed therefore in 
how to selectively localise and optimise the administration of light and generation of 
singlet oxygen. It is suggested that future analysis of the light oxygen effect with 
regards to bladder cancer should focus on the following: the comparison of apoptotic 
processes in bladder cancer cells with and without p53 mutations; the effects of long-
term (>24 hour) exposure at low fluence rates and finally immune responses to LOE in 
representative animal models of bladder cancer.  
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6. TISSUE COMPUTER MODELLING 
6.1 Introduction 
One of the major limitations in the clinical application of autofluorescence spectroscopy 
to the detection of bladder cancer is an inability to reliably delineate the contributions of 
individual fluorophores to the complex fluorescence spectra obtained, especially under 
UV illumination. It is known that several integral tissue fluorophores possess similar 
fluorescence excitation and emission profiles (for instance collagen, elastin and 
NADH)180. The interference between the fluorescence profiles of elastin and NADH has 
previously been discussed as a potential underlying factor of the reduced optical redox 
ratio seen in bladder cancer organoids (chapter 3) and biopsy tissue (chapter 4). A 
system with which to determine the individual contribution of fluorophores to complex 
fluorescence spectra would therefore improve our knowledge of bladder cancer at the 
tissue and molecular level. In recent years, focus has turned to the creation of 
computational tissue simulation models based on measured optical properties of tissues 
and fluorophores of interest268-270. As the endogenous tissue fluorophores collagen, 
elastin, NADH and FAD possess known optical properties (optical cross section, 
quantum yield, absorption and fluorescence properties) and the layers of bladder tissue 
(mucosal and muscular) are easily measurable to obtain optical properties, theoretically 
there is potential to generate a computer model to delineate the contribution of each of 
these fluorophores to tissue fluorescence. The optical properties of human and animal 
tissue have previously been extensively reviewed, thereby providing data repositories 
for the design of such computer simulations198,271,272. This chapter details efforts to 
develop a computational model of light transport and autofluorescence in bladder tissue 
using TracePro software and the Monte-Carlo method. Results from theoretical 
modelling of fluorescence based on contributions from collagen and NADH show 
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strong similarity to measured experimental results, indicating that this methodology 
may be useful in future to further understanding of fluorophore properties in bladder 
tissue. 
6.2 Materials and Methods 
6.2.1 Literature Search 
Relevant medical literature was searched in PubMed to determine the optical properties 
of bladder tissue across a wavelength range of 360-1100nm. The parameters of interest 
for the research were the following: coefficient of scattering; coefficient of absorption; 
anisotropy factor. Results from literature search were used to approximate the physical 
properties of bladder tissue for simulation and modelling.  
6.2.2 Creation of tissue simulation 
TracePro optical modelling software (Lambda software) was used to generate a 2-
layered object (bladder simulation). The separate layers (mucosa and muscle) were 
endowed with their respective absorption and scattering properties recorded from 
literature search of optical properties of porcine bladder tissue (detailed in Table 13). 
The thickness of the mucosal layer was selected as 200µm, while the thickness of the 
muscle layer was selected as 2000µm. Tissue layers were populated with the 
fluorophores NADH (mucosal layer) and collagen (submucosal/muscle layer) at 
approximate concentrations recorded in measured tissue. The optical properties of 
collagen and NADH (absorption cross-section, absorption and emission maxima, 
quantum yield) were recorded from the relevant literature273-276. The Beer-Lambert law 
is used to calculate absorption of light by each layer of tissue (equation 3):  
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Equation 3 Calculation of tissue absorption of light using Beer-Lambert law 
Where Φ is the transmitted flux, Φ0 is the incident flux, µa is the coefficient of 
absorption and t is the sample thickness.  
Additionally, Fresnel’s law was used to account for the refractive index mismatch at the 
interface of the two tissue layers. The Henyey-Greenstein function was used as the 
scattering phase function (equation 4):  
 
Equation 4 Scattering phase function using Henyey-Greenstein function 
Where g is the anisotropy factor and θ is the angle of scatter.  
When the beam encounters a scattering medium it is spread to a random distance (x), 
defined by the probability distribution (equation 5): 
 
Equation 5 Probability distribution 
Where µs is the coefficient of scattering and x is a random value between 0 and 1.  
Fluorescence is modelled in TracePro by entering the parameters of relative absorption 
ab(λ) and relative extinction ex(λ) normalised to the molar extinction coefficient Kpeak 
and the relative emission em(λ). The concentration of fluorescent material in each tissue 
layer is set by entering the molar concentration Cmolar for each fluorophore, defined in 
previous literature273-276. Additionally, the coefficient of fluorophore absorption in 
media is determined by equation 6:  
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Equation 6 Coefficient of absorption 
The path length before absorption is calculated as: 
 
Equation 7 Path length before absorption 
The computer simulation model of bladder tissue constructed in TracePro was used as 
the medium for a Monte-Carlo light transport investigation. A source and detector were 
placed on the tissue surface replicating the dimensions of the LAKK-M system (source 
and detector diameters and source/detector separation distances). Fibre diameters 
(source and detector) were set at 100µm, with NA values of 0.22 each. The separation 
distance between source and detector was 1mm. A wavelength of 365nm was chosen for 
the incident light to closely approximate the dimensions of the UV source of the 
LAKK-M system.  
6.2.3 Experimental Comparison 
Pig bladder from freshly slaughtered pig was purchased from Medical Meat Supplies, 
Ltd. Tissue was dissected transversely to reveal the interior (mucosal surface) and 
rinsed with phosphate buffered saline (PBS). The probe of the LAKK-M was gently 
brought into contact with the mucosal surface of the tissue, after which the UV source 
was activated, spectrum was given 5 seconds to stabilise and was then recorded in the 
optics lab in darkness. In total, UV fluorescence spectra were recorded and averaged 
from 16 sites of the bladder across a wavelength range of 300-800nm at 0.2nm 
increments, recorded in custom built “LDF 3.1” software and exported. The average 
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measured fluorescence spectrum was imported to Origin Pro 8 software and plotted 
alongside the theoretical fluorescence spectrum received from Monte-Carlo modelling.  
6.3 Results 
6.3.1 Literature Review 
Optical properties of bladder tissue were found through a PubMed literature search, 
concerning light at wavelengths of 532nm, 633nm and 1064nm. Additionally, optical 
properties of pig tissue were found at a range of wavelengths during the literature 
search. The optical properties of tissue recorded from literature are included in Tables 
11 & 12, below. The values used for the final TracePro model are included in Table 13. 
Table 11 Optical properties of human bladder tissue 
Tissue Wavelength 
(nm) 
Absorption µa 
(cm-1) 
Scattering µs 
(cm-1) 
Reference 
Whole 532 0.27-0.71 1.28-3.3 277 
Whole 633 0.28-0.76 2.5-6.37 277 
Submucosa 633 1.4 88 271 
Submucosa 1064 0.4 116 278 
Mucous 1064 0.7 75 278 
Wall 1064 0.9 543 278 
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Table 12 Optical properties of porcine bladder tissue 
Tissue Wavelength 
(nm) 
Absorption µa 
(cm-1) 
Scattering µs 
(cm-1) 
Reference 
Whole 458 1.3 255 279 
488 1.4 248 
514 1.8 240 
532 3.5 277 
630 0.57 214 
630 0.99 258 
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Table 13 Parameters used for the generation of each layer in the Monte Carlo model, 
including thickness, coefficient of absorption, coefficient of scattering, anisotropy, 
fluorophore type, coefficient of fluorophore absorption, fluorophore optical cross 
section  and  molar extinction coefficient,  
Layer Thickness
es, μm 
n a, cm-1 s, cm-1 g Fluor
ophor
e 
s, 
cm-1 
ϕf εf, М-
1см-1 
Muco
sa 
200 1.5
5 
458 
nm 
1.3 458 
nm 
25
5 
0.9 NAD
H 
3.15 
 
0.0
5 
6220  
 488 
nm 
1.4 488 
nm 
24
8 
514 
nm 
1.8 514 
nm 
24
0 
532 
nm 
3.5 532 
nm 
27
7 
630 
nm 
0.5
7 
630 
nm 
21
4 
Muscl
e 
2000 1.5
5 
458 
nm 
1.3 458 
nm 
25
5 
0.9 Colla
gen 
0.9 0.3 52940 
488 
nm 
1.4 488 
nm 
24
8 
514 
nm 
1.8 514 
nm 
24
0 
532 
nm 
3.5 532 
nm 
27
7 
630 
nm 
0.5
7 
630 
nm 
21
4 
 
6.3.2 Monte-Carlo Modelling of photon transport in tissue 
Figure 90 below depicts results from Monte-Carlo modelling simulation of the transport 
of individual photons of UV light (365nm) through the mucosal and muscular layers of 
tissue. Photons entering tissue can either be reflected by tissue surface, transmitted 
through the full tissue thickness or be absorbed by the tissue constituent molecules. Fig. 
90a depicts a cross-section of tissue, while Fig. 90b gives a 3D view. From this 
simulation the maximum and median penetration depth of photons into tissue can be 
seen clearly. 
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Figure 90 Optical model of bladder tissue generated in TracePro: (a) cross section of 
tissue; (b) 3D simulation 
6.3.3 Comparison with measured fluorescence 
The predicted tissue fluorescence calculated at 365nm excitation from the TracePro 
model was plotted alongside the experimental tissue fluorescence measurement (Figure 
91). From Figure 91 similar features can be seen between the spectra, indicating a good 
fit of the theoretical model for bladder fluorescence.  
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Figure 91 Comparison of the measured UV fluorescence (black line) with theoretical 
fluorescence simulated from TracePro model (dotted black line) 
6.4 Discussion 
From the results presented in this chapter, it is shown that it is possible to 
computationally simulate a model of bladder tissue with similar optical properties to 
physical tissue. The use of this model allows the calculation of the maximum 
penetration depth of photons into tissue alongside the propensity for incident photons 
from the laser source to be scattered, reflected and absorbed by the individual layers of 
bladder tissue. In this work, only the average values for mucosal and muscle layers of 
bladder tissue have been studied. A common cause of disagreement in the field of 
autofluorescence spectroscopy is the effect of tissue thickening on recorded 
fluorescence118,280. Often, flat lesions can cause proliferation of urothelial cells. The 
result of this may be two-fold: a thickened urothelium may contain increased 
contribution from the metabolic cofactors NADH and flavins while simultaneously 
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dampening fluorescence signals from underlying structural proteins121. As demonstrated 
in this chapter, the maximum penetration depth of UV light in healthy tissue is 
approximately 1.4mm, therefore thickening of the urothelium in bladder cancer may 
further reduce the penetration of light deeper into tissue. It may be that urothelial 
thickening contributes significantly to the measured reduction in bladder cancer 
autofluorescence seen by many groups (ourselves included). Furthermore, urothelial 
keratinisation has been observed in bladder disease281, which may interfere with NADH 
and flavin fluorescence measurements282. The observations previously reported in 
organoid (chapter 3) and human biopsy tissue (chapter 4) still leave a number of 
questions which may be addressed through the use of tissue simulation models. Due to 
the complex nature of UV fluorescence spectra180, it is difficult to say whether the 
phenomena observed (reduced ORR in cancer organoids(ex365em490/ex365em550)) 
are a result of metabolic or structural modifications.  
Key to the application of this Monte Carlo model is the validation of code against 
simple geometries and phantoms of known optical properties. Due to unknown optical 
properties within tissue and also inhomogeneity of fluorophores, it is difficult to 
definitively state the applicability of a model. Before proceeding to further 
modifications, it is crucial to know whether the code and model employed for the Monte 
Carlo method is accurate. For diffuse reflectance measurements, human tissue 
mimicking phantoms can be generated using varying concentrations of haemoglobin 
embedded with polystyrene beads which scatter incoming light283. Similarly, 
fluorescence measurements could be performed on a phantom set with known, uniform 
concentrations of NADH or collagen. This would allow a direct assessment of the 
ability of the method to accurately report on increasing fluorophore concentrations. 
Multiple layer phantoms containing distinct NADH and collagen layers could then also 
be compared against relevant code. Validation is a crucial step of Monte Carlo 
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modelling, therefore this must be performed as a priority before moving forward with 
further testing. 
There are a number of additional adjustments which may serve to improve the accuracy 
and applicability of the model in the future. The first is to replace porcine tissue with 
human. Implementation of suitable equipment and methodology, including 
spectrophotometers and integrating spheres, would allow the measurement of tissue 
optical properties at wavelengths exactly matching the specifications of the LAKK-M 
system. Previously, the calculation of tissue optical properties from measured values has 
been described by using the inverse adding-doubling method284. Work is currently 
ongoing to optimise the use of TracePro simulations of bladder tissue243. 
Secondly, during slaughter tissue is exsanguinated. We have previously published on 
the absorptive and scattering effects of tissue blood supply199, observing a reduced 
autofluorescence signal in tissues rich in blood. Simulation of tissue vasculature in 
computer models may therefore allow a better insight into realistic light transport. 
Similarly, our model would benefit from the addition of additional fluorophores (such 
as elastin and flavins) to their respective tissue regions, and the addition of an extra 
tissue layer to reflect the region of connective tissue (rich in collagen) which lies 
between the mucosal and muscle layers. Finally, the LAKK-M system contains 4 
sources (UV, blue, green and red). The present model only accounts for UV light at a 
wavelength of 365nm, therefore the simulation and inclusion of light transport at the 
other wavelengths would be of value. It is extensively reported that longer wavelength 
light penetrates further into tissue owing to fewer scattering and absorption events44.  
In summary, the computational method described in this chapter is a useful technique 
for simulating the optical properties of tissue and studying parameters such as tissue 
autofluorescence, however this model must be validated.  
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6.5 Conclusion 
 
In this chapter, ongoing efforts to develop tissue mimicking computer simulations were 
discussed for the study of light penetration in bladder tissue to aid in the development of 
diagnostic and therapeutic techniques for bladder disease. A cross-sectional model using 
TracePro has been developed in this chapter which is capable of use for Monte-Carlo 
simulations of photon transport through tissue. Comparison of the theoretical 
fluorescence spectrum from our model shows a good fit with experimental 
measurements from fresh pig bladder, indicating that this is a useful model for future 
studies. Validation and development of this modelling technique, in conjunction with 
organoid development and larger scale biopsy analysis, may allow researchers to better 
understand the contributing fluorophores to healthy and diseased fluorescence spectra, 
improving clinical application of diagnostic ratios such as the ORR.  
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7. CONCLUSION AND FUTURE PERSPECTIVES 
 
The aim of this thesis was to explore new techniques for bladder cancer diagnosis and 
therapy, addressing current concerns with gold standard techniques. Bladder cancer is 
among the most common cancers in the UK, causing significant morbidity to sufferers 
and in the region of 5000 deaths per year1. WLC and VUC suffer from low sensitivity, 
particularly for the flat dysplasia CIS17. Efforts to improve sensitivity using PDD suffer 
themselves from reduced specificity, particularly for tissue previously treated by 
chemotherapy or surgery29. Autofluorescence spectroscopy of tissue has been suggested 
as a suitable technique to address the sensitivity-specificity disparity between these 
techniques ever since first being applied in the 1980s102. Autofluorescence spectroscopy 
and imaging has been covered for a wide range of diseases100, including bladder118, and 
has been shown to increase accuracy of surgical margin demarcation115. Despite over 30 
years of development, clinical application of autofluorescence imaging is still yet to 
occur. Reduced autofluorescence of tissue under UV excitation has been demonstrated 
by a number of research groups112,118, however this has largely been attributed as an 
effect of urothelial thickening. The roles of individual fluorophores of interest (collagen, 
NADH, flavins, porphyrins) in bladder cancer is still relatively unknown and presents a 
considerable gap in understanding in autofluorescence spectroscopy.  
In order to address this, I considered that the optical redox ratio (ORR) may be a useful 
technique with which to study bladder cancer and detect early cellular abnormalities, 
based on previous work in the field190,222. ORR imaging generally relates to metabolic 
abnormalities, rather than structural effects of bladder cancer such as tissue thickening - 
although this may be complicated slightly by spectral overlap from collagen and elastin 
- therefore it was hypothesised that it may provide increased accuracy for CIS detection.  
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The majority of this research has focused on the use of the multi-functional laser system 
“LAKK-M”, which contains a central functional unit for autofluorescence spectroscopy 
alongside sources for monitoring blood flow and tissue oxygenation. The LAKK-M 
system has previously been used to measure the effects of tissue properties on 
fluorescence199 and fluorescence parameters in cardiovascular disease205 therefore it 
could be of worth for bladder cancer. A strength of this system is the ability to measure 
multiple parameters simultaneously (for instance the effects of tissue blood flow on 
measured fluorescence parameters199), furthermore these measurements can be made 
non- or minimally-invasively. The LAKK-M system has not previously been applied to 
the study of bladder tissue, therefore a necessary first step in the clinical validation of 
this system was the study of bladder tissue across the cell to tissue level.  
In chapter 2, the LAKK-M system was demonstrated as suitable for the study of 
common endogenous fluorophores. ORR measurements from the LAKK-M 
(ex365em490/ex450em510, ex365em490/ex450em510 and ex365em490/ex365em550) 
approximately represent increasing relative levels of NADH, although more work is 
necessary to understand the non-linear response of the ORR. Autofluorescence 
measurements from the finger ensured that tissue fluorescence was achievable using the 
LAKK-M setup, making it applicable to bladder tissue for biopsy study. Findings from 
confocal microscopy and flow cytometry analysis on the ORR suggested that NADH 
and flavins were the major contributing fluorophores to cellular fluorescence, while a 
statistically significant difference (p = 2 x 10-16) in the ORR (measured as ex360em425-
475/ex488em515-545) existed between cell types, with cancer cells exhibiting an 
increased ORR relative to healthy bladder cells. In accordance with previous literature 
in other cancer types, bladder cancer cells were found to possess an increased ORR 
relative to healthy control. Unfortunately, this finding could not be replicated using the 
LAKK-M system. There are a few factors which may underlie this result: fluorescence 
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yield from cultured cells using the LAKK-M was very low, even using concentrations 
far above those hypothetically present in voided urine, therefore significant differences 
may have been lost as noise. Additionally, cells in solution showed significant 
variability in ORR values over time (both day-to-day and over 5-30 minute time spans). 
From variability measurements, it is concluded that the most stable ORR measurement 
using the LAKK-M system is NADH(ex365em490)/flavins(ex365em550). This may 
help to inform future studies of the ORR in tissue using the LAKK-M system. It is 
suggested that the use of increased laser powers (>30mW) and design of cuvettes which 
incorporate magnetic stir bars may overcome the limitations encountered in our research 
by increasing fluorescence yield from cells and providing uniform solutions for 
analysis.  
Preliminary analysis of human urine from a healthy volunteer indicates that the urine 
supernatant itself is responsible for the majority of fluorescence, as opposed to voided 
urothelial cells, therefore future studies may benefit from comparing the fluorescence 
parameters (including ORR) of voided urine from healthy participants and patients with 
bladder cancer.  
Flow cytometric analysis of ORR values may present some clinical worth itself. 
Statistically significant differences between cell types were observed based on a 
comparison of 30,000 cells each225. This figure is more in keeping with the normal 
concentration of shed urothelial cells. Furthermore, the generation of the redox 
overview allows for the identification of individual abnormal cells from large 
populations. The Warburg effect postulates that metabolic abnormalities in cancer cells 
occur early during cancer development, therefore this may be a technique with which to 
identify bladder cancer cells at an early stage. The flow cytometry setup is relatively 
straightforward and the use of diagnostic ratios means that system compensation is not 
required. Furthermore, measurements could feasibly be performed directly on shed 
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urine, leading to a completely non-invasive technique. As only a single bladder cancer 
cell type was compared with healthy control, future studies would benefit from applying 
similar measurement parameters to a wide range of bladder cancer cell lines of different 
stages and grades, to determine whether this phenomenon is universal. Following this, 
flow analysis of cells shed in human urine samples may allow the assessment of clinical 
implementation of the technique.  
A key step to the understanding of bladder cancer fluorescence is the ability to observe 
parameters as tumours grow and develop. For this reason, bladder cancer organoids 
were developed which were grown In vitro. Using these organoids, progressive changes 
were observed in the ORR (measured as ex365em490/ex365em550) and elastin/NADH 
and elastin/flavin ratios as organoids developed, compared to control samples. These 
findings may shed new light on how autofluorescence changes as bladder cancer 
develops. The findings of reduced ORR in cancer organoid are in contrast with findings 
from ORR analysis of cell lines in chapter 2. It is considered that this may be caused by 
a more complex network of cells (as scaffolds were not acellular) and the contribution 
of additional fluorophores such as collagen and elastin to tissue fluorescence spectra. 
Organoids were nonetheless useful for allowing the observation of progressive changes 
in fluorescence. Development of diagnostic algorithms in MATLAB revealed that ORR 
and elastin/NADH ratios both show considerable worth for discriminating bladder 
cancer organoid from healthy control tissue, therefore these ratios were explored further 
using human tissue. Human tissue biopsy analysis identified a significant increase in 
porphyrin levels in tumour tissue compared to healthy, therefore organoid data was 
revisited to assess if this was also the case. Unfortunately, no significant differences in 
porphyrin levels between control and organoid were observed. This may be a result of 
the lack of blood flow in the organoid experiments.  
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SHG analysis of organoid sections revealed significant changes in collagen volume and 
alignment in the extra-cellular matrix surrounding cancer cells. This may be attributed 
to cancer cells modifying surrounding collagen to facilitate invasion and to generate 
collagen nests to protect themselves from immune attack. The diagnostic user interface  
developed in MATLAB may be of use for surgical teams as it provides fast automated 
tissue classification based either on autofluorescence spectral features or collagen 
alignment features. This could be further developed for application to human tissue 
data. Combined autofluorescence/SHG imaging has previously been carried out in 
bladder96,98 and may allow us to better address the issue of urothelial thickening as a 
factor of autofluorescence discrepancies. Alongside the LAKK-M, it would be useful in 
future to apply an MPM system capable of autofluorescence and SHG measurements 
simultaneously to developing organoids to develop a better understanding of the spatial 
distribution of fluorophores of interest.  
This promising work would benefit from being corroborated using organoids 
comprising bladder cancer cells of various stages and grades. Comparison of organoid 
samples with human bladder samples also suggests that a method to improve the 
accuracy of the study would be a more thorough recapitulation of the urothelium in 
control samples as this would give a more life-like tissue representation. Equally, 
porcine bladder scaffolds may be replaced in future with excised human biopsy tissue as 
a more appropriate tissue mimic. Finally, organoid samples were exsanguinated 
therefore possessing no blood supply. This likely affected porphyrin measurements but 
may also have affected fluorescence amplitudes as average UV organoid fluorescence 
was found to be greater than that of average human tissue. As was previously discussed, 
tissue blood supply has an effect on measured fluorescence parameters199, possibly 
presenting a contributing factor to this fluorescence discrepancy. Future studies may 
therefore benefit from replicating tissue blood supply if at all possible.  
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Based on findings from organoid analysis, it was hypothesised that human bladder 
cancer tissue would possess a reduced ORR (measured as ex365em490/ex365em550) 
relative to healthy tissue. Results confirm this (p = 0.00891). In particular, the ORR 
displayed strong worth for the discrimination of CIS cases. ORR may therefore 
represent a useful novel biomarker of bladder cancer which is irrespective of tissue 
thickening. Again, this finding was in contrast to previous findings in cell lines. 
Similarly to organoid findings, the reduced ORR in cancer samples may reflect changes 
to a range of cell types, such as surrounding healthy cells and fibroblasts. Porphyrin 
levels were also found to be statistically significantly different in bladder cancer tissue 
(p = 0.00241). The increase in porphyrins in cancer tissue is suggestive of a selective 
accumulation similar to which occurs in PDD but without the need for PS. If true, this 
technique could provide a boost to bladder cancer detection by applying PDD 
methodology without the associated cost and patient lay-up time. Furthermore, the study 
of porphyrins at longer wavelengths into the tissue optical window may provide a 
technique with which to detect bladder cancer deeper in tissue. One concern with the 
application of porphyrin spectroscopy was its low accuracy for CIS. As this was a pilot 
study of 20 participants, it is recommended that a larger scale study will corroborate 
these findings, with particular focus on a larger sample size of CIS cases. SHG imaging 
of human biopsy tissue in future may also be a useful tool for understanding the 
complex role of collagen in developing bladder tumours and the effects of tissue 
thickening on fluorescence yield. In chapter 3, significant changes in the volume and 
distribution of collagen in bladder cancer organoids were identified (p = 2 x 10-16). SHG 
imaging of human tissue may allow a better understanding of this phenomenon and to 
identify whether findings in organoids can be replicated as reliable biomarkers in human 
tissue.  
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In parallel to autofluorescence diagnosis of bladder cancer, in chapter 5 the light oxygen 
effect was explored, following promising results published by other groups in breast197 
and cervical cancer196. The application of the LOE to bladder cancer would overcome 
current limitations to tissue penetration by PS agents and also activating light, by 
instead relying on the spin transition of molecular oxygen by 1268nm laser irradiation. 
Preliminary results show that 1268nm laser irradiation is capable of inducing singlet 
oxygen generation in aqueous media, however the effect of irradiation on bladder 
cancer cells is unconvincing. The results observed indicate that irradiation of cells 
induces a small amount of cell death through necrosis, although this is possibly 
attributable to the heating effects of the laser. Future analysis may benefit from 
focussing on analysis techniques which measure apoptosis and necrosis simultaneously 
(such as flow cytometry) to achieve a better understanding of the processes of cell death 
occurring post-irradiation. Previously it was discussed that limited cell death post-
irradiation may be a result of p53 mutations in the bladder cancer cell line used in the 
study. It would be useful to explore additional cell lines in future to determine whether 
this is the limiting factor. In chapter 5 the effects of PDT on immune priming and 
surrounding non-cancerous cells were discussed. It may be, therefore, that the small 
percentage of cells killed in our study may be sufficient to instigate a large scale 
immune response. Application of LOE in organoids, similar to those developed in 
chapter 3, may also provide some clues on the wide-scale effects of tissue irradiation. If 
heating effects are solely responsible for the cell death observed in this study, this 
technique may not be well suited to clinical application due to non-specific effects on 
surrounding tissue. Thermal ablation of bladder tumours has previously been explored, 
but has been ignored in recent years in favour of PDT.  
Many of the questions still surrounding autofluorescence spectroscopy of bladder 
cancer may be addressed by using tissue simulations such as that which was developed 
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in chapter 6. The model created in TracePro using relevant data from the literature 
demonstrated similar fluorescence parameters to fluorescence measured experimentally 
from fresh bladder tissue. This finding indicated some worth of the developed tissue 
simulation, although further validation is required. The crucial step to be taken before 
advancing any Monte-Carlo modelling studies is the validation of code against tissue 
phantoms of known optical properties and simple geometries (for instance, single 
layered phantoms with flat surfaces). Without this validation, modelling is speculative 
and provides little scientific and diagnostic worth, therefore this is recommended as a 
future avenue of work. Monte-Carlo modelling of tissue indicates that UV light at 
365nm travels significantly deeper into the bladder past the mucosa, suggesting that UV 
fluorescence is partly composed of fluorescence from structural proteins in the 
connective tissue. Modelling various tissue layers (mucosa, muscle, etc.) and simulating 
the presence of fluorophores such as NADH and collagen directly addresses the issues 
of tissue thickening in bladder cancer, leading to a better understanding of the 
contribution of individual fluorophores to complex fluorescence spectra. Accounting for 
measured values from organoid (chapter 3) and human biopsy tissue (chapter 4) will 
allow better understanding of the contributing fluorophores to these observations. 
Techniques such as the inverse adding-doubling method allow the calculation of 
coefficients of attenuation and scattering. Future biopsy studies would therefore benefit 
from simultaneous measurements of light absorption and transmission by tissue along a 
wide wavelength range in addition to fluorescence. This would allow generation of 
suitable patient specific tissue models. Similarly, tissue modelling may also allow a 
better understanding of the processes underpinning LOE at the tissue scale, giving a 
better understanding of the penetration of 1268nm light into bladder tissue, and the 
necessary optical powers to induce cell death at various depths of tissue.  
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Taken together these results contribute to a better understanding of bladder cancer at the 
cell and tissue level and will allow development of the LAKK-M system further 
towards clinical implementation. The ideal system for bladder cancer diagnosis would 
be sensitive, specific and non-invasive to overcome current limitations to WLC, PDD 
and tissue biopsy. Ideally, the system would also contain a therapeutic option. The 
LAKK-M system, with modification, could be a useful tool for minimally invasive, 
multi-parametric analysis of bladder cancer. The optical probe of the system could be 
easily modified to fit the dimensions of the urethra, while the multiple channels in the 
functional unit could provide simultaneous information about tissue autofluorescence, 
blood flow and oxygenation. In this thesis I have identified novel biomarkers for 
bladder cancer diagnosis (ORR and endogenous porphyrins) through organoid 
development and human tissue analysis. Crucially, these may represent potential for the 
diagnosis of CIS. Further analysis of more advanced bladder cancer organoids and in 
larger populations of human volunteers will help to corroborate and further 
understanding of these diagnostic biomarkers, while the use of tissue simulations may 
help to better explore the contributions from individual fluorophores to complex 
fluorescence spectra. Our results indicate that the LAKK-M at present is not suitable for 
cellular analysis, however modifications to cuvette design or laser power may make this 
a more feasible option. Further analysis of the ORR in bladder cancer cell lines using 
flow cytometry or fluorescence microscopy should provide a better understanding of 
autofluorescence at the cellular level. Urine autofluorescence analysis using the LAKK-
M may however provide useful information for future non-invasive diagnostic testing of 
suspected bladder cancer.  
One limitation to the LAKK-M system is an inability to provide tissue imaging. This 
would undoubtedly improve understanding of the individual fluorophores in bladder 
cancer. It is not unreasonable to envision in future a combined imaging and 
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spectroscopy system for fluorescence diagnosis of bladder cancer which provides an 
indication of whether fluorescence is cellular or extracellular and simultaneously 
calculates diagnostic ratios such as the ORR. Previously, MPM has been used to good 
effect in the study of bladder morphology and bladder cancer96,98 therefore it might be 
of worth to employ an MPM setup or similar in future iterations of the LAKK-M. MPM 
would provide image analysis of tissue fluorescence alongside SHG, which could be 
applied both to developing organoids and human biopsy tissue. Furthermore, the use of 
MPM exploits the tissue optical window, leading to deeper tissue penetration by 
excitation light. Finally, corroboration of cell killing effects of the LOE in bladder 
cancer could see the addition of a 1268nm laser source to the LAKK-M, resulting in a 
system which can both diagnose and treat bladder cancer with high sensitivity and 
specificity.  
In summary, bladder cancer is a common cancer in the UK which requires new 
diagnostic and therapeutic techniques to overcome the limitations of current gold 
standards. In this thesis I have explored the application of non-invasive diagnosis of 
bladder cancer across the cell to tissue level, identifying the following: 
1. A statistically significant increase (p = 2 x 10-16) in optical redox ratio (measured 
as ex360em425-475/ex488em515-545) in bladder cancer cell line (5637 cells)  
compared to healthy control cell line (HUC cells) 
2. Progressive changes in the autofluorescence properties of developing bladder 
cancer organoids, including reductions in the ORR (measured as 
ex365em490/ex365em550), elastin/NADH (ex365em450/ex365em490) and 
elastin/flavin ratios (ex365em450/ex365em550) of bladder cancer organoid 
relative to control. 
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3. Significant differences in the ORR, measured as ex365em490/ex365em550 
(decreased in cancer) and endogenous porphyrin levels (increased in cancer) 
between healthy bladder tissue and bladder cancer from human volunteers 
These findings will hopefully contribute to the development of new techniques with 
which to diagnose the disease at an earlier stage, reducing the rates of disease 
recurrence, progression and cancer deaths. With some modification, the multi-functional 
laser system “LAKK-M” could prove useful for the non-invasive diagnosis of disease.  
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